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Abstract 
Adrenal corticosteroids are involved in multiple aspects of homeostatic control. The 
early delayed ( <2h) action of glucocorticoids is mediated by rapid induction of mRNA 
and protein synthesis. Within this time -frame, glucocorticoids potently modify the 
electrical excitability of target cells through regulation of ion channels. Increasing 
evidence suggests that in neurones and endocrine cells, large conductance calcium - 
and voltage- activated potassium channels (BK channels) are important targets for 
glucocorticoid action. The aim of this thesis project was to investigate the 
mechanisms by which glucocorticoid hormones regulate the activity of BK channels 
in human embryonic kidney 293 (HEK 293) cells as the model system for 
glucocorticoid- action. It was shown that glucocorticoids act via endogenously 
expressed type II receptors in a concentration- and time -dependent manner in these 
cells. Dexamethasone (100 nM) had no significant effect on Dexrasl mRNA but 
significantly increased serum- and glucocorticoid- induced protein kinase 1 (SGK -1) 
mRNA. Biochemical analysis showed that SGK -1 protein is increased by 
dexamethasone in a Triton X -100 insoluble fraction. Further work was directed 
toward analysing the possible association of SGK -1 and protein phosphatases with 
two BK channel cc-subunit variants: ZERO -BK and STREX -BK, the latter contains the 
59 amino -acid splice insert encoded by the stress hormone induced exon (STREX). 
HEK 293 cells stably expressing the respective channel subunits were analysed. 
Immunoprecipitations with antisera directed against the BK channel cc-subunits 
showed that protein phosphatase 2A (PP2A) but not SGK -1 is constitutively 
associated with the STREX as well as the ZERO variant BK channel. Furthermore, 
the cytoplasmic C- terminal segment of the STREX -BK channel was necessary for 
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cell -surface expression of the channel and the association of the channel with PP2A. 
Dexamethasone failed to change the apparent amount of immunoreactive PP2A co- 
immunoprecipitating with the channel. In conclusion: SGK -1 but not Dexrasl is a 
protein rapidly induced by dexamethasone in HEK 293 cells. PP2A but not SGK -1 is 
in complex with both ZERO and STREX -BK channels, and dexamethasone does not 
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Chapter One 
An introduction to glucocorticoids 
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Chapter One 
An introduction to glucocorticoids and BK channels 
1.1: Introduction to glucocorticoids 
1.1.1: Generic mechanisms of glucocorticoid action 
Glucocorticoids (stress hormones) are synthesized and secreted by the adrenal cortex. 
Glucocorticoid hormones exert their effects through the glucocorticoid receptors (GRs), 
which belong to the superfamily of nuclear receptors that function as ligand- dependent 
transcription factors (Encio and Detera -Wadleigh., 1991; Carson -Jurica et al., 1990; 
Evans., 1988). The GRs mediate their effects in the body by altering gene expression 
in various tissues, e.g., lung, liver, bone marrow, immune system, and brain (De Kloet 
et al., 1998; Evans -Storms and Cidlowski., 1995; Schmid et al., 1995). 
In addition to nuclear glucocorticoid receptors, there is recurring evidence for fast, non - 
genomic actions of glucocorticoids in several systems (Falkenstein et al., 2000; Chen 
et al., 1999a; Sackey et al., 1997; Gametchu et al., 1993; Orchinnik et al., 1991), 
however, a receptor molecule that mediates such actions has not been characterised. 
1.1.2: The human glucocorticoid receptor gene and protein 
The human glucocorticoid receptor (hGR) gene is located on chromosome 5 and 
consists of 9 exons. Alternative splicing of the hGR gene in exon 9 gives rise to hGRcc 
and hGRß mRNA. Both mRNAs contain exon 1 -8 but different versions of exon 9 (9a 
and 913) that translate into highly homologous receptor isoforms hGRcc and hGR13, 
2 
respectively. The two isoforms of hGR are thus identical through to amino acid 727, but 
then diverge, with hGRa, having an additional 50 amino acids and hGRß having an 
additional, nonhomologous 15 amino acids at their carboxyl -terminal (figure 1.1) 
(Oakley et al., 1996; Hollenberg et al., 1985). hGRcc. is expressed in almost all human 
tissues and cells and represents the classic GR (a 777 amino acid protein) that 
functions as a ligand- dependent transcription factor, whereas hGRß does not bind 
glucocorticoids and inhibits the transcriptional activity of hGRa in a dose -dependent 
manner (Oakley et al., 1999; Oakley et al., 1996; Bamberger et al., 1996). 
The hGRoa is composed of three functional domains: 1) An amino -terminal domain 
(NTD), which consists of amino acids 1 -420 and contains a major transactivation 
domain, termed activation function (AF) -1. 2) A central cysteine -rich DNA -binding 
domain (DBD), which contains two zinc finger motifs through which it binds to a specific 
DNA sequence in the promoter region of target genes ( glucocorticoid response 
elements, GREs). 3) A carboxyl -terminal, ligand- binding domain (LBD), which contains 
amino acids 527 -777 (figure 1.1) (Oakley et al., 1996; Dalman et al., 1991; Carson - 
Jurica et al., 1990; Picard and Yamamoto., 1987; Beato et al., 1987). 
hGRoc forms a complex with two molecules of 90 kDa heat shock protein (hsp90) and 
several other proteins (figure 1.2) that act as negative transcriptional regulators 
preventing DNA binding of the receptor (Rajapandi et al., 2000; Bamberger et al., 1996; 
Pratt W. B., 1993; Dalman et al., 1991; Picard et al., 1990; Scherrer et al., 1990). 
3 
Figure 1.1 
Schematic representation of the structure of the human 
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Figure 1.1: Schematic representation of the structure of the 
human glucocorticoid receptor (hGR) gene and protein. 
Alternative splicing of the hGR primary transcript gives rise to the two mRNA and protein 
isoforms, hGRa and hGRß. hGRa contains an additional 50 amino acids after amino acid of 727 
while hGRß has an additional 15 amino acids after amino acid 727. The functional protein 
domains of hGR are DNA -binding domain (DBD); ligand- binding domain (LBD); amino -terminal 
domain (NTD). The numbered boxes represent the number of exons of the respective genes 
the size of the boxes is an indication of the relative size of the exons. 
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1.1.3: Mechanisms of glucocorticoid receptor action 
Entry of giucocorticoids into the cell and subsequent binding to the LBD of 
glucocorticoid receptor (GR) leads to a series of steps including: 1) Dissociation of 
hsp90 and other proteins from GR complex. 2) Dimerization of GR in the cytoplasm. 3) 
Translocation of the hormone -bound receptor to the nucleus. 4) High- affinity binding of 
the GR to glucocorticoid response element (GRE) which is found in the regulatory 
region of target genes. 5) The interaction of GRE -bound receptors with elements of the 
transcription machinery, resulting in the activation of gene transcription and induction of 
glucocorticoid- induced proteins (GIPs) (figure 1.2) (McNally et al., 2000; Bamberger et 
al., 1996; Becker et al., 1986). 
In contrast to genomic glucocorticoid action, nongenomic glucocorticoid effects (less 
than 15 min) are mediated by modulation of protein function reflecting changes in 
membrane physicochemical properties (Falkenstein et al., 2000; Chen et al., 1999a; 
Sackey et al., 1997), but the receptor molecular has not been characterised. 
The mouse mammary tumor virus long terminal repeat (MMTV -LTR) promoter has 
been used extensively as a useful model for studying the effects of GR on gene 
regulation since the beginning of the 1980s (Zhang et al., 2003; Hager et al., 2000; 
Leckie et al., 1995). The MMTV -LTR has six well- defined positioned nucleosome 
families, designated nucleosomes (Nuc A -F). Nuc A overlaps the TATA region and the 
transcription start site, and Nuc F is the farthest 5' to the transcription start site. Long 
terminal repeat in the MMTV genome is one of the prominent examples of GRE- 
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containing promoters (Cole et al., 1995; Beato et al., 1995; Hynes et al., 1981) which 
contains four GREs and is regulated by glucocorticoid hormones (Hynes et al., 1981). 
When MMTV integrates into the genome of a mammalian cell, it adopts a specific 
chromatin organization (Fragoso et al., 1995; Richard -Foy and Hager., 1987). 
The MMTV promoter is silent in the absence of hormone (i.e. agonist) and is activated 
by glucocorticoid hormones as well as progestins and androgens (McNally et al., 2000; 
Becker et al., 1986). 
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Figure 1.2 










Figure 1.2: Schematic representation of glucocorticoid action 
Genomic action of glucocorticoid hormones is mediated by passing the glucocorticoid hormone 
(G) through the plasma membrane and binding to the ligand- binding domain of the specific 
glucocorticoid receptor (GR). Upon glucocorticoid hormone binding, the glucocorticoid receptor 
undergoes an allosteric change, which results in dissociation from 90 kDa heat shock proteins 
(hsp90) and other proteins, leading to activation of GR. The activated receptor forms a 
homodimer and is translocated to the nucleus through the nucleopore. Inside the nucleus, the 
receptor complex binds to specific DNA response elements (glucocorticoid response elements, 
GREs) to activate gene transcription and result in increased mRNA and protein synthesis. In 
contrast, nongenomic action of glucocorticoid is mediated by altering the membrane 
physicochemical properties (Based on SIGMA -ALDRICH). 
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1.1.4 Biological effects of glucocorticoids 
It has been indicated that glucocorticoids regulate a variety of biologic processes and 
exert profound influences on many physiologic functions, including basal and stress - 
related homeostasis, growth and development, reproduction, the immune system 
including anti -inflammatory and immunosuppressive actions (Tsai et al., 1994; Munck 
et al., 1990; Munck et al., 1984). 
Glucocorticoids can also inhibit a few features of sympathetic function. For example, 
Glucocorticoids inhibit catecholamine release in response to some stressors 
(Komesaroff and Funder., 1994; Kvetnansky et al., 1993) and decrease cardiac 
norepinephrine turnover (Westfall and Osada., 1969). 
It has been determined that release of glucocorticoid into the peripheral circulation on 
response to stress is mediated through activation of the hypothalamic -pituitary- 
(HPA) axis. Increasing evidence suggests that these homeostatic mechanisms, such 
as the immune response, in turn directly modulate the activity of the HPA axis 
(Bateman et al., 1989; Munck et al., 1984). 
1.2 Introduction to the HPA and glucocorticoid inhibition of ACTH 
secretion 
Glucocorticoids are largely under the control of the HPA axis (De Kloet et al., 1998; 
Dallman et al., 1992). Activity of the HPA axis is regulated by many stimuli such as 
inflammation, pain, infection and stress. These stimuli cause excitation of the 
hypothalamus (paraventricular nucleus), which responds by releasing 41 amino acid 
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residue corticotrophin- releasing factor (CRF -41) and arginine vasopressin (AVP), to 
increase the secretion of adrenocorticotrophic hormone (ACTH, a 39 -amino acid 
peptide) from the anterior pituitary gland (Antoni., 1996; Antoni et al., 1992; Antoni, 
1986). 
ACTH enters the systemic circulation and binds to specific high -affinity receptors, a 
seven transmembrane domain protein, located on the surface of cells of the middle 
layer of the adrenal cortex (z. fasciculata). ACTH binding to its receptor in the adrenal 
cortex activates a guanine nucleotide binding protein (Gs protein) resulting in an 
increase of intracellular cyclic adenosine monophosphate (cAMP) and finally enhances 
the production of cortisol (corticosterone in rodents), the main glucocorticoid hormone 
in the body (Newton R., 2000). Glucocorticoids regulate their own production by 
negative feedback at several sites such as the hypothalamus and anterior pituitary 
corticotroph cell (figure 1.3) (De Kloet et al., 1998; Dallman et al., 1992). The anterior 
pituitary corticotroph cell is central to the integration of HPA axis function, and is a 
target for HPA axis feedback regulation by glucocorticoids (Jones and Gillham, 1988; 
Keller -Wood et al., 1988). 
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Figure 1.3 
Schematic representation of regulation of glucocorticoids by 
hypothalamic -pituitary- adrenal (HPA) axis 













Figure 1.3: Schematic representation of regulation of 
glucocorticoids by hypothalamic -pituitary- adrenal (HPA) axis 
Many stimuli including inflammation, pain, infection and stress cause excitation of the 
hypothalamus. The hypothalamus secretes 41 amino acid residue corticotrophin- releasing factor 
(CRF -41) and arginine vasopressin (AVP), which stimulate the release of ACTH from anterior 
pituitary corticotroph cells. ACTH drives the release of glucocorticoids from the adrenal glands and 
glucocorticoids regulate their own production by feedback inhibition of hypothalamic- pituitary- 
adrenal (HPA) activity at several feedback sites, including the hypothalamus and anterior pituitary 
corticotroph. 
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1.2.1 Mechanism of 41 amino acid residue corticotrophin- releasing factor (CRF -41) 
and arginine vasopressin (AVP) stimulated ACTH secretion 
At the level of anterior pituitary corticotroph cells, CRF -41 binds to a G- protein coupled 
receptor (GPCR) and activates GS protein (King and Baertschi., 1990; Taylor et al., 
1990), leading to elevation of cAMP which actives cAMP- dependent protein kinase 
(PKA) (King and Baertschi., 1990; Taylor et al., 1990; Reisine and Jensen., 1986; 
Reisine et al., 1985). 
It has been shown that in anterior pituitary corticotroph AtT20 cells, PKA inhibits the 
large conductance calcium- and voltage- activated potassium (BK) channels which 
results in sustained depolarization and enhanced secretion of ACTH (Shipston et al., 
1996). In addition, Cat+ influx through voltage dependent L -type calcium channels is an 
essential component of CRF -41- stimulated ACTH release in AtT20 cells (figure 1.4) 
(Childs and Burke., 1987; Luini et al., 1985). 
In addition to PKA, ACTH secretion is regulated by protein kinase C (PKC). In anterior 
pituitary corticotroph cells, PKC mediates the sustained phase of ACTH secretion 
stimulated by activation of the phospholipase C pathway by the hypothalamic 
secretagogue vasopressin (Oki et al., 1990; Carvallo and Aguilera., 1989). Vasopressin 
elicits a biphasic elevation of intracellular free calcium (Tse and Lee., 1998; Corcuff et 
al., 1993) and during the sustained phase of calcium influx stimulates PKC translocation 
and enhances PKC activity at the plasma membrane, an effect that is mimicked by the 
cell -permeant PKC- activating phorbol esters (Carvallo and Aguilera., 1989). 
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Figure 1.4 
Schematic representation of CRF -41 action in AtT20 cells 
Large conductance 
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Figure 1.4: Schematic representation of CRF -41 action in AtT20 
cells 
In anterior pituitary corticotroph AtT20 cells, CRF -41 activates adenylyl cyclase (AC) through 
stimulatory guanine nucleotide binding protein (Gs). AC produces cyclic adenosine 
monophosphate (cAMP) and activation of cAMP- dependent protein kinase (PKA). PKA inhibits 
large conductance calcium- and voltage- activated potassium (BK) channel, which results in 
sustained depolarization and enhanced exocytosis. On the other, PKA activates the voltage - 
gated calcium channels (L -type) and increases intracellular calcium and increases ACTH 
secretion (Modified from Antoni., 2000). 
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In AtT20 mouse corticotroph cells, phorbol -ester (an analogue of diacyl glycerol) - 
mediated activation of PKC has been proposed to exert effects both distal and proximal 
on voltage- dependent calcium influx, which may result from activation of different PKC 
isoforms (McFerran et al., 1995) to elicit ACTH release (McFerran et al., 1995; Clark 
and Kemppainen., 1994; Woods et al., 1992; Phillips and Tashjian., 1982). Intracellular 
free calcium measurements in AtT20 cells suggest that PKC- induced calcium influx 
results, at least in part, from inhibition of tetraethylammonium (TEA)- sensitive potassium 
conductances. This inhibition results in membrane depolarization and subsequent, 
indirect, enhancement of voltage -gated calcium influx (Reisine T., 1989; Reisine and 
Guild., 1987). 
In addition, glucocorticoids inhibit ACTH secretion evoked by activation of the PKA 
(Shipston et al., 1996) or the PKC (McFerran et al., 1995; Clark and Kemppainen., 
1994; Woods et al., 1992) signaling pathways. 
1.2.2 Glucocorticoid inhibition of CRF- stimulated ACTH secretion 
Corticosteroid feedback inhibition of the HPA axis is a key process in the maintenance 
of body homeostasis (De Kloet et al., 1998; Dallman et al., 1992) and is mediated at 
several sites such as the hippocampus, the hypothalamus and anterior pituitary 
corticotroph cells (figure 1.3) (De Kloet et al., 1998; Dallman et al., 1992). At the level 
of anterior pituitary corticotroph cells, glucocorticoid inhibition of CRF -stimulated ACTH 
secretion is best described as developing in two phases that involve distinct changes of 
gene expression (Dayanithi and Antoni., 1989). 
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Early phase: Occurring between 15 min to less than 3 h is a potentially generic 
mechanism of glucocorticoid action involving induction of de novo protein and mRNA 
synthesis. 
Late phase: occurring more than 3 h to days and involves suppression of differentiated 
cell function, including metabolism or ACTH synthesis and down regulation of CRF 
signaling pathways (Bilezikjian and Vale., 1983). 
1.2.3 Mechanism of early glucocorticoid inhibition of CRF -stimulated ACTH 
secretion 
It has been demonstrated that glucocorticoid hormones inhibit CRF- stimulated ACTH 
secretion directly at the pituitary level (Shipston et al., 1996; Oki et al., 1991). Shipston 
and co- workers demonstrated that BK channels are important targets of early 
glucocorticoid- mediated inhibition of CRF -stimulated ACTH secretion in anterior 
pituitary corticotroph AtT20 cells (Shipston et al., 1996). Patch -clamp analysis in AtT20 
cells revealed a significant and selective inhibition of BK channels upon activation of 
PKA by CRF. The synthetic glucocorticoid dexamethasone prevented PKA- mediated 
inhibition of BK currents and iberiotoxin (a highly specific blocker of BK channels) 
(Galvez et al., 1990) abolished early glucocorticoid- induced inhibition of CRF - 
stimulated ACTH release (Shipston et al., 1996). Thus in anterior pituitary corticotroph 
AtT20 cells, glucocorticoids inhibit CRF -stimulated ACTH secretion, by blocking PKA - 
mediated inhibition of BK channels. 
In primary cultures of rat anterior pituitary cells, the secretion of ACTH induced by CRF 
was markedly inhibited upon a 2 h exposure to 100 nM corticosterone. Application of 
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the broad specificity K+ channel blockers clofilium and astemizole produced no 
significant enhancement of CRF- induced ACTH release (Lim et al., 2002), but blocked 
the inhibitory action of corticosterone. In contrast, blockers of BK- channels such as 
TEA and charybdotoxin failed to influence the inhibition by corticosterone. In contrast 
to AtT20 cells, BK channels appear to have no pivotal role in glucocorticoid action in 
normal (rat) corticotroph cells. Thus, the unraveling of the glucocorticoid signaling 
pathway to BK channels as observed in AtT20 cells (Tian et al., 1998; Shipston et al., 
1996) and recapitulated in human embryonic kidney 293 (HEK 293) cells (Tian et al., 
2001b) should provide novel and valuable information as to the mechanism of action of 
glucocorticoid hormones. 
Summary: cAMP- dependent phosphorylations of L -type calcium channels as well as 
BK -type potassium channels are required for triggering the ACTH secretory response to 
CRF (Shipston et al., 1996; Luini et al., 1985). Proteins rapidly (within 2 h) induced by 
glucocorticoids acting via the type II GR block PKA- mediated inhibition of BK channels 
in pituitary corticotroph tumour cells. The action of the steroid is pivotal for its early 
inhibitory effect on the secretion of ACTH (Shipston et al., 1996); however, the 
mechanisms of this regulation are poorly understood. 
1.3 Introduction to BK channels 
The large super -family of potassium channels is a wide range of functionally and 
structurally diverse transmembrane ion channels responsible for conducting the 
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physiologically important cation, potassium (Coetzee et al., 1999; Brown A. M., 1993). 
Within this family, the calcium- activated potassium (Kca) channels are distinct due to 
their activation by elevation in intracellular free calcium with the subsequent potassium 
ion efflux contributing to cellular hyperpolarisation (Coetzee et al., 1999; Vergara et al., 
1998). Kca channels are sub -divided according to the relative potassium conductance 
into three sub -families (Coetzee et al., 1999); large (BK), intermediate (IK) and small 
(SK) conductance of Kca channels (Table 1.1). 
Table 1.1 
Relative conductances of the three Kca channel families 
KCa channel sub -family Abbreviation Conductance range gated by 
(picoSiemens, pS) 
Small conductance SK 2 -20 internal Cat+ 
Intermediated conductance IK 20 -80 internal Cat+ 
Large conductance BK 150 -350 internal Cat+ and 
membrane potential 
Table 1.1: At least three types of calcium- activated potassium (Kca) channels have been 
described including large conductance (BK) channels with conductance 150 -350 pS, small 
conductance (SK) channels with conductance 2 -20 pS, and intermediate conductance (IK) 
channels with conductance 20 -80 pS. 
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The BK (Maxi -K or Slo) channels have an unusually large potassium conductance, 
approximately ten -fold greater than other potassium channels, and are activated by 
both transmembrane voltage and intracellular free calcium levels (Sah and Faber., 
2002; Weiger et al., 2002; Gribkoff et al., 2001; Hu et al., 2001; Shi and Cui., 2001; 
Zhang et al., 2001; Toro et aL, 1998). In contrast, other Kca channels (IK and SK 
channels) are activated by calcium and not depolarization (Vergara et al., 1998) and K 
channels are sensitive to voltage but not calcium (Hong et aL, 2001). 
1.3.1 BK channel cc-subunit 
BK channels are assembled as tetramers (Quirk and Reinhart., 2001; Shen et al., 
1994) of pore- forming alpha (0- subunits encoded by a single gene, KCNMA1 (also 
referred to as SIo1) that undergoes extensive alternative splicing (TsengCrank et aL, 
1994). SIo1 homologues have been identified and described in numerous species such 
as mouse (Butler et al., 1993), chicken (Jiang et al., 1997), cow (Moss et al., 1996) and 
the human gene mapped on chromosome 10 (Pallanck and Ganetzky., 1994). 
1.3.1.1 Structure of BK channel oc- subunit 
BK channel x- subunits contain sequence similarities to voltage -gated potassium (Ku) 
channels in having six transmembrane helices (S1 -S6). The BK channel x- subunits 
have an additional transmembrane segment (SO) at the amino -terminal (N- terminal). 
The S5 -S6 transmembrane segments constitute the P -loop, which acts as the lining of 
the pore (figure 1.6) (Choe S., 2002; Doyle et al., 1998; Meera et al., 1997). The P- 
domain contains the sequence glycine- tyrosine -glycine (GYG), which has been termed 
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the K+ selectivity sequence (figure 1.5) (Heginbotham et al., 1994; Yellen G., 1987). 
The BK channel pore is suggested to exhibit distinct electrostatic and conformational 
pore properties resulting from unique aromatic and associated residues that provide 
proximal cation binding sites to maximise the ionic repulsion between fluxing potassium 
ion concentration for faster reactivity (Lagrutta et al., 1998). The P -loop shares 
sequence homology with other potassium channels and is the site of action of wide - 
spectrum potassium channel blockers such as TEA (Lagrutta et al., 1998). 
The S4 transmembrane segment of the BK channel ac- subunit contains positively 
charged amino acids that are conserved among voltage- dependent channels (Cui and 
Aldrich., 2000; Diaz et al., 1998) and is likely to function as the voltage sensor. 
Carboxyl -terminal (C- terminal) domain 
The cytoplasmic C- terminal domain of the BK channel ix-subunit protein constitutes 
-70% of the total protein mass. This domain is suggested to be soluble, cytoplasmic 
and to include four putative hydrophobic a- helices (S7 -S10) (Tanaka et al., 1997; Meera 
et al., 1997). The C- terminus contains two calcium- binding sites, the calcium bowl as 
well as the regulatory potassium conductance (RCK) segment, that are involved in 
activation of the BK channel by Cat+ (figures 1.5 and 1.6) (Jiang et al., 2002). The 
cytoplasmic C- terminal tail of the BK channel cc- subunit also contains five sites of 
alternative splicing (figures 1.5 and 1.6) (Coetzee et al., 1999). 
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Figure 1.5 
The amino acid sequence of BK channel STREX splice variant 
cc- subunit 
so 
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721 MRHDPLLIPG NDQIDNMDSN VKKYDSTGMF HWCAPKEIEK VILTRSEAAM TVLSGHVVVC 
S9 
781 IFGDVSSALI GLRNLVMPLR ASNFHYHELK HIVFVGSIEY LKREWETLHN FPKVSILPGT 
841 PLSRADLRAV NINLCDMCVI 
901 SQGFTPPGMD RSSPDNSPVH 
S10 
961 INNINE0 TAFAVSVLDS 
LSANQNNIDD TSLQDKECIL ASLNIKSMQF DDSIGVLQAN 
4 PKA ® Calcium bowl 
GMLRQPIITT GVNIPII 
LMSATYFNDN ILTLIRTLVT GGATPELEAL IAEENALRGG 
1021 YSTPQTLANR DRCRVAQLAL LDGPFADLGD GGCYGDLFCK ALKTYNMLCF GIYRLRDAHL 
1081 STPSQCTKRY VITNPPYEFE LVPTDLIFCL MQFDHNAGQS RASLSHSSHS SQSSSKKSSS 
50 
1141 VHSIPSTANR PNRPKSRESR DKQNRKEMVY R 
Figure 1.5: The amino acid sequence of BK channel STREX 
splice variant cc- subunit 
The murine STREX channel alpha (oc)- subunit sequence (NCB' accession number: AAD49225). 
The yellow boxes show the alpha helices, SO -S6 transmembrane helices and putative 
cytoplasmic helices S7 -S10. The triangles show sites of alternative splicing (1 to 5). PKA 
phosphorylation sites are showed by pink and the 59 residue STREX insert at splice site 2 is 
showed by green box. Calcium bowl and regulatory potassium conductance (RCK) domain are 
shown with gray box. 
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Figure 1.6 
Schematic representation of functional domains of the BK 
channel o- subunit 
4 
Figure 1.6: Schematic representation of functional domains of 
the BK channel cc- subunit 
The BK channel ix-subunit contains 7 putative transmembrane segments SO -S6. The pore - 
forming P -loop, containing the K+ ion selectivity signature, lies between segments S5 and S6 
while the S4 segment is the predominant voltage sensing domain. The C- terminal contains 
additional four hydrophobic segments (S7 -S10), two Cae+ regulatory sites (RCK and Cae+ bowl) 
and five established sites of alternative splicing (1 to 5). 
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Furthermore, the C- terminal of the cc- subunit also contains a structural motif (Leucine 
zipper, LZ) that was originally described in classes of DNA -binding proteins 
(Landschulz et al., 1988). It has been reported that LZ plays an important role in 
coordinating both the assembly of ion channels as well as their interaction with protein 
kinase and protein phosphatase signaling complexes. Tian and co- workers 
demonstrated that Leucine zipper 1 (LZ1) in the C terminus of mammalian BK channels 
(residues 513 -543) is required for the association and regulation of the channels by 
PKA, and other putative leucine zippers in the BK channel protein may provide 
anchoring for other regulatory enzyme complexes (Tian et aL, 2003). 
In addition, several accessory proteins and modulatory factors (section 1.3.4) like 
protein kinases and protein phosphatase, lipid, redox reagents and hormones directly 
or indirectly associate with, or exert influence through, the C- terminal domain (Lu et al., 
2006). 
Calcium bowl and RCK 
Each cc- subunit of the BK channel has a calcium bowl, which consists of 28 -amino acid 
residues and is located in the hyper -conserved region between helices S9 and S10 
(figures 1.5 and 1.6). The calcium bowl, a negatively charged, aspartate -rich motif was 
identified by mutagenesis (Wei et al., 1994) and exhibits homology with calcium- binding 
proteases (Moss et aL, 1996) and plasma membrane calcium pumps (Schreiber and 
Salkoff., 1997). The calcium bowl is involved in the modulation of the BK channel by the 
ubiquitous second messenger, Cat+ (Schreiber and Salkoff., 1997; Wei et al., 1994; 
Schreiber., 1992). 
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The C- terminal structure contains the regulator of RCK domain, a second potential 
regulatory element (figures 1.5 and 1.6) (Jiang et al., 2002). The RCK domain is 
implicated in calcium sensing by its analogy to homologous regions in other calcium - 
gated channels (Shi and Cui., 2001). 
It has been shown that most of the negatively charged residues of the Cat+ bowl and 
the RCK domain are aspartic acid, a key residue for coordinating Cat+ in Cat+ binding 
proteins (McPhalen et al., 1991). Mutation of five consecutive aspartate residues 
located in the Cat+ bowl (mSlo1 residues 897 -901) reduced the calcium sensitivity of the 
BK channels (Schreiber and Salkoff., 1997). 
The RCK domain contains three aspartate residues (D362, D367 and D369 in mSlo1) 
conserved in SIo1 forms. It has been shown that aspartate 367 is more sensitive to Cat+ 
as the mutations D362A and D369A each resulted in currents with Cat+ sensitivity 
similar to wild -type currents. In contrast, D367A produced a marked reduction in the 
ability of Cat+ to shift gating (Xia et al., 2002). 
It has been shown that BK channels can function as purely voltage -gated in the 
absence of intracellular free Cat +, but this requires high -voltage depolarization 
(Horrigan and Aldrich., 1999; Meera et al., 1997). In the presence of physiological 
intracellular free Cat+ levels, the voltage range of activation is shifted to more negative 
potentials that are physiologically relevant (Zhang et al., 2001; Jacquin and Gruol., 
1999; Moss et al., 1999; Meera et al., 1997). 
1.3.1.2 N- terminal domain 
As noted in section 1.3.1.1, the BK channels posses an additional transmembrane helix 
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at the N- terminus - SO -which is not found in other potassium channel proteins (figure 
1.6) (Toro et al., 1998). The N- terminal domain of the pore- forming c- subunit is crucial 
for interaction with modulatory beta (ß)- subunits of BK channels (Wallner et al., 1996). 
The study of Xenopus oocytes transfected with N- terminally truncated or C- terminally 
truncated forms of mouse Slo showed that open -time, conductance, and voltage 
dependence of BK channels are determined by the N- terminal core, whereas Cat+ 
sensitivity of the channel appears to involve a region of several negatively charged 
residues at the C- terminal core (Wei et aL, 1994). 
1.3.1.3 Splicing of the BK channel cc- subunit gene 
Alternative pre -RNA splicing is a mechanism that enables the generation of multiple 
proteins with divergent functional and regulatory properties from a single gene by the 
processing of the nuclear pre -mRNA into several discrete isoforms with distinct exon 
combinations (Grabowski and Black., 2001; Dredge et al., 2001). Alternative pre -mRNA 
splicing enables the generation of BK channel variants with distinct properties including, 
differences in calcium and voltage- dependence (Liu et al., 2002; Ha et al., 2000; 
Shipston et aL, 1999; Saito et al., 1997; TsengCrank et al., 1994), regulation by protein 
phosphorylation (Zhang et al., 2004; Zhou et al., 2001; Tian et al., 2001a), and other 
intracellular signaling cascades (Erxleben et al., 2002; Tian et al., 2001 b) as well as cell 
surface expression (Kwon and Guggino., 2004; Zarei et al., 2004). 
The cytoplasmic C- terminal tail of the BK channel rx- subunit is the region of the greatest 
diversity among BK channel isoforms due to the presence of five sites of alternative 
23 
splicing throughout the domain (figures 1.5 and 1.6) (Coetzee et al., 1999; TsengCrank 
et al., 1994). 
Distinct cc- subunit splice- variant mRNAs may be expressed in the same cell, 
differentially expressed between tissues, or even neighboring cells (Rosenblatt et al., 
1997; Navaratnam D. S., 1997), and dynamic modification of splice- variant mRNA 
expression (Xie and Black., 2001; Xie and McCobb., 1998) may result in altered BK 
channel phenotype and cellular regulation (Lovell and McCobb., 2001). 
The STREX insert 
Stress hormones including glucocorticoids and adrenal androgens are suggested to 
induce complex alternative splicing of BK channel mRNA to fine -tune chromaffin cell 
excitability and secretory activity (Lai and McCobb., 2002; Lovell and McCobb., 2001; 
Xie and McCobb., 1998) leading to the naming of the insert, STREX, for stress - 
regulated, or stress axis -related -exon (Xie and McCobb., 1998). STREX (a cysteine- 
rich 59 amino acid) inserts at splice site 2 in the C- terminal of the BK channel cc- subunit 
(figures 1.5 and 1.7) (Saito et al., 1997; Shipston et al., 1999). Channels containing 
STREX (STREX variant BK channels) are highly expressed in endocrine tissues such 
as the adrenal and pituitary gland, whereas ZERO variant BK channels (lacking a 59 
cysteine -rich amino acid splice inserts) are the predominant brain variant (Chen et al., 
2005; Shipston et al., 1999; Saito et al., 1997). STREX channels are more sensitive to 
the intracellular free calcium level than channels composed of the ZERO variant. Also 
cAMP- dependent PKA activates the ZERO variant channels, whereas it inhibits STREX 
variant channels (figure 1.7) (Chen et al., 2005; Tian et al., 2001 a). 
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Figure 1.7 
Schematic representation of STREX and ZERO BK channel 
cc- subunit splice variants 
N- terminal 
59 amino acids 
STREX 
4++++++ ++++++++44+++++++ +++++++ + +++++++++++++++++ +++++++"+ +4++++++++++44444 
4444+++ 4 4444+++++4++4+4++ 
STREX BK channel a- subunit 
splice variant 
C- terminal 






*1 + ++ +4444 ++ +4444 + +a C- terminal 
+ + + + + + + + + + + + + + + + + 
ZERO BK channel a- 
subunit splice variant 
Figure 1.7: Schematic representation of STREX and ZERO BK 
channel cc- subunits splice variants 
Full- length channel protein from the STREX BK channel a- subunit splice variant is identical to the 
ZERO variant protein except for the inclusion of the 59 amino acids STREX insert at splice site 2. 
PKA phosphorylation site in STREX variant BK channels is located in STREX insert at serine -4 
(S4strex) which shown with color box. 
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1.3.2 The beta (ß)- subunit 
Biochemical purification (Garcia -Calvo et aL, 1994) and co- immunoprecipitation (Knaus 
et al., 1994) of the BK channel complex have identified four individual ß- subunits that 
confer distinct regulatory influences upon BK channels activity. The BK channel 13- 
subunits are encoded by four distinct genes, KCNMB1 -4 (Uebele et al., 2000; Behrens 
et al., 2000; Brenner et al., 2000). The BK channel ß- subunits do not form ion channels 
when expressed in the absence of the ex-subunits, but alter the intrinsic properties of 
the BK channels, namely calcium sensitivity, gating kinetics and response to 
modulators like protein kinases (Ramanathan et al., 2000; Ramanathan et aL, 1999; 
Chang et al., 1997; Meera et al., 1996; Dworetzky et al., 1996; McManus et al., 1995; 
Garcia -Calvo et al., 1994). All four ß- subunits share a common topology of two 
transmembrane helices with intracellular termini, N- linked glycosylation and molecular 
weights between 25 -31 kDa ( Weiger et al., 2002; Weiger et al., 2000; Wanner et aL, 
1999). 
The ß1- subunit (KCNMB1) was identified as a protein associated with BK channels in 
smooth muscle membrane preparation and exhibits limited expression in the brain 
(Brenner et aL, 2000; Jiang et al., 1999; Saito et al., 1997; Meera et al., 1996; 
Dworetzky et aL, 1996; TsengCrank et al., 1996; McManus et al., 1995). Cloning and 
expression of and ß1- subunits revealed that while the cc- subunit forms a functional 
channel, co- expression of the ß1- subunit increases the sensitivity of the channel to Cat+ 
for a wide range of membrane voltages (Cox and Aldrich., 2000; Wallner et al., 1996; 
TsengCrank et al., 1996; McManus et al., 1995). 
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Co- expression of cc and ß2- subunit (KCNMB2) produces inactivating BK currents in 
several tissues including adrenal chromaffin cells (Weiger et aL, 2002; Weiger et al., 
2000) and pancreatic f3-cells where they are observed to modulate neurosecretion 
patterns (Xia et al., 1999; Li et al., 1999). 
The ß3- subunit is in enriched in the testes, pancreas and spleen (Xia et al., 2000) and 
has slight influence to enhance BK channel activation rates (Behrens et al., 2000). In 
contrast 134- subunit (KCNMB4) exhibits low expression outwith the nervous system and 
is enriched in brain tissue where it slows BK channel gating kinetics and modulates 
calcium sensitivity in a calcium- dependent manner (Jin et al., 2002; Weiger et al., 2000). 
1.3.3 The physiological roles of BK channels 
When BK channels are open, K+ flows out of cells through the open channels, driving 
the repolarization and hyperpolarization of the membrane potential. This change in 
membrane potential allows BK channels to control diverse physiological processes 
including regulation of vascular tone (Sausbier et al., 2005; Brenner et al., 2000), 
micturition (Meredith et aL, 2004), neuronal excitability (Sausbier et al., 2004; Shao et 
aL, 1999), innate immunity (Ahluwalia et al., 2004) and hearing (Ruttiger et al., 2004; 
Pyott et al., 2004). 
It has been indicated that BK channel activity is enhanced by increasing intracellular 
calcium and the incumbent hyperpolarisation is crucial to the negative feedback of 
calcium signaling, resulting in the termination of calcium entry by the closure of voltage - 
gated calcium channels (Robitaille and Charlton., 1992). Through this regulation, BK 
channels are critical to several secretory processes ranging from sweating to 
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neurotransmitter release. The BK channels of epithelial cells (Huang et al., 1999; 
James and Okada., 1994) are suggested to be integral to calcium- mediated 
transepithelial fluid secretion such as that of equine sweat glands (Huang et al., 1999). 
In endocrine tissues such as glomus and chromaffin cells, the blockade of the BK 
channels can elicit catecholamine secretion (Pardal et al., 2000). In AtT20 cells, BK 
channels are important targets of glucocorticoid- mediated inhibition of CRF- induced 
ACTH secretion (Shipston et al., 1996). 
1.3.4 Modulation of BK channels 
In addition to direct actions of Cat+ and voltage, the BK channels are subject to 
regulation by many cellular factors including protein kinases, protein phosphatases 
(section 1.3.4.1), lipids, nitric oxide, redox reagents, and hormones (see section 
1.3.4.2). These enable BK channels to react to and facilitate many physiological 
processes. Some of these regulatory mechanisms are described below. 
1.3.4.1 Protein phosphorylation 
Protein phosphorylation is one of the most common mechanisms of protein modulation. 
Numerous signal transduction pathways exert physiologically relevant actions by 
altering the activities of protein kinases and protein phosphatases thus controlling the 
reversible phosphorylation and subsequent functional regulation of target proteins 
(Levitan., 1999; Armstrong., 1989). Activated protein kinases induce the hydrolysis and 
transfer of the terminal phosphate of adenosine 5'- triphosphate (ATP) onto the hydroxyl 
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group of serine, theronine or tyrosine residue of specific, targeted consensus 
sequences. Protein phosphatases act in opposition, mediating the dephosphorylation 
of such residues. Although, some studies have indicated a direct influence of ATP on 
the activity of BK channels in the absence of protein kinase activation through 
mechanisms that is undetermined currently (Clark et aL, 1999), most investigators 
concur that the use of non -hydrolysable ATP analogues such as AMP -ANP has no 
influence on channel activity (Esguerra et al., 1994) This suggests a requirement for 
ATP hydrolysis in the regulation BK channels involving phosphorylation by native 
protein kinases (Esguerra et al., 1994). The reversibility of this modulation implicates 
the activity of protein phosphatases and thus indicates that reversible protein 
phosphorylation has a significant role in the regulation of BK channels (Zhou et al., 
2001; Tian et al., 1998; Esguerra et al., 1994). 
Intracellular signal transduction pathways that impinge on BK channels 
Several, distinct protein kinases are implicated as regulators of the activity of the BK 
channel including serine -threonine kinases such as cAMP- dependent protein kinase 
(Tian et al., 2004; Gong et al., 2002; Shipston et al., 1999; Klaerke et al., 1996; 
Shipston et al., 1996; Lee et al., 1995; Levitan., 1994; Esguerra et al., 1994; White et 
al., 1991), protein kinase C (Hall and Armstrong., 2000; Tian et al., 1999; Shipston and 
Armstrong., 1996), protein kinase G (White et al., 1993) and tyrosine -phosphorylating 
protein kinases (Ling et al., 2000; Wang et al., 1999). Equally, protein phosphatases 
(PP) such as PP1 and PP2A are implicated as modulators of BK channels (Widmer et 
al., 2003; Shipston et al., 1996; White et. al., 1991). As individual protein kinases and 
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phosphatases are regulated by distinct signal -transduction pathways, these findings 
demonstrate that several factors of physiological control converge on these ubiquitous 
ion channels. 
PKC is stimulated by phospholipids and calcium generated and released through 
inositol phospholipid hydrolysis via activation of phospholipase C (PLC) (Zhou et al., 
2001; Chik et al., 2001; Dekker and Parker., 1994). In many neurons (Doerner et al., 
1988) and endocrine cells (Hall and Armstrong., 2000; Tian et al., 1999; Shipston and 
Armstrong., 1996), PKC is a potent inhibitor of BK channel activity. In rat pituitary cell 
line (GH4C1 cells), PKC has been proposed to limit the maximal activity of BK 
channels, irrespective of the prevailing voltage and calcium conditions (Hall and 
Armstrong., 2000). 
Moreover, the BK channels are regulated by protein kinase G (PKG), which is 
stimulated by elevation of intracellular cyclic guanosine monophosphate (cGMP) 
following activation of soluble guanylyl cyclase (GC) isoforms by nitric oxide (NO) or 
activation of plasma membrane guanylyl cyclase receptors for peptides including atrial 
natriuretic peptide (Fukao et al., 1999; Alioua et al., 1998; White et al., 1993). 
Finally, PKA regulates the BK channels through intracellular cAMP concentration 
influenced by indirect hormonal modulation of membranous adenylate cyclase by 
several physiological processes and responses (Taylor et al., 1990; Flockhart and 
Corbin., 1982). Sequence analysis in combination with site directed mutagenesis has 
identified several putative phosphorylation target sequences within the or- subunit, 
particularly in the C- terminal domain (Toro et al., 1998; Alioua et al., 1998). Serine -942 
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(S942) of the drosophila BK channel was identified as a putative site of direct 
phosphorylation by PKA following the inhibition of the PKA- mediated response (Nara et 
al., 1998; Esguerra et aL, 1994). In mSlo, serine 869 (S869 which is the same of S942 
in drosophila) and serine4sTREx (S4STREX) were identified as targets of phosphorylation 
by PKA (Tian et aL, 2001a). It has been shown that splice variants of BK channels 
provide the diversity and plasticity of BK channel sensitivities to PKA, as cAMP- 
dependent PKA actives the ZERO variant channels by phosphorylation of the C- 
terminal PKA consensus site (S869) while cAMP- dependent PKA inhibits STREX 
variant channels by phosphorylation of (STREX)- specific PKA consensus site (S4STREx) 
(figure 1.7) (Tian et al., 2001a). Furthermore, cAMP- dependent PKA phosphorylation of 
S869 site in all four a.- subunits is required for channel activation while, inhibition of BK 
channel activity requires phosphorylation of only a single a- subunit at S4sTREx site (Tian 
et al., 2004). 
PKA and protein phosphatases 
BK channel proteins are regulated by PKA and protein phosphatases (PP2A/PP1) 
which are associated as a regulatory complex at the plasma membrane of excitable 
cells (Widmer et al., 2003; Shipston., 2001; Tian et aL, 2001 b; Hall and Armstrong., 
2000; Levitan., 1999; Wang et al., 1999; Reinhart and Levitan., 1995; Bielefeldt and 
Jackson., 1994; White et al., 1991). For example in mammalian pituitary tumour cells, 
somatostatin (an agonist of Gi- coupled receptor) increases the activity of BK channels 
through dephosphorylation of a cAMP- dependent phosphorylation site in the BK 
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channel protein or a closely associated regulatory molecule by one or more protein 
phosphatases (White et al., 1991). 
In rat cerebellar Purkinje cells, single -channel analysis from inside -out patches 
demonstrated that the activity of BK channels is regulated by multiple endogenous 
protein kinases and protein phosphatases present in the membrane patch (Widmer et 
al., 2003). The low activity phenotype BK channels in these cells were activated by 
PKA associated with the patch and the extent of PKA activation was limited by an 
opposing endogenous PP2A. Furthermore, PKA activation was dependent upon the 
prior phosphorylation status of the BK channel complex controlled by PP1 (Widmer et 
al., 2003). 
BK channels purified from rat brain and reconstituted in lipid bilayers showed two 
different biophysical and regulatory phenotypes: so- called type 1 and type 2 channels. 
Type 1 channels (fast gating, high sensitivity to charybdotoxin, activated by low Cat +) 
are stimulated by PKA and this effect was reversed by PP2A but not by PP1. Type 
2 channels (slower open and closed times, less sensitive to charybdotoxin and Cat +) 
are down regulated by PKA, an effect also specifically reversed by PP2A (Reinhart et 
a/., 1991; Chung et al., 1991). 
In many neurons and smooth muscle cells, PKA activates BK channels (Schubert and 
Nelson., 2001; Levitan., 1999; Lee et al., 1995; Reinhart et al., 1991), whereas in 
endocrine cells of the anterior pituitary gland, BK channels are inhibited (Shipston et al., 
1996; White et al., 1991; Sikdar et al., 1989). It has been demonstrated that in AtT20 
cells (Tian et al., 1998) and HEK 293 cells (Tian et al., 2001 b), the STREX BK channel 
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splice variant is potently inhibited by PKA activity intimately associated with the channel 
complex and the extent of PKA inhibition is limited by PP2A. 
Although BK channels are potently regulated by dephosphorylation by multiple protein 
phosphatases (Widmer et al., 2003; Tian et al., 2001 b; White et al., 1991), how these 
enzymes are targeted to BK channels is unknown. Dynamic interaction of protein 
phosphatases with the channel complex would provide an important mechanism to 
tune BK channel function and behavior. Thus, to further examine the association of 
protein phosphatase with BK channels, we examined the association of BK channels 
with protein phosphatase in HEK 293 cells. 
1.3.4.2 Other modes of regulation 
In addition to protein phosphorylation, many other factors influence BK channel activity 
such as Nitric oxide and glucocorticoid hormones. 
Nitric oxide (NO) 
The free radical gas NO is now recognized as a major messenger molecule that has 
diverse functions throughout the body (Hobbs and Ignarro., 1996; Furchgott and 
Zawadzki., 1980). Activation of cellular NO synthase generates production of 
endothelium- derived relaxing factor (Hofmann et al., 2000). This diffusible gas activates 
soluble guanylate cyclase (GC) inducing cGMP production and subsequent activation 
of PKG and regulates BK channels through phosphorylation (Hofmann et al., 2000). 
Inhibition of NO synthase reduces the BK channel open probability (Po) in rat smooth 
muscle cells (Ye et al., 2000). 
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Glucocorticoid hormones 
Increasing evidence suggests that glucocorticoids, via induction of de novo protein 
synthesis, can rapidly modulate multiple protein phosphorylation/ dephosphorylation 
cascades. For example, in hepatocytes glucocorticoids rapidly induce the p21 cyclin- 
dependent kinase (CDK) inhibitor that blocks CDK2 phosphorylation pathways (Cha et 
a/., 1998); in rat mammary epithelial cells, glucocorticoids upregulate the inducible 
serine /threonine kinase SGK -1 (Webster et al., 1993a) and glucocorticoids block PKC 
signaling in osteoblasts via a putative tyrosine phosphatase pathway (Hulley et al., 
1998). 
In neuroendocrine anterior pituitary corticotroph AtT20 cells, proteins rapidly (within 2h) 
induced by glucocorticoids block PKA- mediated inhibition of BK channel activity (Tian 
et al., 1998; Shipston et al., 1996). This action of the steroid was abolished by blockers 
of protein phosphatase 1/2A and mimicked by the catalytic subunit of PP2A (figure 1.8) 
(Tian et al., 2001b; Tian et al., 1998). 
Characterisation of the expression of BK channel subunits in AtT20 cells showed no 
evidence for [3-subunits and the predominance of the STREX splice variant cc- subunit 
(Shipston et al., 1999). Importantly, when the STREX variant cc-subunit was transfected 
into HEK 293 cells, the regulation by glucocorticoids was identical to that seen in AtT20 
cells (Tian et al., 2001 b; Tian et al., 1998; Shipston et al., 1996). This indicates that the 
same pool of genes is induced by glucocorticoids in mouse corticotroph tumour cells as 
well as HEK 293 cells. In addition, as mentioned above, increasing evidence suggests 
that the activity of BK channels is dynamically regulated by the interaction of protein 
kinases and phosphatases intimately associated with the channel complex (Reinhart 
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Figure 1.8 
Control of STREX BK channel splice variant by CRF -41 and 
glucocorticoid induced protein(s) 
Figure 1.8: Control of STREX BK channel splice variant by CRF - 
41 and glucocorticoid induced protein(s) 
In AtT20 corticotroph cells, CRF -41 binds to its receptor and activates Gs protein. Gs activates 
adenylyl cyclase (AC) which results in enhanced production of cAMP which actives PKA. PKA 
phosphorylation inhibits the STREX variant BK channel. Synthetic glucocorticoid hormone, 
dexamethasone, binds to intracellular type Il glucocorticoid receptor that regulates gene 
transcription from target gene and induces glucocorticoid- induced protein(s) (GIPs). The 
blockade of PKA- mediated inhibition of BK channel activity by GIPs presumably is a result of 
modified PP2A -like activity closely associated with the BK channel complex. 
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and Levitan., 1995; Levitan., 1994; White et al., 1993; White et al., 1991). As these 
phenomena are apparent in isolated patches of membrane, it is reasonable to 
hypothesize that they involve protein -protein interactions within tightly coupled 
signaling complexes including BK channel subunits. Identification of the BK channel 
complex as a target for glucocorticoid action should allow us to characterize 
glucocorticoid- induced proteins involved in ion channel regulation and provide further 
insights into the mechanism and role of rapid glucocorticoid regulation of excitability in 
neuroendocrine and neuronal cells. 
Thus taken together, we used HEK 293 cells as a model for a generic action of 
glucocorticoids involving protein phosphatase(s), which can influence the activity BK 
channels. 
1.4 Glucocorticoid -inducible proteins 
The rapid induction of serum and glucocorticoid- inducible kinase -1, SGK -1 (Chen et al., 
1999b; Webster et al., 1993a) and glucocorticoid- inducible Ras proteinl, Dexrasl 
(Kemppainen and Behrend, 1998) in several system raises the possibility that they may 
be glucocorticoid- induced proteins in HEK 293 cells and involved in regulation of BK 
channels. 
1.4.1 Dexrasl 
Dexrasl was identified as a dexamethasone -inducible member of the Ras superfamily 
of G proteins in AtT20 mouse corticotroph cells (Kemppainen and Behrend., 1998). 
Treatment of AtT -20 cells with dexamethasone for 30 min resulted in increased mRNA 
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for Dexrasl; the highest expression level appeared after 2 h of treatment (Kemppainen 
and Behrend., 1998). Dexrasl mRNA is expressed in a broad tissue distribution 
including brain, anterior pituitary, heart, kidney, and liver (Brogan et al., 2001; Tu and 
Wu., 1999; Kemppainen and Behrend., 1998). 
Dexrasl shares structural similarity with the Ras family of small molecular weight 
GTPases (Graham et al., 2001). It has molecular masses ranging from 30.2 to 33.4 
kDa, which is significantly larger than other Ras family members that are 20 to 24 kDa. 
The increased molecular mass can be accounted for by the presence of an extended 
carboxyl terminus variable region (Kemppainen and Behrend., 1998; Malumbres and 
Pellicer., 1998; Bourne etal., 1991). 
Orthologues of mouse Dexrasl have been reported, in human (GenBank Accession 
No. AF069506; (Cismowski et al., 1999) and rat (GenBank Accession No. AF239157), 
and share 98% homology with mouse Dexrasl. Human Dexrasl is located on 
chromosome 2q32. The most closely related paralogue of Dexrasl is human Dexras2 
and rat Dexras2 (GenBank Accession Nos. HS569D19 and AF134409) which share 
approximately 80% homology with human and mouse Dexrasl. Human Dexras2 is 
located at chromosome 22g13.1, and was identified as tumor endothelial marker -2, a 
potential regulator of tumor angiogenesis and revascularization (St Croix et al., 2000). 
Rat Dexras2 is also known as the ras homolog enriched in striatum due to a particularly 
high level of expression in that tissue (Graham et al., 2001; Falk et al., 1999). 
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The Dexrasl protein is activated by S- nitrosylation induced by neuronal nitric oxide 
(NO) synthase in brain (Fang et al., 2000). It has been shown that Dexrasl activation 
by neuronal NO synthase is enhanced in the presence of CAPON, neuronal NO 
synthase adaptor protein, (Fang et al., 2000). As mentioned in section 1.3.4.2, NO 
activates soluble guanylate cyclase (GC) induction cGMP production and subsequent 
activation of PKG regulates BK channels by phosphorylation (Hofmann et al., 2000). 
Inhibition of NO synthase reduces the BK channels open probability (Po) in rat smooth 
muscle cells (Ye et al., 2000) and it has been suggested that NO modulates BK 
channels via direct chemical modification of the cc-subunit of the channel or an 
associated protein (Ahern et al., 1999). These findings raise the possibility that the 
regulation of BK channel by NO involves Dexrasl. 
Human Dexrasl has been also identified as a receptor- independent activator of the 
Gi /Go family heterotrimeric G- proteins (hence its alternative name is activator of G- 
protein signaling -1, AGS -1) (Cismowski et al., 2000; Cismowski et al., 1999). 
Expression of AGS -1 in yeast and in mammalian cells results in the activation of Gi /Go. 
In addition, the in vivo and in vitro properties of AGS -1 are consistent with it functioning 
as a direct guanine nucleotide exchange factor (GEF) for Gi /Go (Graham et al., 2004; 
Cismowski et al., 2000). 
The induction of Dexrasl by glucocorticoids suggests that Dexrasl may represent a 
nexus between Gi- and glucocorticoid- dependent signaling pathways. 
It has been shown that Dexrasl inhibits adenylyl cyclase activity through 
ligand /receptor independent activation of Gi (Graham et al., 2004) and it also inhibits 
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cAMP- dependent secretion in AtT -20 corticotroph cells (Graham et al., 2001). 
Moreover, both glucocorticoids (Shipston et al., 1999; Shipston et al., 1996) and 
agonists of Gi- coupled receptors, such as somatostatin (Reisine et al., 1988; Luini et al., 
1986) inhibit stimulus -coupled ACTH secretion. Somatostatin appears to inhibit 
secretagogue -stimulated release of ACTH by multiple mechanisms including inhibition 
of adenylyl cyclase and voltage- dependent calcium current (Luini et al., 1986; Luini et 
al., 1985; Reisine et al., 1985), activation of a K+ channel (Pennefather et al., 1988), 
and direct blockage of secretion via a G protein (Luini and De Matteis., 1990). 
It also known that BK channels are important targets of glucocorticoid- mediated 
inhibition of CRF- induced ACTH secretion in AtT20 cells (Shipston et al., 1996).Taken 
together, it is justified to hypothesize that Dexrasl could mediate the glucocorticoid- 
dependent inhibition of ACTH secretion (a model for glucocorticoid action) via BK 
channels. 
1.4.2 SGK -1 
Activation of the glucocorticoid receptor by ligand binding directly regulates the 
transcription of several mediators, including SGK -1 (Mikosz et al., 2001; Webster et al., 
1993a). SGK -1 contains a catalytic domain that is approximately 45 -55% homologous to 
the catalytic domains of several well characterized serine /threonine protein kinases that 
are constitutively expressed such as protein kinase B (Akt/PKB), PKA, PKC and the rat 
ribosomal S6 protein kinase (S6K) (Webster et al., 1993a; Webster et al., 1993b). 
39 
It has been reported that SGK -1 mRNA expression is increased by glucocorticoid 
hormones in various cells including rat mammary epithelial tumor cells (Webster et al., 
1993a) and A6 cells (Chen et al., 1999b). In addition to glucocorticoids, SGK -1 
transcript levels have been shown to be stimulated in a tissue -specific manner by serum 
(Webster et al., 1993a), mineralocorticoids (Pearce., 2001; Wang et al., 2001; Chen et 
al., 1999b), osmotic changes (Waldegger et al., 2000; Waldegger et al., 1997), 
cytokines (Cooper et al., 2001; Cowling and Birnboim., 2000), ischemic injury of the 
brain (Imaizumi et aL, 1994), changes in cell volume ( Warntges et al., 2002; Klingel et 
al., 2000), chronic viral hepatitis (Warntges et al., 2002) and insulin and IGF -1, insulin - 
like growth factor 1 (Perrotti et aL, 2001; Kobayashi et al., 1999; Park et al., 1999). 
Furthermore, SGK -1 can be phosphorylated and activated by phosphatidylinositol 3 
(P13)- kinase (Gamper et al., 2002b; Park etal., 1999; Kobayashi et al., 1999). 
Function of SGK -1 
It has been proposed that SGK -1 participates in the regulation of epithelial transport 
(Wagner et aL, 2001, Lang et aL, 2000) cell volume (Bohmer et al., 2000), cell 
proliferation (Gamper et al., 2002a) and neuronal excitability (Warntges et al., 2002). 
SGK -1 has been linked to the function of ion channels, such as epithelial Na + channel 
(Wagner et al., 2001) and voltage -gated potassium channels involved in neuronal 
excitability (Warntges et al., 2002). It has been demonstrated that SGK -1 is a 
physiological mediator of aldosterone action in kidney cells (McCormick et al., 2005; 
Volk et al., 2001; Wang et al., 2001; Shigaev et al., 2000; Chen et al., 1999b; Naray- 
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Fejes -Toth et al., 1999). In cells of the ascending limb of Henle, SGK -1 phosphorylates 
the ubiquitin ligase Nedd4 -2, which causes a significant reduction in the interaction of 
this ligase with the epithelial sodium channel, resulting in the net mineralocorticoid- 
dependent elevation in epithelial sodium channel levels in the membrane of renal cells 
and increasing the epithelial Na+ absorption (Zhou and Snyder., 2005; Snyder et al., 
2002; Kamynina and Staub., 2002). 
Several observations point to a physiological role of SGK -1 in the regulation of 
potassium channels. Electrophysiological studies in HEK 293 cells (Gamper et al., 
2002a) and in Xenopus oocytes (Henke et al., 2004) showed that transfected SGK -1 
stimulates voltage -gated K+ channels. In a patch -clamp study, insulin -like growth factor - 
1 up- regulates outwardly rectifying whole -cell K+ current and this current is inhibited by 
potassium channel blocker (TEA), K,,1 channel blocker (margatoxin) and inhibitors of 
PI3- kinase (Wortmannin and LY294002). Moreover, this whole -cell K+ current is 
mimicked by overexpression of human SGK -1 (Gamper et al., 2002b). SGK -1 also up- 
regulates the activity of ROMK, renal outer medullary potassium, channels (Yoo et al., 
2003; Yun et al., 2002). 
Therefore, the rapid induction of SGK -1 mRNA in response to dexamethasone in 
several cells and regulation of potassium channel by SGK -1 together raise the 
possibility that SGK -1 may be a glucocorticoid- inducible protein in HEK 293 cells and 
could contribute to the regulation of BK channels. 
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Aims of this thesis 
Adrenal glucocorticoids are pivotal for adaptation to environmental challenge in a wide 
range of tissues including the central nervous and endocrine systems. In neurons and 
endocrine cells, potassium channels are important targets for glucocorticoid action. 
Proteins rapidly (within 2h) induced by glucocorticoids regulate the activity of BK 
channels in pituitary corticotroph tumour AtT20 cells, but the mechanisms of this 
regulation are largely not understood. The identification of the glucocorticoid signaling 
pathway to BK channels should provide novel and valuable information as to the 
actions of glucocorticoid hormones on ion channels. 
The present study aims to investigate the molecular mechanism of glucocorticoid 
action in HEK 293 cells. Chapter 3 investigates whether Dexrasl and /or SGK -1 are 
glucocorticoid- induced protein(s) in HEK 293 cells and associate with BK channels. In 
chapter 4, the assembly of the BK channel complex is investigated, with focus on the 
association of protein phosphatases with the channel cc- subunit. 
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Chapter Two 
Materials and Methods 
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Section 2: Materials and Methods 
2.1 Molecular biology solutions and reagents 
General molecular biology reagents used throughout this study were obtained from 
Sigma Chemical Company, except where stated otherwise. 
For autoclaving, solutions were autoclaved at 121°C for 20 min by ASTELL, model 
Number: ASA 240. 
2.1.1 depc- treated distilled water (depc -dH2O) 
0.05% diethylpyrocarbonate (v /v; depc) in distilled water (dH2O) 
2.1.1.2 Luria Bertani (LB) - broth 
20 g of LB broth (w /v, Sigma, L -3022) dissolved in dH2O to reach 1 litre final volume 
with stirring and sterilized by autoclaving. 
2.1.1.3 Luria Bertani (LB) - Agar 
35 g of LB Agar (w /v, Sigma, L -2897) dissolved in dH2O to reach 1 litre final volume with 
stirring and sterilized by autoclaving. 
2.1.1.4 Isopropyl- beta -D- Thiogalactopyranoside (IPTG) 
1 M IPTG (Calbiochem) prepared by dissolving 2.383 g in 10 ml of dH2O and stored at - 
20 °C. 
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2.1.1.5 DNA marker 
0.5 ,ug of 100 bp DNA marker (Invitrogen 15628 -019 or Biolab 3231S) or 1 Kb DNA 
marker (Biolab N3232S). 
2.1.1.6 Tris, Boric acid, EDTA (TBE) buffer 
10x TBE buffer: 0.44 mM Tris, 0.49 mM Boric acid, 16 mM EDTA (Ethylene Diamine 
Tetra Acetic acid, Gibco) in dH2O. Diluted as required. 
2.1.1.7 DNA loading buffer 
6x stocks prepared with 720 pl 50x TBE buffer (section 2.1.1.6), 330 pl glycerol and 
bromophenol blue, diluted to lx with dH2O and DNA for use. 
2.1.1.8 RNA marker 
4 pl of RNA marker (Promega, G319A) was used in agarose -formaldehyde gel. 
2.1.1.9 RNA gel buffer (MOPS /EDTA buffer) 
10x MOPS /EDTA: 0.2 M 4- morpho- linepropanesulfonic acid (MOPS), 50 mM sodium 
acetate (NaAc), 10 mM EDTA. Adjusted pH to 7.0 with 10 M NaOH and autoclaved. 
Diluted as required. 
2.1.1.10 Sodium Saline Citrate (SSC) 
20x SSC: 3M NaCI and 0.3 M sodium citrate in dH2O. Adjusted pH to 7.0 with 1 M HCL 
and autoclaved. Diluted as required. 
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2.1.1.11 Sodium Chloride- Sodium Phosphate -EDTA (SSPE) 
150 mM NaCI, 10 mM NaH2PO4 and 1mM EDTA in dH2O. Adjusted pH to 7.4 with 10M 
NaOH and autoclaved. 
2.1.1.12 Northern blot hybridization buffer 
50% v/v (50 ml) deionised formamide (Sigma F9037) + 5x SSPE (25 ml of 20x SSPE, 
section 2.1.1.11) + 0.1% w/v SDS (1 ml of 10% SDS, Sodium Dodecyl Sulfate) + 0.2 
mg /ml carrier DNA (2 ml of DNA 10mg/mi) + 1 mM EDTA (400 pl of EDTA 0.25 M) + 
10% w/v Sodium Dextran Sulfate (10 g) + 5x Denhardt's (10 ml of 50x Denhardt's: 5 g 
Ficoll + 5 g Polyvinylpyrrolidone (PVP) and 5% w/v BSA fractionV dissolved in 50 ml 
dH2O and filtered through 22 pm sterile filter). 
2.1.1.13 Protein marker 
4 pl of perfect protein marker 10 -225 kDa (Bioscience, 69079 -3). 
2.1.1.14 Phosphate Buffered Saline (PBS) 
137 mM NaCI, 2.7 mM KCI, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, adjusted to pH 7.4. 
2.1.1.15 Phosphate Buffered Saline + 0.1% Tween -20 (PBS -T buffer) 
PBS (section 2.1.1.14) supplemented with 0.1% (v /v) Tween -20. 
2.1.1.16 Western blotting buffer 
25 mM Tris, 192 mM glycine, 20% v/v Methanol. Adjusted pH to 8.3. 
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2.1.1.17 PSD (Phosphate SDS -DTT) 
Total concentration in samples: 50 mM Phosphate, 1% w/v SDS, and 91 mM 
Dithiothreitol (DTT). 
2.1.1.18 1% Triton X -100 lysis buffer 
150 mM NaCI, 50 mM Tris, pH 7.4, 1% Triton X -100 
2.1.1.19 4% Paraformaldehyde - 0.1 M sodium phosphate buffer 
For making 8% w/v paraformaldehyde, 8 g paraformaldehyde powder was dissolved in 
dH2O to reach 99 ml and added 1 ml of 1 M NaOH to total volume 100 ml. Then the 
solution was stirred on a hot plate, less than 65 °C, until the solution was virtually clear. 
Finally 50 ml of above solution was mixed with 20 ml of 0.5 M sodium -phosphate, pH 
7.3 and 30 ml dH2O. 
The solution was filtered over Whatman No. 1 filter paper and kept in dark bottle at 4 °C 
(maximum 1 week). 
2.1.1.20 Ampicillin (Amp) 
A stock solution of Amp 100 mg /ml in dH2O was diluted to 100 pg /ml in LB broth 
(section 2.1.1.2) or agar (section 2.1.1.3) for selection of bacteria expressing vector. 
2.1.1.21 Geneticin (G 418) 
A stock solution of 0.8 g /ml of G 418 (Calbiochem, 345810) in sterile Dulbeccos' 
Modified Eagle's Medium (DMEM, Gibco) was diluted to 100 mi in DMEM +10% v/v 
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FCS to reach total concentration 0.8 mg /ml. This solution was used to culture the HEK 
293 cells expressed with STREX -HA or ZERO -HA BK channel x- subunits. 
2.2 General molecular biology protocols 
2.2.1 General DNA analysis protocols 
2.2.1.2 Agarose gel electrophoresis 
1% agarose gels were prepared by dissolving 0.25 g agarose (electrophoresis grade, 
w /v; Invitrogen) in 25 ml depc -dH2O. Then 25 pl of 0.5 mg /ml ethidium bromide ( 
dissolved in 1 x TBE buffer) was added to 1% agarose gels. Gels were run on a 
Pharmacia gel electrophoresis apparatus (GNA -100) in 1 x TBE buffer (2.1.1.6). 
Samples were separated with 40 mA current for 25 min. 
2.2.1.3 Purification of DNA from agarose gels 
DNA bands cut from agarose gels were purified using the QIAGEN QIAEX II purification 
kit as per manufacturer's instructions. Briefly, the DNA band was cut from agarose gel 
and dissolved in QX1 buffer (3 volumes of buffer to 1 volume of gel) with 10,u1 of QIAEX 
II. Then the mixture was heated at 50 °C for 10 min to solubilise the agarose and bind 
DNA to QIAEXII resin. The solution was centrifuged for 30 sec. The pellet was washed 
with QX1 buffer (for removing residual agarose) and then with PE buffer (for removing 
salt contaminates). The pellet was air -dried for 10 -15 min at room temperature and then 
resuspended with 20 pl depc -dH2O (section 2.1.1) and incubating at room temperature 
for 5 min. The reaction was pelleted by centrifugation (Eppendorf centrifuge 5415 C) at 
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10,000 g for 30 sec and supernatant (contains purified DNA) was stored at -20 °C until 
use. 
2.2.1.4 Sub -cloning of DNA into PGEM -T Easy vector 
The PCR product was ligated into PGEM -T Easy vector following the manufacturer's 
instructions (Promega, A1360). The ligations were transformed into 100 ,uL of XL -1 
blue E. coli competent cells by heating at 42 °C for 45 sec. The ligations were recovered 
on ice for 5 min. The samples were diluted with 0.9 ml LB broth (section 2.1.1.2) and 
incubated by shaking (150 rpm) at 37 °C for 1.5 h. 100 pl of each transformation culture 
was plated in a LB /ampicillin /IPTG/X -Gal plates. The plates were incubated for 16 h at 
37 °C. Assessment of ligation transformation was determined by selection of white 
colonies and plating onto another LB /ampicillin /IPTG/X -Gal plates. The plates were 
incubated at 37 °C for 16 h. Then white colonies were selected for purification by alkaline 
lysis (2.2.1.6). 
2.2.1.5 Restriction digestion of DNA 
Restriction digestion is the process of cutting DNA molecules into smaller pieces with 
special enzymes called restriction endonucleases. These special enzymes recognize 
specific sequences in the DNA molecule and cut the DNA to produce restriction 
fragments. For restriction digestion of DNA, -1 ,ug of DNA was combined with 
endonuclease(s) in appropriate buffer (Promega). The mixture was incubated at an 
appropriate temperature and time for optimal endonuclease activity as recommended by 
the enzyme manufacturers. Samples were analysed by agarose gel electrophoresis. 
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2.2.1.6 Alkaline lysis: Plasmid DNA purification 
Mini- preparation 
Plasmid DNA was transferred in XL -1 blue E. coli competent cells in appropriate 
medium/ ampicillin (100 pg /ml) at 37 °C for 16 h. The solution was briefly spun and 
cellular pellet of bacterial was resuspended in 100 µl of resuspension solution (25 mM 
Tris /HCI pH 8.0, 10 mM EDTA, 50 mM Glucose and 20 mg Lysozyme) and incubated 
for 5 min at RT. Gently, 200 µl of lysis solution (0.2 M NaOH plus 1% w/v SDS) was 
added and incubated for 5 min at room temperature to lyse the bacterial cells. Then, 
150 µl of neutralization solution (3M sodium acetate, pH 5.2) was added gently and left 
on ice for 5 min to precipitate the plasmid DNA. The insoluble fraction, pellet, was 
removed by centrifugation at 10,000g for 5 min. 800 µl of 100% ethanol (v /v) was 
added to supernatant, incubated on ice for 15 min and spun 5 min. The pellet was 
resuspended in 200 µl dH2O and following phenol /chloroform (1/1) for separating 
aqueous plasmid DNA at room temperature for 5 min. The mixture was spun for 5 min 
and the supernatant retained. The phenol was removed by adding 200 µl chloroform 
and the supernatant was kept after spinning for 5 min. 20 pi of sodium acetate (3M) 
plus 500111 of 100% ethanol (v /v) were added to the supernatant and precipitated at 4 °C 
overnight. Following centrifugation (30 min at 10,000 g), the supernatant was aspirated 
and 70% ethanol (v /v) was added to the pellet for removing residual salt. The DNA was 
pelleted and dried at room temperature with 20 to 50 pi of dH2O after centrifugation. 
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Midi- and Maxi -preparation 
Midi- ( <200 Ng) or maxi- ( >200 ,ug) preparation of plasmid DNA were performed using 
the QIAGEN Midi and Maxi plasmid preparation kit, following the manufacturer's 
instructions ( QIAGEN). 
2.2.1.7 DNA quantification and determination of concentration 
Measurement of the optical density of a DNA solution at 260 nm, O.D260, allows the 
nucleic acid concentration to be determined. The ratio of O.D260/O.D280 was used as a 
measure of protein and phenol contamination with a value less than 1.5 indicative of 
high contamination. 
The total DNA was estimated from the absorbance of samples at 260 nm according to 
the following formula: 
[DNA] =A260 x dilution x 50,ug /m1 (1 A260 O.D. Unit for DNA = 50,ug/mI) 
2.2.2 General RNA analysis protocols 
2.2.2.1 Total RNA extraction 
Cells ( --107) were washed 3 times with cold PBS (section 2.1.1.14) and cells removed 
from the flask using Hanks' Buffered Salt Solution (HBSS, GIBCO, 2007 -3) + 0.1% 
EDTA. Cells were pelleted at 200 g for 10 min. The cells were incubated with 1 ml 
TRlzol ® Reagent (phenol /guanidine isothiocyanate, Invitrogen, 15596 -026). The cells 
were incubated at room temperature for 5 min in order to lyse the cells and dissolve the 
DNA in phenol. 0.2 ml of chloroform + isoamylalcohol (24:1) was added and gently 
shaken for 15 sec and left at room temperature for 3 min. After spinning at 10,000 g for 
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15 min at 4 °C, the supernatant (total RNA) was separated from DNA, proteins and 
lipids. The RNA was precipitated with 0.5 ml isopropanol and incubated at room 
temperature for 10 min. The pellet (RNA) was pelleted by centrifuging at 10,000 g for 10 
min at 4 °C. The pellet was washed with 75% ethanol by gently vortexing and spun at 
10,000g for 5 min. The pellet (RNA) was air -dried at room temperature for 10 min. The 
RNA was resuspended in an appropriate volume of depc -dH2O (section 2.1.1) and 
incubated at 60 °C for 10 min. 
The total RNA was estimated by calculation of the absorbance of samples at 260 nm 
according to the following formula: 
[RNA] =A260 x dilution x 40,ug /ml (1 A260 O.D. Unit for RNA = 40,ug/m1) 
The pure RNA was considered using A260/A280 with the ratio 1.8 to 2.0. 
To the remaining RNA, the RNA was mixed with 350 pl depc -dH2O + 40,u1 3M sodium 
acetate pH 5.2 and 1 ml absolute (100 %) alcohol. The mixture was centrifuged at 
10,000 g for 15 min and stored at -70 °C. 
2.2.2.2 RT -PCR 
For Reverse Transcription -Polymerase Chain Reaction (RT -PCR), HEK 293 cells were 
seeded into 75 -cm2 flask and allowed to reach 80 -90% confluence. RNA was isolated 
using TRlzol ® Reagent (section 2.2.2.1). Total RNA from HEK 293 cells was used as 
template Reverse Transcription with lx buffer RT, 0.5 mM dNTP, 1 pM Oligo -dT primer, 
10 units RNase inhibitor, and 4 units Omniscript Reverse Transcriptase using 
Omniscript Reverse Transcriptase kit (Qiagen, Cat. No. 205111) in a total volume of 20 
pl for 60 min incubation at 37 °C. 0.25 ,ug of RT product were used as template in PCR 
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with 0.2 pM of each forward and reverse primers (see table 2.1), 200 pM dNTP, 2.5 mM 
MgCl2, 1 unit Taq DNA polymerase and 1 x pfu DNA polymerase buffer (200mM Tris - 
HCI, pH 8.8 at 25 °C, 100mM KCI, 100mM (NH4)2SO4, 20mM MgSO4i 1.0% Triton X -100 
and 1 mg/ml nuclease -free BSA). The PCR of full -length human Dexrasl was carried out 
by forward primer A and reverse primer B which amplified for full -length (table 2.1). 
Otherwise, two fragments of Dexrasl (section 3.2.2) were carried out by forward primer 
A and reverse primer D or forward primer C and reverse primer B (table 2.1). PCR was 
carried out with 1 cycle for initial denaturation (95 °C for 1 min), following 45 cycles for 
denaturation phase (95 °C for 0.5 min), annealing phase (56 °C for 0.5 min), extension 
phase (72 °C for 1 min), and 1 cycle for final extension (72 °C for 10 min). Products were 
loaded on 1% agarose gel electrophoresis (section 2.2.1.2). Gels were viewed in an 
ultraviolet viewing box. 
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Table 2.1 
Characteristics of RT -PCR primers 
Primers Sequence 
A: Full- length of 
Dexrasl, forward 
5'-CACATGAAACTGGCCGC-3' 
B: Full- length of 
Dexrasl , reverse 
5'- CTAGCTGATGACGCAGCG -3' 
C: Fragment of 
Dexrasl, forward 
5'- CTGCGACGTGCTGCAC -3' 
D: Fragment of 
Dexrasl, reverse 
5' -CTAG CTG ATG ACG CAG CG -3' 
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2.2.2.3 Northern blot analysis 
1% agarose gel was prepared by dissolving 0.75 g agarose (electrophoresis grade, w /v, 
Invitrogen) in 75 ml depc -dH2O using microwave with swirling. The gel was allowed to 
cool and 10 ml RNA gel buffer (section 2.1.1.9) and 5 ml of 37% v/v formaldehyde (in 
fume cupboard) were added to the gel. RNA was extracted with TRIzol Reagent 
(Invitrogen) as described in section 2.2.2.1. 15.5,u1 RNA sample buffer (0.2ml deionised 
formamide, 40 pl RNA gel buffer (section 2.1.1.9) and 70 pl formaldehyde) were added 
to 20 jig RNA (in 4.5 pl dH2O). The RNA was denatured at 65 °C for 15 min. The 
denatured -RNA was immediately put on ice and 2 pl RNA loading buffer (1 mM EDTA, 
0.4% w/v Bromophenol blue, 0.4% Xylene cyanol, 50% Glycerol) plus 1 pl of 10 mg /ml 
ethidium bromide were added to denatured -RNA. The samples were loaded on the 1% 
agarose formaldehyde gels. 
The gel was run in the RNA electrophoresis buffer (lx RNA gel buffer (section 2.1.1.9) 
in depc -dH2O (section 2.1.1) for 2 h at voltage 100. After electrophoresis, the 
formaldehyde was removed by soaking the gel in the 20x SSC (section 2.1.1.10) for 60 
min with gentle shaking at RT. Nylon membrane (Amersham Life Science, Hybond -N, 
0.45 micron, RPN203N) was pre- wetted by floating on dH2O for < 5 min and following 
by soaking in 20x SSC (section 2.1.1.10) for 5 min. 
RNA was transferred from gel to membrane using capillary action in RNA 
electrophoresis buffer overnight at 4 °C using 3 MM paper bridge and 20 alternate 
stacked blue towels (500g weight on top). The gel and nylon membrane were 
photographed after transferring. 
RNA was fixed in the blot using heating the blot at 80 °C for 3 h between 3 MM paper. 
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Generation of Dexrasl, SGK -1 and cyclophilin A cDNA probes 
Dexrasl 
A single RT -PCR expected band (207 bp, nucleotide 639 -846, NCBI accession number 
AF172846) corresponding to human Dexrasl cDNA was amplified by PCR from HEK 
293 cells RNA using the forward primer E (5'- CTGCGACGTGCTGCAC -3') and reverse 
primer B (5'- CTAGCTGATGACGCAGCG -3'). This fragment was used as hybridization 
probe in the mRNA blot for checking the levels of Dexrasl mRNA in HEK 293 cells 
(figure 2.1) 
SGK -1 
A 238 bp segment (nucleotide 108 -346, NCBI accession number: CAA71138) of SGK -1 
cDNA was amplified by RT -PCR from HEK 293 cells RNA using forward primer F (5'- 
GAACGACTTTATTCAGAAGATTGC-3') and reverse primer G (5'- 
TAGAAGAACCTTTCCAAAACTGCC-3') (figure 2.1). 
Cyclophilin A 
A 170 bp segment (nucleotide 295 -465) of cyclophilin A cDNA was amplified by RT- 
PCR from HEK 293 cells RNA using forward primer H (5' -CCATG GCAAATGCTGGAC- 
3') and reverse primer K (5'- CTTCTTGCTGGTCTTGCC -3') (figure 2.1). 
Labelling the probe (using Ready To -Go DNA labelling beads and a 32P, dCTP) 
The DNA probes were denatured by heating for 2 min at 95- 100 °C. Denatured -probes 
were immediately placed on ice for 2 min and then briefly centrifuged. 
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About 50 ng (in 45 pl dH2O) of denatured -probe plus 5 pl of [cc-32P] dCTP (Amersham, 
AA0005) were added to bead (Amersham Bioscience, 27- 9240 -01). The probes were 
incubated at 37 °C for 15 min. The probes were purified using G -50 column (Amersham 
Biosciences, 27- 5335 -01) following the manufacturer's instructions. 
Pre -hybridization and hybridization 
Pre -hybridization 
The transferred membranes were soaked in dH2O for 3 min following 20x SSC 
(2.1.1.10) for 3 min. The membranes were incubated at 55 °C with 100 ml hybridization 
buffer (section 2.1.1.12) for 1.5 h in a sealed plastic box. 
Hybridization 
Labelled probes were incubated at 60 °C for 10 min. The denatured -probes were 
incubated with membranes in 25 ml of hybridization buffer (section 2.1.1.12) at 55 °C for 
16 h. The membranes were rinsed twice with 30 ml of 2x SSC + 0.1% w/v SDS at room 
temperature and 15 min in 100 ml of 2x SSC + 0.1% SDS with gentle agitation. Then 
the membranes were washed twice with 100 ml of 0.1x SSC + 0.1% SDS for 15 min 
each time. 
Exposure of the membrane with multi sensitive film 
Autoradiograph was prepared by exposing the membranes with multi sensitive film 
(Cyclone storage phosphor screen, Packard) for 0.5 -1 days. All bands on each image 
(membrane) were outlined and the optical density (O.D) in each band was determined 
by OptiQuant image analysis software. 
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2.3 Cell culture 
HEK 293 cells stably expressing STREX -HA and ZERO -HA variants BK channel cc- 
subunits were made by Tian et al (Tian et al., 2001b). Briefly, cDNA encoding STREX 
and ZERO mouse BK channel variant cc- subunit with an epitope HA (Hemagglutinin) 
fusion partner at the C- terminus were sub -cloned into the mammalian expression vector 
pcDNA3 and transfected into HEK 293 cells using lipofectamine 2000 reagent following 
the manufacturer's instructions (Invitrogen, 11668-019). 
The pcDNA3 vector confers geneticin- resistance to cells that express it (Shipston et al., 
1999; Clark et al., 1999). Therefore, HEK 293 cells transfected with STREX -HA and 
ZERO -HA BK channel -pcDNA3 vectors were cultured in DMEM containing 10% Foetal 
Calf Serum (v /v., FCS, Harlan) and 0.8 mg /ml geneticin (antibiotic G 418 Sulfate, 
section 2.1.1.21) in a fully- humidified incubator containing 5% CO2 at 37 °C. Wild type 
HEK 293 cells and AtT20 cells were grown in 75 -cm2 flasks containing 10 ml of DMEM 
supplemented with 10% v/v FCS in a fully- humidified incubator containing 5% CO2 at 
37 °C. Cells were routinely passaged every 5 -7 days (passage 9 -30) using Hanks' 
Buffered Salt Solution containing 0.1% EDTA. 
2.3.1 Transient transfection 
Wild type HEK 293 cells were cultured in a new flask to reach 40 -60% confluence after 
24 h in DMEM (Gibco) containing 10% FCS (Harlan). Cells were transfected with 1 
Ng /ml of the plasmid using Lipofectamine 2000 reagent (Invitrogen, 11668 -019) in 
DMEM for 5 h following the manufacturer's instruction. The solution was replaced with 
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DMEM supplemented with 10% FCS in a fully- humidified incubator containing 5% CO2 
at 37 °C for 48 h. 
2.3.2 Treating the cells with dexamethasone 
The cells were maintained in DMEM supplemented with 1x ITS (insulin transferrin 
selenium, Sigma, 13146) for 24 h in a humidified incubator containing 5% CO2 at 37 °C 
(Leckie et al., 1995). The cells were pretreated with DMEM supplemented with 25 mM 
HEPES pH 7.4 and 0.25% w/v bovine serum albumin (BSA) for 2 h at 37 °C. Then the 
cells were treated with dexamethasone or vehicle, equal volume (0.001 %) of Dimethyl 
Sulfoxide (DMSO) in DMEM supplemented with 25 mM HEPES pH 7.4 and 0.25% w/v 
at 37 °C. 
2.4 Protein analysis 
2.4.1 Cell lysate preparation with Triton X -100 lysis buffer 
Cells in 75 cm2 flasks at 80 -90% confluence were quickly washed 3 times with cold PBS 
(section 2.1.1.14) and subsequent scraped with 0.5 ml 1% Triton X -100 lysis buffer 
(section 2.1.1.18) supplemented with 1/100 of protease inhibitor cocktail (Sigma, P 
8340). The cells were sonicated on ice with five sonication cycles, each consisting of 10 
sec pulses at 10 sec intervals with an ultrasonic Cole -Parmer sonicator (TORBEO, 
36800) at setting 3. Cell lysate (Triton X -100 soluble fraction) was prepared by removing 
the supernatant after spinning at 10,000 g for 15 min at 4 °C. 
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2.4.2 Cell lysate preparation with Nonidet P -40 (NP -40) lysis buffer 
The cells in 75 cm2 flasks at 80 -90% confluence were quickly washed 3 times with cold 
PBS (section 2.1.1.14) and scraped with 0.5 ml 1% NP -40 lysis buffer (25 mM HEPES 
pH 7.4, 150 mM NaCI, 1 mM EDTA , 0.5 mM DTT and 1% NP -40) supplemented with 
1/100 of protease inhibitor cocktail. The cells were sonicated on ice with five sonication 
cycles, each consisting of 10 sec pulses at 10 sec intervals with an ultrasonic Cole - 
Parmer sonicator at setting 3. Cell lysate (NP -40 soluble fraction) was prepared by 
removing the supernatant after spinning at 10,000 g for 15 min at 4 °C. 
2.4.3 Determination of protein concentration 
Bradford assay 
Analysis of protein concentration was determined by a Bradford Coomassie protein 
assay kit (PIERCE) following the manufacturer's instruction. Briefly, BSA with 
concentrations of 9 to 576 ,ug /ml was used to generate standard curve. Proteins were 
diluted 30 times and 10 pl of diluted samples was pipetted into the appropriate 
microplate wells. 290 pl of Coomassie reagent was added to each well and mixed with a 
pipette. The plate was left for 10 min at room temperature and the absorbance was 
measured at 595 nm with a spectrophotometer reader (DYNATECH, MR 7000). 
Bio -Rad DC protein Assay 
The protein concentration of samples contained 1% Triton -X100, 1% NP -40, 1% SDS or 
1mM DTT were performed using a Bio -Rad DC protein assay as recommended in the 
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instruction manual (Catalog Number 500 -0116). The standard, BSA, was prepared in 
the same buffer as the samples 
2.4.4 Preparing the Triton X -100 insoluble and soluble fractions after 20,000 g 
After lysing the cells with Triton X -100 lysis buffer (section 2.4.1), the cell lysate was 
centrifuged at 1000g for 5 min at 4 °C. The resultant supernatant was pelleted with 
ultracentrifuge (BECKMAN, model TL -100) at 20,000 g for 30 min at 4 °C to separate 
insoluble (pellet, P20K) and soluble (supernatant, S20K) fractions 
2.4.5 Immunoprecipitation 
2.5 mg of 1% Triton X -100 cell lysates (in 500 pl) was pre -cleared by incubation with 10 
pl of 50% PGS (protein -G- sepharose (Sigma p3296) supplemented with 1% Triton X- 
100 (section 2.1.1.18) and agitated for 1 h at 4 °C. Beads were spun at 10,000 g for 1 
min at 4 °C and the pre -cleared cell lysates used for immunoprecipitation. 
2.4.5.1 Immunoprecipitation of BK channel cc- subunit using sheep antisera anti - 
STREX + anti -S869 
5 pl of antisera raised in sheep against BK channels (5 pl of anti -STREX serum against 
amino acids 628 -641 and 5 pl of anti -S869 serum against amino acids 919 -933 of the 
mouse STREX channel a.- subunits) was added to the pre -cleared cell lysates and 
incubated overnight at 4 °C. 16.6 pl of 50% PGS was added and incubated for 2 h at 
4 °C. The immunoprecipitates (IPs) were pelleted at 10,000 g for 1 min at 4 °C. 
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2.4.5.2 Immunoprecipitation of PP2A -A and PP1 
5 pl of rabbit anti- PP2A -A antibody (Upstate, 07 -250) or rabbit anti -PP1 antibody 
(Upstate, 06 -221) was added to the pre -cleared cell lysates and incubated overnight at 
4 °C and subsequent 16.6 pl of 50% PGS was added for 2 h at 4 °C. The lysates were 
pelleted at 10,000 g for 1 min at 4 °C. 
2.4.5.3 Immunoprecipitation of 1322 -HA channel 
5 pl of rabbit anti -HA antibody (Zymed, 71 -5500) was added to the pre -cleared cell 
lysates and incubated overnight at 4 °C and then 16.6 pl of 50% PGS was added for 2 h 
at 4 °C. The lysates were pelleted at 10,000 g for 1 min at 4 °C. 
The pellets (IPs of BK channel a, subunits, PP2A -A, PP1 or 1322 -HA channel) were 
washed 3 times with 1% Triton X -100 lysis buffer (section 2.1.1.18) and once with 
dH2O. The IPs were denatured at 100 °C for 5 min in PSD (section 2.1.1.17). IPs were 
loaded onto a SDS -PAGE gel and separated using PhastSystem (next section 2.4.6). 
2.4.6 Western blot analysis 
Western blot analysis was performed using wet transfer of protein in acrylamide gels 
onto lmmobilonTMP transfer membranes. Lysates or IPs were mixed with PSD 
(2.1.1.17) and denatured at 100 °C for 5 min. Proteins with large molecular weight ( >70 
kDa) were analysed by a 7.5% Sodium Dodecyl Sulphate -Polyacrylamide Gel 
Electrophoresis homogeneous gel (SDS -PAGE, Amersham Biosciences). Small 
molecular weight proteins ( <70 kDa) were separated by a 12.5% SDS -PAGE gel using 
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a Pharmacia Biotech PhastSystem apparatus (Pharmacia Biotech, Uppsala, Sweden). 4 
,ul of each extract with 1 ,ug /,ul concentration was electrophoresed onto a SDS -PAGE 
homogeneous gel. The electrophoresis was started with current 10 mA and Volthours 1 
before loading the proteins on a gel. Then, the current was decreased to 1 mA during 
loading the proteins on the gel. After loading, current was increased to 10 mA and 
Volthours to 75 in a 12.5% SDS -PAGE gel and 10 mA and 60 Volthours in a 7.5% gel. 
ECL detection 
lmmobilonTMP Polyvinylidene Fluoride (PVDF) transfer membranes (MILLIPORE, IPVH 
20200) were activated by methanol and soaked in Western blotting buffer for 15 min 
(section 2.1.1.16). The proteins were transferred from SDS -PAGE homogeneous gels 
to the methanol- activated membranes in PhastSystem microelectrophoresis apparatus 
(Amersham) with current 25 mA and Volthours 5. Equivalent protein transfer in the blots 
was determined using Coomassie blue staining (50% methanol, 0.05% Coomassie blue 
R -250) for 5 min at RT. Then the blots were de- stained with 100% methanol. The 
methanol was removed by washing the blots for 5 times for 5 min each time with dH2O. 
The transferred blots were blocked in ECL blocking buffer (PBS -T buffer, section 
2.1.1.15, + 5% (w /v) low fat milk, marvel) for 1 h at RT. Then blots were incubated 
overnight in appropriate primary antibody (table 2.2) in ECL blocking buffer. Blots were 
washed 4 times for 4 min each time with PBS -T buffer (section 2.1.1.15) and incubated 
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Table 2.2 
Characteristics of Western blotting primary antibodies 
Antibody Species Supplier Epitope sequence Dilution for WB 
Anti- PP2A -A 
(purified IgG) 
Rabbit Upstate C- MAAADGDDSLY 1/500 
Anti- PP2A -C 
(purified IgG) 











Rabbit Zymed YPYDVPDYA 1/1000 





C- terminal (residues 
1098 -1196) of mouse 
cc- subunit of BK channel 
1/300 
Anti -Cyclophilin A 
(antiserum) Rabbit Upstate 
Recombinant full length 
protein corresponding 
to human Cyclophilin A 
1/1000 






WB: Western blotting 
IgG: antibody 
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for 1 h at room temperature with secondary antibody conjugated to horseradish 
peroxidase (HRP) (table 2.3) in PBS -T buffer (section 2.1.1.15). Following exposing the 
blots to secondary antibody, the blots were washed 4 times for 4 min each time with 
PBS -T buffer (2.1.1.15). Then, the Blots were incubated with Amersham Pharmacia 
Biotech enhanced chemiluminuescence reagents (ECL, Amersham Biosciences, RPN 
2209) according to the manufacturer's protocol. ECL reactions were detected by high 
performance chemiluminuescence film (Hyper film ECL, Amersham Biosciences, 
RPN2103K). The blots were developed for 4 min in developer (P7042 -1 GA, Sigma 
Aldrich) and 1 minute in fixer (P7167 -1 GA, Sigma Aldrich). Bands were outlined and 
O.D of each band was measured by ImageJ software. 
LI -COR detection 
Western blotting analysis for two -colour detection was performed using the Odyssey 
Western blotting protocol (Bioscience, Doc# 988 -07568) for detection of two different 
antigens simultaneously on the same blot using antibodies labelled which dyes specify 
(table 2.3) and visualized in different fluorescence channels (700 and 800 nm). Two 
different host species primary antibody were used in each blot. FL -PVDF (MILLIPORE) 
membranes were activated by methanol and rinsed 5 times with dH2O for 5 min each 
time, following 3 times for 5 min each time with Western blotting buffer (section 
2.1.1.16). The proteins were transferred from SDS -PAGE homogeneous gel to 
methanol- activated FL -PVDF membrane using current 25 mA and Volthours 5. 
Transferred membranes were washed 4 times for 4 min each time with dH2O and 
blocked with 50% LI -COR blocking buffer (50% OBB: Odyssey Blocking Buffer, LI -COR 
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Table 2.3 
Characteristics of Western Blotting secondary antibodies 
Antibody Species Supplier Dilution for WB 
Anti -mouse -HRP 
antibody 
Sheep Amersham 1/3000 
Anti -rabbit -HRP 
antibody 
Donkey Amersham 1/3000 
Alexa680- conjugated 





anti -rabbit antibody 
Goat Rockland 1/3000 
WB= Western blot 
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Biosciences, 927 -40000, diluted 1:1 with PBS) at room temperature for 1 h. The blots 
were incubated with appropriate primary antibody for overnight at 4 °C (table 2.2) in 50% 
OBB supplemented with 0.1% Tween-20. Following washing the blots 4 times for 4 min 
each time with dH2O. Secondary antibodies (table 2.3) were applied 1 h at room 
temperature in LI -COR blocking buffer supplemented with 0.1% Tween-20. The blots 
were washed 4 times for 4 min each time with PBS -T buffer (section 2.1.1.15) with 
gentle shaking. The membranes were rinsed with PBS (section 2.1.1.14) to remove 
residual Tween -20. The membranes were dried at 37 °C for 10 min and scanned with an 
Odyssey Infrared Imager (LI -COR, model, 9120). 
2.4.6.1 Immunoabsorption 
13.5% rabbit anti -SGK -1 antibody (07 -315, Upstate) was made in 5% marvel blocking 
buffer (PBS -T buffer, section 2.1.1.15, + 5% (w /v) low fat milk, marvel). 
25 ,ug of SGK -1 peptide (12 -482, Upstate) was dissolved in 25 pl of 50 mM HCL and 
added 345 pl of 13.5% SGK -1 antibody (immunoabsorbed antibody using -10.5 M 
antigen) and incubated with rolling at 4 °C for ON. For control 345 pl of 13.5% SGK -1 
antibody was added to 25 pl of 50 mM HCL and rolled for over night (ON) at 4 °C. The 
Mixtures were centrifuged at 10,000g for 15 min. The blots were incubated with the 
supernatants of antibody + antigen or control for ECL detection as described in section 
2.4.6. 
67 
2.4.7 Western blot membrane stripping 
To enable re- probing of Western blot membranes, antibodies were removed by 
incubating the blots at 50 °C for 30 min in Western blot stripping buffer (2% w/v SDS, 
100 mM Mercaptoethanol, 62.5 mM Tris, pH 6.7). Then the blots were washed 3 times 5 
min each time with PBS -T buffer (section 2.1.1.15) to remove the stripping buffer. The 
blots were incubated with primary and secondary antibodies as described in ECL 
detection section 2.4.6. 
2.4.8 Protein visualization in the gel 
Proteins in SDS -PAGE gels were visualized using Sypro Ruby gel stain (Molecular 
Probes, S- 12001) using the protocol recommended by the manufacturer for gels. 
Briefly, gels were incubated with undiluted Sypro Ruby gel stain for 3 h at RT. Gels 
were incubated for 30 min in 10% v/v methanol, 7% v/v acetic acid to reduce the 
background fluorescence and increase sensitivity. The gels were viewed and 
photographed with an ultraviolet viewing box. 
2.4.9 Immunocytochemistry 
Six coverslips of 10 mm (VWR international) were put in each well of 6 -well plates. To 
sterilize glass coverslips, 2 ml of 70% ethanol was put in each well of 6 -well plates to 
cover the coverslips. Ethanol was washed off 3 times with sterile dH2O. 2.5 ml of sterile 
10 pg /ml poly L lysine solution was applied to each well for 10 min. The wells were 
washed with sterile dH2O and then washed with DMEM. The cells were removed with 
trypsin supplemented with 0.1% EDTA. The cells were split to 6 -well plates containing 
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coverslips with DMEM + 10% FCS and left at humidified incubator to reach 50 -60% 
confluence for 24 h. 
The DMEM + 10% FCS were removed and cells rinsed once with PBS at 4 °C. Pre -cold 
4% paraformaldehyde in 0.1 M sodium phosphate buffer (2.1.1.19) was applied to the 
cells and left on ice for 20 min. The paraformaldehyde was removed immediately and 
100% methanol was added at 20 °C for 2 min. Methanol was replaced with 50 mM 
ammonium chloride (NH4CI) in PBS (section 2.1.1.14) for 15 min at RT. The solution 
was changed to PBS + 0.1% NaN3 (sodium azide) and stored at 4 °C. Each coverslip 
(contains fixed cells) was placed into each well of a 24 well -plate with 1 ml PBS. PBS 
was replaced with antibody dilution solution (2% goat serum + 0.1% BSA + 0.1% 
saponin + 0.1% Sodium azide, NaN3, in PBS) and incubated at room temperature for 5 
min. The cells were incubated with 1/500 rabbit anti -HA antibody (Zymed, 71 -5500) in 
dilution solution for 2 -3 h at room temperature with no shaking. The solution was 
removed and washed 2 times with PBS. The coverslips were incubated with 1/500 goat 
Alex Fluor ® 488 anti -rabbit antibody (Nanoprobes) at room temperature for 30 min. 
Coverslips were washed with PBS and drain and mounted on superfrost slides on a 
drop (3 pi) of pre- warmed Permafluor. The slides were kept in dark and stored at 4 °C. 
The sections were viewed under a Zeiss LSM 510 confocal microscope. 
2.4.10 Luciferase assay 
3x105 cells per well of a six -well plates multiplate were grown overnight in DMEM +10% 
FCS in a humidified atmosphere at 37 °C under 5% CO2 until reach 40 to 60% 
confluence. HEK 293 cells were transiently transfected with 1 µg /ml of mouse mammary 
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tumor virus long terminal repeat (MMTV -LTR) luciferase reporter construct (Leckie et 
al., 1995), using lipofectamine 2000 reagent (Invitrogen, 11668-019) in DMEM for 5 h 
following the manufacturer's instruction. Then solution was changed to DMEM 
supplemented with 10% FCS and left in a humidified atmosphere at 37 °C under 5% 
CO2 for 48 h. 
Cells were treated with varying concentrations and times with the synthetic 
glucocorticoid agonist dexamethasone or DMSO (0.001%) at 37 °C as described in 
section 2.3.2 Cells were quickly washed 3 times with cold PBS and lysis buffer (25 mM 
Tris- phosphate, pH 7.8, 2 mM DU, 1% Triton X -100, 10 % glycerol, 2 mM 1,2- 
diaminocyclohexane- N,N,N(,N( -tetra acetic acid and 2.5 mg/ ml BSA) supplemented 
with 1/100 of protease inhibitor cocktail (Sigma, P 8340). The cells were homogenized 
and briefly centrifuged at 10,000 g. Duplicate (20 pl) aliquots of the resulting 
supernatants were assayed for luciferase activity using 100 pl of Promega luciferase 
assay reagent (Promega, E1483) and emitted light detected with a T20/20 luminometer 
(Turner Designs, Sunnyvale, CA). Light emission was averaged over 10 sec with a 2 
sec delay. Data from various experiments were compared with percentage of maximum 
light production (100 %) in transfected HEK cells treated with 100 nM dexamethasone 
for 2 h. 
2.5 Statistics 
Data are expressed as mean ± standard error of mean (S.E.M), n= number of 
independent experiments. Statistical analysis for each group was performed by one -way 
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ANOVA after log transformation to achieve homogeneity of variances. Dunnett's one- 
tailed post hoc test was used at a 95% confidence interval. 
2.6 Supplier details 
Amersham Biosciences: Amersham Biosciences UK Limited, Pollards Wood, 
Nightingales Lane, Chalfont St. Giles Bucks, UK, HP8 4SP 
MWG Biotech Company: Anzinger Strasse 7a, 85560 Ebersberg, Germany 
Upstate Biotechnology: Gemini Crescent, Dundee Technology Park, Dundee, Scotland, 
DD2 1SW. 
Sigma: Fancy Road, Poole Dorset, England, BH12 4QH. 
Promega: Promega UK Ltd, Delta House, Chilworth Science Park, Southampton 
UK, SO16 7NS. 
Molecular Probes Inc: Poortgebouw, Rijnsburgerweg 10, 2333 AA Leiden, Netherlands. 
Calbiochem: CN BIOSCIENCES (UK) LTD, Boulevard Industrial Park, Padge Road, 
Beeston, Nottingham, UK, NG9 2JR 
Invitrogen Ltd: 3 Fountain Drive, Inchinnan Business Park, Paisley, UK, PA4 9RF. 
QIAGEN Ltd: Boundary Court, Gatwick road, Crawley, west Sussex, RH10 2AX. 
Roche Diagnostic: Roche Molecular Biochemicals, D -68298 Mannheim, Germany. 
Turner Designs, Inc.: 845 W. Maude Avenue, Sunnyvale, CA 94085. 
Rockland Immunochemicals, Inc.: P.O. Box 326, Gilbertsville, PA 19525. 
CHEMICON International, Inc.: 28820 Single Oak Drive, Temecula, CA 92590. 
Harlan: Dodgeford Lane, Loughborough Leicestershire, LE12 9TE, England. 
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Biolabs: New England Biolabs, 240 County Road, Ipswich, MA 01938 -2723. 
Zymed: Now Invitrogen Corporation. 
Gibco: Now part of Invitrogen. 
Pharmacia Biotech: S -751 82 Uppsala, Sweden. 
Calbiochem: EMD Biosciences, 10394 Pacific Centre Ct, San Diego, CA 92121. 
Nanoprobes: 95 Horse Block road, Yaphank, NY 11980-9710. USA. 
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Chapter Three 
Glucocorticoid- inducible proteins, 




Based on evidence summarised in chapter 1 section 1.4, the rapid induction of Dexrasl 
mRNA (Kemppainen and Behrend., 1998) and SGK -1 mRNA (Chen et al., 1999b) by 
giucocorticoids raised the possibility that Dexrasl and SGK -1 may be glucocorticoid- 
induced proteins in HEK 293 cells. There is currently no published information about the 
induction of endogenous SGK -1 or Dexrasl in response to dexamethasone in HEK 293 
cell. Thus, the aims of the present study were to determine: 
i) Are Dexrasl and /or SGK -1 glucocorticoid- inducible protein(s) in HEK 293 cells? 
ii) If Dexrasl and /or SGK -1 are glucocorticoid- inducible protein(s) in HEK 293 cells, do 
they associate with BK channels? 
3.2 Results 
The presence of functional glucocorticoid receptors in HEK 293 cells was assessed 
upon transfection with a luciferase gene regulated by the glucocorticoid- inducible 
hormone response element that is found in the MMTV -LTR (Leckie et al., 1995). 
3.2.1 MMTV -LTR luciferase activity in HEK 293 cells 
The transcriptional behavior of the MMTV -LTR promoter was measured during 
exposure to the synthetic glucocorticoid dexamethasone. 
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Time -course of glucocorticoid action in HEK 293 cells 
To characterise the time -course of glucocorticoid action in HEK 293 cells, the cells 
transiently transfected with MMTV -LTR luciferase reporter were incubated with 100 nM 
dexamethasone for 15 to 180 min. HEK 293 cells treated with DMSO (0.001%) for 120 
min were assayed as the control vehicle group. Luciferase activity at dexamethasone 
120 min was calculated and the corresponding ratio for vehicle and other 
dexamethasone time points were expressed as percentage of this value. All 
dexamethasone treatment time -points were compared with the vehicle control group 
and a difference with a p value less than 0.05 was considered statistically significant. 
Monitoring of dexamethasone -stimulated MMTV -LTR luciferase activity revealed a time - 
dependent increase of luciferase expression by 100 nM dexamethasone. Luciferase 
activity was significantly increased following 30 min dexamethasone exposure 
compared with the vehicle group (figure 3.1). Maximal luciferase activity was observed 
at 120 min of dexamethasone administration (up to five -fold) and this activity was 
constant up to 180 min (Figure 3.1) (p <0.05, one -way ANOVA and Dunnett's test, 
results were typical of three similar experiments). 
As a control for DMSO, HEK 293 cells transfected with MMTV -LTR luciferase reporter 
were treated with DMEM for 120 min. The results showed that DMSO (0.001%) had no 
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Figure 3.1: Time -course of the effect of dexamethasone on 
luciferase activity in HEK 293 cells 
Human embryonic kidney 293 (HEK 293) cells transiently transfected with 1 pg of mouse 
mammary tumour virus long terminal (MMTV -LTR) luciferase reporter were treated with 100 nM 
dexamethasone for various times as indicated. The vehicle group received 0.001% of Dimethyl 
sulfoxide, DMSO, for 120 min. As a control group for vehicle, the cells were treated with 
Dulbeccos' Modified Eagle's Medium (DMEM) for 120 min. 20 pl of whole cell lysate were 
assayed for luciferase activity as described under "Material and Methods" section 2.4.10. Data 
are expressed as a percentage of the luciferase activity measured in samples treated with 
dexamethasone for 120 min. The results shown are average of three independent experiments 
for each group. Data are Means ± S.E.M, * significant difference (p<0.05, one -way ANOVA and 
Dunnett's test, n =3 /group) versus vehicle group. 
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Concentration -response of glucocorticoid action in HEK 293 cells 
As 120 min was the maximally effective time -point for glucocorticoid receptor- induced 
luciferase activity, the effect of varying the concentration of dexamethasone was 
determined at this time point. 
Exposure of HEK 293 cells transiently transfected with the MMTV -LTR plasmid to 
dexamethasone (0.1 to 1000 nM) for 120 min increased luciferase activity in a 
concentration -dependent manner (figure 3.2). The minimal effective concentration of 
dexamethasone was 1 nM and the maximal effect occurred at 100 nM (up to 5 -fold 
above control level) (p <0.05, one -way ANOVA and Dunnett's test, results were typical of 
three similar experiments). 
Summary 
The data showed that glucocorticoids act via endogenous glucocorticoid receptors in a 
concentration- and time -dependent manner in HEK 293 cells with maximal activity at 
100 nM dexamethasone for 120 min exposure. In subsequent experiments, 100 nM 
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Figure 3.2: Concentration dependence of the effect of 
dexamethasone on luciferase activity in HEK 293 cells 
HEK 293 cells transiently transfected with 1 pg of MMTV -LTR luciferase reporter were treated 
with various concentrations of dexamethasone for 120 min as indicated. The control vehicle 
group received DMSO (0.001 %) for 120 min. 20 pl of whole cell lysate was assayed for 
luciferase activity. Data are expressed as a percentage of the luciferase activity measured in 
samples treated with 100 nM dexamethasone for 120 min. The results shown are average of 
three independent experiments for each group. Data are Means ± S.E.M, * significant difference 
(p< 0.05, one -way ANOVA and Dunnett's test, n =3 /group) versus vehicle group. Half- maximal 
effective concentration (EC50) was observed at 33.6 nM dexamethasone. 
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3.2.2 Effect of dexamethasone on the level of Dexrasl mRNA using RT -PCR 
To address the effect of dexamethasone on the level of Dexrasl mRNA in HEK 293 
cells, the cells were treated with 100 nM dexamethasone for various times (30 to 120 
min). The cells treated with DMSO (0.001%) for 120 min were assayed as a control 
vehicle group. RT -PCR analysis of total RNA isolated from HEK 293 cells (described in 
"Material and Methods" section 2.2.2.1) failed to detect full -length human Dexrasl 
mRNA using forward primer A and reverse primer B, which were designed to amplify 
full -length human Dexrasl cDNA ( "Materials and Methods" table 2.1). Furthermore, 100 
nM dexamethasone (30 to 120 min exposure) failed to induce full -length human 
Dexrasl mRNA in HEK 293 cells (figure 3.3B) as determined by RT -PCR. 
To address whether Dexrasl primers A and B are suitable to amplify full -length Dexrasl 
mRNA, the human Dexrasl pBluescript plasmid was used as template for PCR. The 
PCR analysis demonstrated that the full -length human Dexrasl is amplified from human 
Dexrasl pBluescript plasmid by primers A and B (figure 3.3C). 
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Figure 3.3 
Reverse transcription -polymerase chain reaction (RT -PCR) 
analysis of Dexrasl in HEK 293 cells 
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Figure 3.3: Reverse transcription -polymerase chain reaction 
(RT -PCR) analysis of Dexrasl in HEK 293 cells 
A: Schematic representation of human Dexrasl. 1) Schematic representation of full -length 
human Dexrasl amplified by forward primer A and reverse primer B ( "Materials and Methods" 
table 2.1). 2) Schematic representation of a 595 bp human Dexrasl fragment (nucleotide 1 -595) 
amplified by forward primer A and reverse primer D. 3) Schematic representation of a 577 bp 
human Dexrasl fragment (nucleotide 269 -846) amplified by forward primer C and reverse primer 
B. B: HEK 293 cells were treated with 100 nM dexamethasone for different times (as shown 
above). The control vehicle group received DMSO (0.001%) for 120 min. RT -PCR was carried 
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out with total RNA isolated with TRIzol (described in "Materials and Methods" section 2.2.2.1) 
using forward primer A and reverse primer B, selected to amplify the entire 846 -nucleotide open 
reading frame of human Dexrasl. RT -PCR products were loaded onto a 1% agarose gel stained 
with ethidium bromide (section 2.2.1.2). The DNA molecular size marker is indicated in kilo base 
pairs (kbp) C: Forward primer A and reverse primer B were verified using human Dexrasl 
pBluescript plasmid as template. The Dexrasl sequence was checked by restriction enzymes 
analysis and DNA Sequencing. The DNA molecular size marker is indicated in base pairs (bp). 
D: Agarose gel electrophoresis of PCR of Dexrasl products amplified from HEK 293 cells. 
Reverse transcription was carried out with total RNA isolated from HEK 293 cells. PCR was 
carried out using RT template and specific Dexrasl primers that amplified 577 and 595 bp 
human Dexrasl cDNA fragments. The PCR products were loaded onto a 1% agarose gel. The 
sequences of two fragments were confirmed by restriction enzymes analysis and MWG DNA 
Sequencing. DNA molecular size marker is indicated in bp. 
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As full -length Dexrasl mRNA could not be detected, two sets of overlapping PCR 
primers were designed and used to amplify Dexrasl in the RT reaction mixture (figure 
3.3A). RT -PCR analysis, using total RNA isolated from HEK 293 cells, showed a 595 bp 
fragment of Dexrasl cDNA using forward primer A and reverse primer D and a 577 bp 
Dexrasl cDNA fragment using forward primers C and reverse primer B (figure 3.3D). 
Thus full -length Dexrasl mRNA appears to be present in HEK 293 cells, but 
amplification of the full -length sequence from the RT -PCR reaction mixture was 
suboptimal under our conditions. 
3.2.3 Northern blot analysis of Dexrasl 
As Dexrasl mRNA could not be detected by RT -PCR in vehicle- treated or 
dexamethasone- treated HEK 293 cells, the level of Dexrasl mRNA was examined by 
Northern blot analysis. 
Effect of dexamethasone on the level of Dexrasl mRNA in HEK 293 cells stably 
expressing STREX -HA BK channel cc- subunit (STREX -HA stable) 
STREX -HA stable HEK 293 cells were treated with 100 nM dexamethasone for 15 to 
120 min and the cells treated with an equal volume of DMSO (0.001%) for 120 min 
served as the vehicle- treated control group. Northern blot analysis was performed on 
total RNA extracted with TRIzol (described in "Materials and Methods" section 2.2.2.1) 
from vehicle- treated or dexamethasone- treated cells. Total RNA (20 ,ug) was 
electrophoresed on a 1% agarose- formaldehyde gel and transferred to a nylon 
membrane as described under "Materials and Methods" section 2.2.2.3. 
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Dexrasl mRNA was detected by hybridizing the Northern blots with a 32P- labeled 207 
bp human Dexrasl cDNA probe corresponding to bases 639 to 846 of the Dexrasl 
coding sequence (see "Materials and Methods" section 2.2.2.3). RNA loading was 
normalised for each lane, by stripping and rehybridizing the blots with a 32P- labeled 170 
bp cyclophilin A cDNA probe, which is not regulated by glucocorticoid (Adkins et al., 
1998), corresponding to sequence 295 to 465 of human cyclophilin A (described in 
"Materials and Methods" section 2.2.2.3). A 5 kbp Dexrasl mRNA (Tu and Wu., 1999) 
and a 0.74 kbp cyclophilin A mRNA (Adkins et al., 1998) were detected in the vehicle - 
treated as well as the dexamethasone- treated STREX -HA stable HEK 293 cells (figure 
3.4A). Radioactive bands on each blot were outlined and the optical density (0.0) in 
each band was determined by OptiQuant image analysis software. 0.D of the Dexrasl 
hybridizated signal is divided by the 0.D of the cyclophilin A signal of the same lane, to 
correct for different mRNA loading. The ratio of Dexrasl mRNA to cyclophilin A mRNA 
showed that 100 nM dexamethasone had no significant effect on the level of Dexrasl 
mRNA compared with control vehicle group in HEK 293 cells at any time points 
examined (15 to 120 min) (p <0.05, one -way ANOVA and Dunnett's test, results were 
typical of five similar experiments) (figure 3.4B). 
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Figure 3.4 
Lack of an effect of dexamethasone on Dexrasl mRNA in 
STREX -HA stable HEK 293 cells 
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Figure 3.4: Lack of an effect of dexamethasone on Dexrasl 
mRNA in STREX -HA stable HEK 293 cells 
A: Northern analysis for Dexrasl and cyclophilin A mRNA. HEK 293 cells stably expressing 
STREX -HA variant BK channel o:.-subunits (STREX -HA stable HEK 293 cells) were treated with 
100 nM dexamethasone for various times as indicated. The vehicle group received DMSO 
(0.001%) for 120 min. The total RNA was extracted with TRlzol and 20 erg were loaded onto a 
1% agarose -formaldehyde gel. The blots were incubated with a 32P- labeled 207 bp Dexrasl 
cDNA probe which hybridized with a single 5 kbp band (zop row). To normalize RNA loading in 
each lane, the blot was stripped and reprobed with a 3`P-labeled 170 bp cyclophilin A cDNA 
probe (bottom row). B: Average of the ratio of the optical densities (O.D) of Dexrasl to 
cyclophilin A mRNA from five independent experiments. The ratio of O.D of Dexrasl to 
cyclophilin A mRNA was calculated for the vehicle group and the corresponding ratio for 
dexamethasone time points (15 to 120 min) was expressed as percentage of this value. Data are 
Means ± S.E.M, (p <0.05, one -way ANOVA and Dunnett's test, n =5 /group) versus control vehicle 
group. 
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Expression of Dexrasl mRNA by dexamethasone In wild -type HEK 293 cells 
To address whether the lack of an effect of dexamethasone on the level of Dexrasl 
mRNA in STREX -HA stable HEK 293 cells was due to the overexpression of BK 
channel cc- subunit in these cells, the wild -type HEK 293 cells, were treated with 100 nM 
dexamethasone (15 to 120 min) or vehicle (0.001% DMSO) for 120 min under the same 
condition used for STREX -HA stable HEK 293 cells. Northern blot analysis of Dexrasl 
revealed that 100 nM dexamethasone had no effect on the level of Dexrasl mRNA 
compared with control vehicle group at any of the time points (15 to 120 min) tested 
(Data not shown). 
Summary 
1) Full- length Dexrasl mRNA could not be amplified by RT -PCR from STREX -stable 
HEK 293 cells, but experiments with overlapping primer pairs showed the presence of 
full -length Dexrasl mRNA. Indeed, the presence of full -length Dexrasl mRNA was also 
indicated by the results of Northern RNA analysis. 
2) The levels of Dexrasl mRNA were readily detectable in HEK 293 cells but no change 
induced by dexamethasone could be discerned. 
3.2.4 Northern blot analysis of SGK -1 in response to dexamethasone in HEK 293 
cells 
To address whether SGK -1 is a glucocorticoid- inducible protein in HEK 293 cells, and to 
verify the HEK 293 system for glucocorticoid induction of endogenous genes, possible 
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changes of SGK -1 mRNA in response to dexamethasone were examined using 
Northern blot analysis. 
STREX -HA stable HEK 293 cells were treated with 100 nM dexamethasone for various 
time intervals (15 to 120 min) or 0.001% DMSO (vehicle) for 120 min. Blots of 
electrophoresed RNA were hybridized with a 32P- labeled 238 bp SGK -1 cDNA probe 
(corresponding to bases 108 to 346 of the coding region of SGK -1 mRNA). Gel loading 
was normalized by stripping and rehybridization of the blots with a 32P- labeled 170 bp 
cyclophilin A cDNA probe, corresponding to bases 295 to 465 of the human cyclophilin 
A mRNA coding region (described in "Materials and Methods" section 2.2.2.3). 
A 2.6 kbp band corresponding to the expected size of human SGK -1 mRNA (Chen et 
al., 1999b) reacted with the SGK -1 probe in both vehicle- treated and dexamethasone - 
treated STREX -HA stable HEK 293 cells (figure 3.5). After standardisation with the 
cyclophilin A signal, the data revealed that 100 nM dexamethasone increased SGK -1 
mRNA in a time -dependent manner: statistically significant increase was found after 15 
min which was maximal by 30 min and remained elevated until 120 min (results were 
typical of five similar experiments, p<0.05, one -way ANOVA and Dunnett's test) (figure 
3.5). Similar data were obtained in wild -type HEK 293 cells (Data not shown). 
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Figure 3.5 
Time -course of the effect of dexamethasone on SGK -1 mRNA in 
STREX -HA stable HEK 293 cells 
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Figure 3.5: Time -course of the effect of dexamethasone on SGK - 
1 mRNA in STREX -HA stable HEK 293 cells 
A: Northern analysis for SGK -1 and cyclophilin A mRNA. STREX -HA stable HEK 293 cells were 
treated with 100 nM dexamethasone for the indicated times. The vehicle group received DMSO 
(0.001 %) for 120 min. Total RNA was extracted with TRizol and 20 pg were loaded onto a 1% 
agarose -formaldehyde gel. The total RNA was transferred to a nylon membrane. The blots were 
hybridized with 32P- labeled 238 bp SGK -1 cDNA probe. SGK -1 message constituted a single 
major band on Northern blot with a size of 2.6 kbp (top row). Blots were stripped and 
rehybridized with a probe for cyclophilin A with a size of 0.74 kbp (bottom row). B: Average of 
the ratio of the O.D of SGK -1 to cyclophilin A mRNA from five independent experiments. The 
ratio of O.D of SGK -1 to cyclophilin A mRNA was calculated for vehicle group and the 
corresponding ratio for dexamethasone time points (15 to 120 min) was expressed as 
percentage of this value. Data are Means ± S.E.M, * significant difference (p <0.05, one -way 
ANOVA and Dunnett's test, n =5 /group) versus control vehicle group. 
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Summary, Northern blot analysis revealed that SGK -1 mRNA is induced in response to 
100 nM dexamethasone (minimal induction at 15 min and maximal by 30 min) in both 
wild -type HEK 293 cells and HEK 293 cells stably expressing STREX -HA variant BK 
channel cc-subunit. 
3.2.5 Western blot analysis of SGK -1 in response to dexamethasone in HEK 293 
cells 
Northern blot analysis (section 3.2.4) revealed that SGK -1 mRNA is increased by 100 
nM dexamethasone. Therefore it was of interest to investigate whether or not, the rapid 
induction of SGK -1 mRNA leads to an increase of the level of SGK -1 protein in HEK 
293 cells. 
3.2.5.1 Specificity of SGK -1 antibody to SGK -1 protein in HEK 293 cells 
A purified rabbit anti -SGK -1 (C- terminal) antibody (Upstate, "Materials and Methods" 
table 2.2) was used to detect SGK -1 protein in HEK 293 cells. Cells were lysed and 
fractionated in 1% Triton X -100 lysis buffer (described in section 2.4.1). The Triton X- 
100 soluble fractions were separated on 12.5% polyacrylamide gels in SDS -PAGE and 
blots were probed with anti -SGK -1 antibody. The bands were detected by ECL 
chemiluminescence as described in "Materials and Methods" section 2.4.6. Anti -SGK -1 
antibody reacted with a major -50 K band, which is in line with the expected molecular 
weight of SGK -1 protein (Kobayashi et al., 1999), in both wild -type and STREX -HA 
stable HEK 293 cells (figure 3.6A). Some spurious bands of much lower intensity also 
evident but not in reproducible pattern. 
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Figure 3.6 
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Figure 3.6: Specificity of the anti -SGK -1 antibody in HEK 293 
cells 
HEK 293 cells and STREX -HA stable HEK 293 cells were homogenized in 1% Triton X -100 lysis 
buffer as described in "Materials and Methods" section 2.4.1. 4 pl of 1% Triton X -100 soluble 
fraction (1 ,ug /1pI) were loaded onto a 12.5 % SDS -PAGE gel and electrotransferred to a PVDF 
membrane in Phastsystem apparatus (Amersham -Pharmacia, Uppsala, Sweden). A: The blot 
was probed with rabbit anti -SGK -1 antibody and immunoreactive bands were visualized at 
approximately 50 K by chemiluminescence (ECL) reagents. B and C: The specificity of SGK -1 
antibody was determined by omitting the primary antibody or pre- incubation of the SGK -1 
antibody with SGK -1 peptide antigen (described in "Materials and Methods" section 2.4.6.1). 
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The specificity of the SGK -1 detection method was determined by probing the blots with 
HRP- conjugated anti -rabbit secondary antibody alone (figure 3.6 B). Furthermore, pre - 
absorption of the SGK -1 antibody with SGK -1 peptide antigen (Upstate), described in 
"Materials and Methods" section 2.4.6.1, abolished the reaction with the -50 K band 
(figure 3.6C). Thus, the commercially available anti -SGK -1 antibody appeared to 
produce specific staining of SGK -1 in immunoblots. 
3.2.5.2 Effect of dexamethasone on the level of SGK -1 protein 
In order to investigate the effect of dexamethasone on endogenous SGK -1 protein in 
STREX -HA stable HEK 293 cells, the cells were treated with 100 nM dexamethasone 
for 15 to 120 min. Controls were exposed to (0.001%) DMSO in DMEM for 120 min. 
Cell extracts prepared in 1% Triton X -100 lysis buffer (Triton X -100 soluble fraction, 
section 2.4.1) were processed for immunoblots as described in "Materials and Methods" 
section 2.4.6. The blots were incubated with anti -SGK -1 antibody and developed with 
ECL reagents (figure 3.7A). The level of SGK -1 protein was standardized in each lane 
upon staining for cyclophilin A as follows (figure 3.7B). The SGK -1 and cyclophilin A 
bands in each blot were outlined and optical density of bands were measured by 
Image) software. The ratio of optical density of SGK -1 to cyclophilin A protein at vehicle 
group was calculated and the corresponding ratio for dexamethasone time -points (15 to 
120 min) was compared with this value. The results showed that 100 nM 
dexamethasone had no effect on the level of SGK -1 protein in the Triton X -100 soluble 
fraction when compared with the vehicle group in STREX -HA stable HEK 293 cells at 
any of the time -points examined (figure 3.7C) (results were typical of three similar 
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Figure 3.7 
Effect of dexamethasone on the levels of SGK -1 protein in 1% 
Triton X -100 soluble fraction in STREX -HA stable HEK 293 cells 
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Figure 3.7: Effect of dexamethasone on the levels of SGK -1 
protein in 1% Triton X -100 soluble fraction in STREX -HA stable 
HEK 293 cells 
A and B: Western analysis for SGK -1 and cyclophilin A protein in 1% Triton X -100 soluble 
fraction. STREX -HA stable HEK 293 cells were treated with 100 nM dexamethasone for the 
indicated times. The vehicle group received DMSO (0.001%) for 120 min. 4 pl of 1% Triton X- 
100 soluble proteins (1 pg /1/al) were subjected to a 12.5 % SDS -PAGE gel and Western blotting 
by rabbit anti -SGK -1 antibody (A) in Phastsystem apparatus. The blots were probed with anti - 
cyclophilin A antibody (B) as loading control. C: Average of the ratio of O.D of SGK -1 to 
cyclophilin A protein in 1% Triton X -100 soluble fraction from three independent experiments. 
The ratio of O.D of SGK -1 to cyclophilin A protein was calculated for the vehicle group and the 
corresponding ratio for dexamethasone time points (15 to 120 min) was expressed as 
percentage of this value. Data are Means ± S.E.M, (p <0.05, one -way ANOVA and Dunnett's test, 
n =3 /group) versus control vehicle group. 
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experiments). Similar data were obtained in wild -type HEK 293 cells (data not shown). 
Taken together, the results showed no changes in the levels of SGK -1 protein in the 
Triton X -100 soluble fraction in response to dexamethasone in HEK 293 cells. 
It has been reported that the amount SGK -1 protein is rapidly and strongly enhanced by 
100 nM dexamethasone after 30 min in A6 cells homogenized in NP -40 lysis buffer 
(Chen et al., 1999b). Thus, to determine the effect of NP -40 detergent on the 
expression of the SGK -1 protein, wild -type HEK 293 cells and STREX -HA stable HEK 
293 cells were treated with 100 nM dexamethasone for 15 to 120 min or 0.001% DMSO 
for 120 min (vehicle) and subsequently lysed with 1% NP -40 lysis buffer ( "Materials and 
Methods" section 2.4.2). Once more, the results showed no change in the expression of 
SGK -1 protein in response to 100 nM dexamethasone in either STREX -HA stable HEK 
293 cells (figure 3.8) or wild -type HEK 293 cells (Data not shown). 
Taken together, application of 100 nM dexamethasone for 15 to 120 min does not 
change the level of endogenous SGK -1 protein in the 1% Triton X -100 or 1% NP -40 
soluble fractions of either wild -type or STREX -HA stable HEK 293 cells. 
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Figure 3.8 
Effect of dexamethasone on the levels of SGK -1 protein in 1% 
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Figure 3.8: Effect of dexamethasone on the levels of SGK -1 
protein in 1% Nonidet -P40 soluble fraction in STREX -HA stable 
HEK 293 cells 
A and B: Western analysis for SGK -1 and cyclophilin A protein in 1% Nonidet -P40 soluble 
fraction. STREX -HA stable HEK 293 cells were treated with 100 nM dexamethasone for 
indicated times and homogenized in 1% Nonidet -P40 lysis buffer. The cells treated with DMSO 
(0.001%) for 120 min were assayed as a control vehicle group. 4 pl of 1% Nonidet -P40 soluble 
fractions (1 Ng /1pI) were analysed by Western blotting using a 12.5 % SDS -PAGE gel in 
Phastsystem apparatus. The blots were probed with anti -SGK -1 antibody (A) and SGK -1 
proteins were visualized by ECL detection. Variations of gel loading were corrected against the 
corresponding cyclophilin A (B) blot values. C: Average of the ratio of O.D of SGK -1 to 
cyclophilin A protein in 1% Nonidet -P40 soluble fraction from three independent experiments. 
The ratio of O.D of SGK -1 to cyclophilin A protein was calculated for the vehicle group and the 
corresponding ratio for dexamethasone time points (15 to 120 min) was expressed as 
percentage of this value. Data are Means ± S.E.M, (p <0.05, one -way ANOVA and Dunnett's test, 
n =3 /group) versus control vehicle group. 
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3.2.5.3 Lack of an effect of proteasome inhibitors on SGK -1 protein expression 
It has been reported that there is intensive degradation of SGK -1 cellular protein by the 
proteasome (Brickley et aL, 2002). To address whether the lack of an effect of 
dexamethasone on SGK -1 protein was due to the rapid degradation of SGK -1 protein 
by the proteasome, STREX -HA stable HEK 293 cells and wild -type HEK 293 cells were 
pre- treated with 10 pM ALLN (N- Acetyl- Leu- Leu- Nle -CHO, calpain inhibitor 1 with weak 
proteasome inhibitory action) for 1 hour. The cells were subsequently exposed to 100 
nM dexamethasone for various times (15 to 120 min) or 0.001% DMSO for 120 min 
(vehicle group) in the presence of the proteasome inhibitor. No changes on the levels of 
SGK -1 protein in Triton X -100 soluble fraction in response to dexamethasone were 
found in either wild -type HEK 293 cells or STRX -HA stable HEK 293 cells despite the 
presence of proteasome inhibitor (one -way ANOVA and Dunnett's test, results were 
typical of three similar experiments) (data not shown). 
Due to the weak effect of ALLN on the proteasome, the expression of SGK -1 protein 
was also examined in the presence of the more potent proteasome inhibitor, MG -132 
( Carbobenzoxy -L- leucyl -L- leucyl -L- leucinal) (Leithe and Rivedal., 2004; Coux et aL, 
1996; Rock et al., 1994). STREX -HA stable HEK 293 cells and wild -type HEK 293 cells 
were pre- treated for 1 hour with 10 pM MG -132 and subsequently exposed to 100 nM 
dexamethasone for various times (15 to 120 min) or 0.001% DMSO for 120 min (vehicle 
group) in the presence of MG -132. The Western blot analysis revealed that MG -132 had 
no effect on the level of SGK -1 protein expression at any time points examined with 100 
nM dexamethasone in both wild -type HEK 293 cells (data not shown) and STREX -HA 
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Figure 3.9 
Effect of specific proteasome inhibitor MG -132 on the levels of 
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Figure 3.9: Effect of specific proteasome inhibitor MG -132 on 
the levels of SGK -1 protein in STREX -HA stable HEK 293 cells 
A and B: Western analysis for SGK -1 and cyclophilin A protein in the presence of proteasome 
inhibitor. STREX -HA stable HEK 293 cells were pre- treated with 10 uM specific proteasome 
inhibitor MG -132 ( Carbobenzoxy- L- leucyl -L- leucyl -L- leucinal) for 1 h and then treated with 100 
nM dexamethasone for different times (15 to 120 min) or 0.001% DMSO for 120 min (vehicle) in 
the presence of MG -132. 4 pl of 1% Triton X -100 soluble proteins (1 ,ug /1/ßl) were separated by a 
12.5% SDS -PAGE gel in Phastsystem apparatus. SGK -1 and cyclophilin A protein were 
evaluated by Western blot analysis using anti -SGK -1 antibody (A) and anti -cyclophilin A antibody 
(B). C: Average of the ratio of O.D of SGK -1 to cyclophilin A protein in the presence of MG -132 
from three independent experiments. The ratio of O.D of SGK -1 to cyclophilin A protein was 
calculated for the vehicle group and the corresponding ratio for dexamethasone time points (15 
to 120 min) was expressed as percentage of this value. Data are Means ± S.E.M, (p <0.05, one - 
way ANOVA and Dunnett's test, n =3 /group) versus control vehicle group. 
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stable HEK 293 cells (figure 3.9) (one -way ANOVA and Dunnett's test, results were 
typical of three similar experiments). 
3.2.5.4 Distribution of SGK -1 protein in HEK 293 cells 
Previous data in HEK 293 cells (Brickley et al., 2002) showed that transfected SGK -1 is 
localized to the plasma membrane and it is only partially solubilised by non -denaturing 
detergents. Moreover, similar data were also reported for rat kidney tissue (Alvarez de 
la Rosa et al., 2003). These data raised the possibility that only a certain pool of SGK -1 
protein is influenced by dexamethasone. To examine the distribution of endogenous 
SGK -1 protein in STREX -HA stable HEK 293 cells, the cells were homogenized in the 
absence of detergents and centrifuged at 20,000 g (described in "Materials and 
Methods" section 2.4.4). Western blot analysis of the pellet and supernatant fractions 
revealed that SGK -1 was only detectable in the particulate fraction (figure 3.10). When 
the same protocol was followed using Triton X -100 lysis buffer, Western blot analysis of 
the high -speed pellet and supernatant fractions indicated that over 50% of the total 
SGK -1 was found in the Triton X -100 soluble fraction (figure 3.10). 
Taken together, the results showed that endogenous SGK -1 is largely in the particulate 
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Figure 3.10: Distribution of SGK -1 protein in STREX -HA stable 
HEK 293 cells 
STREX -HA stable HEK 293 cells were homogenized in the absence of detergent or the 
presence of 1% Triton X -100. The homogenates were centrifuged at 20,000 g and equal 
amounts of protein from the pellet and the supernatant were separated by a 12.5% SDS -PAGE 
gel in Phastsystem apparatus. The proteins were transferred to a PVDF membrane and then 
analysed by Western blotting with anti -SGK -1 antibody. A: In the absence of detergents, SGK - 
1 was only detected in the pellet, particulate fraction. B: In the presence of 1% Triton X -100, 
SGK -1 was found in the pellet (insoluble fraction) and the supernatant (soluble fraction). 
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3.2.5.5 Dexamethasone increases the SGK -1 protein level in 1% Triton X -100 
insoluble fractions 
The expression of endogenous SGK -1 protein in Triton X -100 insoluble fraction (figure 
3.10) raised the possibility that dexamethasone may selectively influence the Triton X- 
100 insoluble fraction of SGK -1. 
As maximal glucocorticoid induced mRNA (SGK -1) level was obtained with 100 nM 
dexamethasone given for 120 min, STREX -HA stable HEK 293 cells were treated with 
100 nM dexamethasone or vehicle (0.001% DMSO) for 120 min. The cells were 
homogenized in the presence of detergent (1% Triton X -100). The Triton X -100 
insoluble fraction (pellet) and Triton X -100 soluble fraction (supernatant) separated at 
20,000 g ( "Materials and Methods" section 2.4.4) and subjected to SDS -PAGE and 
Western blot analysis using anti -SGK -1 antibody. The blots with the Triton X -100 
soluble fraction were standardized by staining for cyclophilin A (figure 3.11 B). 
Most proteins are stained by Coomassie Blue to approximately the same extent. It is 
therefore convenient to estimate the amount of protein in the gel by Coomassie- stained 
band. Thus, the amount of protein in the Triton X -100 insoluble fraction was 
standardized by prominent Coomassie blue stained band in the blot (figure 3.11 B). 
The results showed that dexamethasone had no significant effect on the level of SGK -1 
protein in the supernatant (figure 3.11C). In contrast, 100 nM dexamethasone for 120 
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Figure 3.11: Effect of dexamethasone on the levels of SGK -1 
protein in 1% Triton X -100 insoluble fraction 
STREX -HA stable cells were treated with 0.001% DMSO for 120 min (control vehicle group) or 
100 nM dexamethasone for 120 min (Dex120). The cells were homogenized in the present of 1% 
Triton X -100 lysis buffer. Equal amounts of proteins from supernatant (Triton X -100 soluble 
fraction) or pellet (Triton X -100 insoluble fraction) were loaded onto a 12.5 % SDS -PAGE gel and 
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transferred to a PVDF membrane in Phastsystem apparatus. A: ECL staining for SGK -1. B: 
Amount of loaded protein was determined by Coomassie blue staining (selected band is shown 
by arrow) for Triton X -100 insoluble soluble fraction and by cyclophilin A protein for Triton X -100 
soluble fraction. C: The average of the ratio of O.D of SGK -1 to Coomassie blue or cyclophilin A 
from three independent experiments. The ratio of the O.D of SGK -1 to Coomassie blue in Triton 
X -100 insoluble fraction for the respective vehicle group was calculated and the corresponding 
ratio for dexamethasone 120 min was expressed as percentage of this value. The ratio of the 
O.D of SGK -1 to cyclophilin A in Triton X -100 soluble fraction for the respective vehicle group 
was calculated and the corresponding ratio for dexamethasone 120 min was expressed as 
percentage of this value. Values are reported as Means ± S.E.M,* significant difference (p <0.05, 
ttest, n =3 /group) vs. vehicle control group. 
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3.2.5.6 Lack of an association of SGK -1 protein with STREX -HA variant BK 
channels 
The rapid induction of SGK -1 mRNA (section 3.2.4) by dexamethasone in HEK 293 
cells raised the possibility that SGK -1 could be a mediator of the glucocorticoid control 
of BK channels. In order to probe for a potential physical interaction of SGK -1 with the 
BK channel complex, STREX -HA variant BK channel cc- subunits were 
immunoprecipitated using sheep antisera against the BK channel cc- subunits (anti - 
STREX + anti -S869) (described in section 2.4.5.1) from STREX -HA stable HEK 293 
cells pretreated with 100 nM dexamethasone or 0.001% DMSO (vehicle) for 120 min. 
Immunoprecipitates were probed for the presence of SGK -1 and HA reactive protein 
bands in immunoblots using anti -SGK -1 antibody and anti -HA antibody ( "Materials and 
Methods" table 2.2). No co- immunoprecipitation of endogenous SGK -1 protein was 
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Figure 3.12: Lack of an association of SGK -1 with STREX -HA 
variant BK channel 
HEK 293 cells stably expressing the STREX -HA variant BK channel cc- subunits were treated with 
0.001% DMSO for 120 min (control vehicle group) or 100 nM dexamethasone for 120 min. The 
cells were lysed in 1% Triton X -100 lysis buffer. STREX -HA BK channels were 
immunoprecipitated with sheep antisera against BK channel cc- subunit (anti -STREX + anti - 
S869). Whole cell extracts and immunoprecipitates (IPs) were loaded onto a 12.5% SDS -PAGE 
gel and electrotransferred to a PVDF membrane in Phastsystem apparatus. A: an 
immunoreactive band of -132 K molecular weight corresponding to the STREX -HA BK channel 




In an attempt to detect the glucocorticoid- inducible proteins in HEK 293 cells, we 
demonstrated that: 
i) Glucocorticoids regulate the transcription of glucocorticoid responsive reporter 
plasmids via endogenous glucocorticoid receptors in a concentration- and time - 
dependent manner in HEK 293 cells. 
ii) Levels of Dexrasl mRNA are readily detectable in HEK 293 cells and are not altered 
by exposure to dexamethasone. In contrast, dexamethasone rapidly augmented SGK -1 
mRNA expression in HEK 293 cells. 
iii) Glucocorticoids increased the level of SGK -1 protein in Triton X -100 insoluble 
fraction. 
iv) SGK -1 was not associated with STREX -HA variant BK channel cc- subunit and 
treatment with dexamethasone did not lead to the association of SGK -1 with the BK- 
channel cc- subunit. 
3.3.1 MMTV -LTR luciferase activity in HEK 293 cells 
Previously Tian et al (Tian et al., 2001b) have shown the presence of type II 
glucocorticoid receptor immunoreativity in HEK 293 cells as well as concentration 
dependent stimulation of luciferase activity driven by the MMTV -LTR promoter in 
transient transfections. As this work was restricted to 120 min exposure to 
dexamethasone, the present study set out to examine more detail the time -course and 
concentration -dependence of glucocorticoid action in HEK 293 cells. Measurements of 
MMTV -LTR luciferase activity confirmed that dexamethasone acts via endogenous 
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glucocorticoid receptors in HEK 293 cells in a concentration- and time -dependent 
manner with maximal activity at 120 min exposure to 100 nM as previously reported by 
Tian et al (Tian et al., 2001 b). 
Tian and co- workers (Tian et al., 2001b) reported that dexamethasone produced a 
concentration -dependent stimulation of luciferase activity with a KD of 4.5 ± 3.6 nM in 
HEK 293 cells, we found the EC50 of luciferase activity at 33.6 nM dexamethasone. 
The shifting of the concentration - response curve of luciferase activity to the right in this 
study compared with Tian's study may be due to several factors like different 
concentrations and conditions used for transient transfection of MMTV -LTR- luciferase 
reporter construct, different cell passages, different pre- treatment and dexamethasone 
treatment ways. 
MMTV luciferase activity in different cells such as culture of transformed monkey 
kidney, COS -7 cells (Ray et al., 1999) and breast cancer cells, MDA -MB -453 (Wilson et 
al., 2002) showed the activation of the type ll glucocorticoid receptor by 
dexamethasone. In COS -7 cells, significant MMTV luciferase activity was achieved at 
0.1 nM by dexamethasone and maximal activity at 100 nM (Ray et al., 1999). 
3.3.2 Effect of dexamethasone on the level of Dexrasl mRNA in HEK 293 cells 
Kemppainen showed that Dexrasl mRNA is increased by dexamethasone in AtT -20 
corticotroph cells (Kemppainen and Behrend., 1998). Presence of Dexrasl has been 
recently reported in pituitary tissue (Kemppainen et al., 2000) and human tissues like 
heart, liver, skeletal muscle, kidney and pancreas cells (Tu and Wu., 1999). Another 
104 
study has identified a putative glucocorticoid response element in the Dexrasl promoter 
(Kemppainen et al., 2000). 
Our RT -PCR revealed no detection of full -length Dexrasl mRNA in HEK 293 cells, but 
two fragments of overlapping Dexrasl cDNA in the PCR indicated that full -length 
Dexrasl mRNA appears to be present in HEK 293 cells. This was confirmed by 
Northern mRNA analysis. 
Many different things might have caused the failure to amplify full -length of Dexrasl, for 
example; Insufficient template, insufficient primer, poor primer design, e.g. low melting 
temperature, contamination that inhibits the DNA polymerase (proteins, residual salts, 
residual organic chemicals, detergents). 
DNA template quality and the amount of template are very important in order to obtain a 
PCR reaction and too little DNA fails to gives a PCR product (Chandler et al., 1998). 
One possible explanation of a lack of amplification of Dexrasl cDNA from HEK 293 
cells may be the quality or low abundance of RT template in the PCR reaction. Further 
RT -PCR, with greater RT concentration ( >0.25 pg) could resolve this issue. 
Indeed it appeared that shorter products could be readily amplified from the Dexrasl 
mRNA in the same reactions indicating that Dexrasl mRNA is indeed present in HEK 
293 cells. As these PCR reactions amplified across the entire Dexrasl coding region it 
appears likely that PCR reaction conditions as opposed to lack of sufficient full -length 
template were at fault. 
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Northern blot analysis of Dexrasl 
The present data showed the presence of a 5 kbp Dexrasl mRNA in HEK 293 cells 
which was similar to that reported in human fibrosarcoma HT -1080 cells (Tu and Wu., 
1999). Although 100 nM dexamethasone induced Dexrasl mRNA within 30 min 
exposure the highest induction occurred at 120 min in AtT20 cells (Kemppainen and 
Behrend., 1998). In HEK 293 cells, we found no change of the level of Dexrasl mRNA 
in response to 100 nM dexamethasone up to 120 min. A possible explanation of the 
lack of induction of Dexrasl mRNA in HEK 293 cells is that the basal level of the 
Dexrasl mRNA was already high and readily detectable in HEK 293 cells. In contrast 
Dexrasl mRNA was undetectable by Northern analysis in AtT20 cells (Kemppainen and 
Behrend., 1998). Thus varying the conditions of the experiment to achieve low basal 
Dexrasl mRNA level may lead to a system where Dexrasl is induced. Indeed a 
glucocorticoid response element has been identified 3' of the Dexrasl polyadenylation 
site and shows complex, context dependent activity in reporter gene constructs 
(Kemppainen et al., 2003). Overall, the lack of induction of Dexrasl mRNA by 
dexamethasone in HEK 293 cells does not exclude Dexrasl as a potential mediator of 
dexamethasone action. Further experiments with Dexrasl gene knock -down technology 
could address this issue. 
As a positive control for glucocorticoid mediated gene- induction, the expression of SGK- 
1 mRNA was assessed by Northern blot in HEK 293 cells. These studies showed that 
dexamethasone (100 nM) significantly increased SGK -1 mRNA in a time -dependent 
manner, a significant increase occurred within 15 min of steroid exposure and maximal 
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induction was found by 30 min. Similar results were reported in A6 cells by induction of 
SGK -1 mRNA in a time -dependent manner in response to 100 nM dexamethasone with 
maximal activity at 30 min (Chen et al., 1999b). Therefore, the rapid induction of SGK -1 
mRNA in A6 cells (Chen et al., 1999b) and HEK 293 cells in the present study (section 
3.2.4) raised the possibility that SGK -1 is a glucocorticoid- induced mediator in HEK 293 
cells. 
3.3.3 Western blot analysis of SGK -1 
The present study showed that 100 nM dexamethasone had no effect on endogenous 
SGK -1 protein levels in Triton X -100 or NP -40 soluble fractions prepared from HEK 293 
cells. In contrast SGK -1 protein levels in the Triton X -100 insoluble fraction were 
increased by dexamethasone. Under condition used in the present study, SGK -1 is 
largely restricted to the particulate fraction in HEK 293 cells and a substantial proportion 
(over 50 %) is solubilised by 1% Triton X -100 (figure 3.10). Dexamethasone appeared to 
increase the SGK -1 protein in a membrane domain which was not solubilised by Triton 
X -100. The lack of a detectable change in the amount of total SGK -1 protein is likely to 
be due to the relative amount of the Triton X -100 insoluble protein being low as a 
proportion of the total protein. 
It has been shown that glucocorticoids increase phosphoinositide 3 (P13) kinase (a 
subfamily of lipid kinases) activity by more than four -fold in a concentration -dependent 
manner, an effect which was blocked by RU486, LY294002 and wortmannin (Hafezi- 
Moghadam et al., 2002). Furthermore, SGK -1 is also regulated by the P13- kinase 
signaling pathway (Gamper et al., 2002b; Park et al., 1999; Kobayashi et al., 1999). It 
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has been shown that the key phosphorylation sites on SGK -1 are Thr256 and Ser422, 
that are targeted by PI3 kinase (Kobayashi and Cohen., 1999). Furthermore, Western 
blot analysis revealed a direct interaction between PI3 kinase and the catalytic domain 
of SGK- 1(Park et al., 1999). 
Therefore, it is hypothesize that the distribution of SGK -1 in Triton X -100 soluble and 
insoluble fraction (crude particular fraction) is regulated by phosphorylation via P13 
kinase. The identification of the upstream components between PI3- kinase and SGK -1 
will be crucial for understanding this signaling pathway. 
Lack of association of endogenous SGK -1 protein with BK channel 
Although, our results revealed that endogenous SGK -1 is not associated with STREX- 
HA BK channel cc- subunit in vehicle- treated and dexamethasone- treated STREX -HA 
stable HEK 293 cells, the data do not rule out that dexamethasone regulates BK 
channels through SGK -1. 
It has been demonstrated that SGK -1 regulates the epithelial sodium channels via 
binding and phosphorylation of Nedd4 -2 protein (Snyder et al., 2002; Debonneville et 
al., 2001). A similar scenario is also possible for BK channels. In order to address this, 
gene knock -downs of SGK -1 could be carried out in combination with 
electrophysiological analysis of BK- channel activity. In case of a positive outcome, 
indicating an involvement of SGK -1 in the regulation of BK channels, 
immunoprecipitation of SGK -1 protein from vehicle- treated and dexamethasone -treated 
BK channel stable HEK 293 cells could be carried out followed by analysis of the 
108 
immunoprecipitates for associated proteins by mass spectrometric methods. This 
should provide evidence as to the nature of SGK -1 target protein in HEK 293 cells. 
In conclusion: SGK -1 but not Dexrasl is a protein rapidly induced by dexamethasone 
in HEK 293 cells. SGK -1 is not in complex with STREX -HA BK channels, and 
dexamethasone does not lead to the association of SGK -1 with the channel. 
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Chapter Four 
Association of protein 
phosphatase 2A with BK channels 
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4.1 Introduction 
Based on evidence summarised in chapter 1 section 1.3.4 it is justified to hypothesize 
glucocorticoids may exert their effects through protein phosphatase activity at the level 
of the BK channel complex. Identification of the BK channel complex as a target for 
glucocorticoid action should allow us to characterize glucocorticoid- induced proteins 
involved in ion channel regulation and provide further insights into the mechanism and 
role of rapid glucocortiçoid regulation of excitability in neuroendocrine and neuronal 
cells. 
Thus to address this hypothesis, we used biochemical approaches to investigate: 
i) Does PP2A associate with the BK channel complex? 
ii) Do glucocorticoids alter the amount of PP2A associated with the channel? 
iii) Is PP2A association with the BK channel dependent on the presence of the STREX 
splice insert? 
iv) Which region of the BK channel cc- subunit is involved in the association with PP2A? 
v) Is PP2A association region involved in trafficking of BK channels to the plasma 
membrane? 
4.2 Results 
4.2.1 Validation of anti -[HA] antibody in Western blot analysis of STREX -HA and 
ZERO -HA variant BK channels in extracts of HEK 293 cells 
HEK 293 cells stably transfected with HA epitope tagged BK channel a: subunits 
(STREX and ZERO variants) (Tian et al., 2003) were lysed in 1% Triton X -100 lysis 
buffer (described in "Materials and Methods" section 2.4.1) and processed for 
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immunoblots. HA reactive protein bands were detected using rabbit anti -HA antibody 
( "Materials and Methods" table 2.2) which reacts specifically with HA- tagged fusion 
proteins (Tu and Wu., 1998). Western blot analysis revealed the expression of -132 K 
and -125 K protein bands which conform to the expected molecular masses of STREX 
and ZERO variant BK channel cc- subunits, respectively (figures 4.1 and 4.2). 
STREX -HA and ZERO -HA splice variant BK channel cc- subunits stably expressed in 
HEK 293 cells were immunoprecipitated with antisera raised in sheep (anti -STREX 
serum against amino acids 628 -641 and anti -S869 serum against amino acids 919 -933 
of the mouse STREX variant BK channel cc- subunit) (described in "Materials and 
Methods" section 2.4.5.1). The immunoprecipitates (IPs) were separated by SDS -PAGE 
and blotted to PVDF membrane. An immunoreactive band migrating at -132 K was 
observed in IPs from STREX -HA stable HEK 293 cells (figure 4.1) and a -125 K 
immunoreactive band was observed in IPs from ZERO -HA stable HEK 293 cells (figure 
4.2). 
The specificity of the IPs was confirmed in three ways: i) The HA reactive bands were 
not detected in the IPs from non -transfected (wild -type) HEK 293 cells (figure 4.3) or 
pcDNA3 transfected HEK 293 cells (figure 4.5). ii) Immunoprecipitation with preimmune 
sera from the respective sheep in did not result in the pull -down of the -132 K HA 
reactive bands in STREX -HA stable HEK 293 cells (figures 4.1 and 4.2). iii) The 
specificity of Western blot antibody (anti -HA antibody) was demonstrated with 
incubation of blots with HRP secondary antibody alone and no reaction was found 
(figure 4.1 and 4.2). 
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Figure 4.1: Immunoprecipitation of STREX -HA BK channel ff.- 
subunits from HEK 293 cells stably transfected with STREX -HA 
BK channel cc- subunits 
HEK 293 cells stably transfected with hemagglutinin (HA) epitope- tagged STREX variant BK 
channel cc-subunit pcDNA3 plasmid were lysed in 1% Triton X-100 lysis buffer (described in 
"Materials and Methods" section 2.4.1). The cell extracts were immunoprecipitated with antisera 
raised in sheep against BK channel cc- subunits (anti -STREX serum against amino acids 628 -641 
and anti -S869 serum against amino acids 919 -933 of the mouse STREX channel cc- subunit) as 
described in section 2.4.5.1. The lysate and immunoprecipitates (IPs) were run on 7.5% 
homogeneous SDS -PAGE gel and the proteins were transferred to methanol- activated PVDF 
membrane in PhastSystem microelectrophoresis apparatus (Amersham -Pharmacia, Uppsala, 
Sweden) as described in "Materials and Methods" section 2.4.6. A: The transferred blots were 
incubated with rabbit anti -HA antibody, which reacts specifically with HA- tagged fusion proteins 
(Tu and Wu, 1998) and a -132 K HA- reactive protein band (arrow), was found in whole cell 
extracts and IPs. The HA- immunoreactive band was absent from IPs with sheep non -immune 
serum, demonstrating specificity of IP antisera. B: The specificity of Western blot antibody (anti - 
HA antibody) was checked by incubating the blots with HRP- conjugated anti -rabbit antibody 
alone. Western blot analysis: Rabbit anti -HA antibody (1/1000). HRP- conjugated anti -rabbit 
antibody (1/3000); Detection was by ECL. 
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Figure 4.2 
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Figure 4.2: Immunoprecipitation of ZERO -HA BK channel c.- 
subunits from HEK 293 cells stably transfected with ZERO -HA 
variant BK channel cc- subunits 
HEK 293 cells transfected with HA epitope- tagged ZERO variant BK channel cc-subunits were 
lysed in 1% Triton X -100 lysis buffer (described in "Materials and Methods" section 2.4.1). The 
cells extracts were immunoprecipitated with sheep antisera (described in section 2.4.5.1). The 
extracts and IPs were run on 7.5% homogeneous SDS -PAGE gel and transferred to PVDF 
membrane in PhastSystem apparatus (section 2.4.6). A: The transferred blots were incubated 
with rabbit anti -HA antibody and a -125 K HA- immunoreactive band (arrow) was found in the IPs 
and whole cell lysates. The specificity of IP antisera was demonstrated by sheep non -immune 
serum B: The specificity of Western blot antibody was determined by incubating the blots with 
HRP- conjugated anti -rabbit antibody alone. Western blot analysis: Rabbit anti -HA antibody 
(1/1000). HRP- conjugated anti -rabbit antibody (1/3000); Detection was by ECL. 
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4.2.2 Co- immunoprecipitation of endogenous protein phosphatases with BK 
channels in stably transfected HEK 293 cells 
Electrophysiological studies demonstrated that dexamethasone blocks the PKA- 
mediated inhibition of STREX variant BK channel via regulation of PPase activity 
associated with the channel complex (Tian et al., 2001 b; Tian et al., 1998). To probe a 
potential stable physical association between the BK channel protein and protein 
phosphatases, the BK channel oc- subunits were immunoprecipitated with sheep antisera 
against the BK channel cc-subunits (described in "Materials and Methods" section 
2.4.5.1) from STREX -HA and ZERO -HA stable HEK 293 cells. The IPs were separated 
by 12.5% SDS -PAGE gel and blots were probed with anti -PP2A antibodies (rabbit anti - 
PP2A-A, regulatory subunit of PP2A, antibody and mouse anti -PP2A -C, catalytic 
subunit of PP2A, antibody). The results showed co- immunoprecipitation of the -65 K 
regulatory subunit of PP2A (PP2A -A subunit) as well as the -36 K catalytic subunit of 
PP2A (PP2A -C subunit) with both STREX -HA and ZERO -HA variant BK channel cc- 
subunits (figure 4.3). 
IPs from non -transfected HEK 293 cells and HEK 293 cells transfected with pcDNA3 
vector were used in parallel as controls of specificity. The Western blot analysis showed 
no protein phosphatase subunit immunoreactivity in the IPs of wild -type HEK 293 cells 
(figure 4.3) or HEK 293 cells transfected with pcDNA3 vector (figure 4.5), indicating that 
the PP2A subunits are associated with the BK channels. 
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Figure 4.3 
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Figure 4.3: Co- immunoprecipitation of STREX -HA and ZERO -HA 
variant BK channel cc- subunits with PP2A 
Wild -type HEK 293 cells and HEK 293 cells stably expressing STREX -HA and ZERO -HA variant 
BK channel cc-subunits were lysed in 1% Triton X -100 lysis buffer (section 2.4.1). The extracts 
were immunoprecipitated with sheep antisera anti -BK channel cc- subunits (section 2.4.5.1). The 
IPs were subjected to 12.5% SDS -PAGE and Western blot (section 2.4.6) A: A -132 K HA- 
reactive protein band (corresponding to STREX -HA channel cc- subunits, top arrow) and a -125 K 
HA- reactive protein band (corresponding to ZERO -HA channel cc- subunits, bottom arrow) were 
detected using 1/1000 rabbit anti -HA antibody. No HA- reactive band was found in wild -type HEK 
293 cells. B: Co- immunoprecipitation of BK channel cc-subunits (STREX -HA and ZERO -HA 
variants) with regulatory subunit of PP2A, PP2A -A, subunit ( -65 K, shown by arrow) were 
revealed using 1/500 rabbit anti -PP2A -A antibody (Upstate). C: The present of catalytic subunit 
of PP2A, PP2A -C, subunit ( -36 K, shown by arrow) was revealed in the IPs of STREX -HA and 
ZERO -HA channel cc- subunits with 1/500 mouse anti -PP2A -C antibody (Upstate). Western blot 
analysis: HRP- conjugated anti -rabbit antibody (1/3000), HRP- conjugated anti -mouse antibody 
(1/3000); Detection was by ECL. 
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As a further test to verify the association of STREX variant BK channel oc- subunits with 
PP2A, the PP2A -A subunits were immunoprecipitated using rabbit anti- PP2A -A 
antibody (Upstate) and the IPs were analysed for the presence of BK channel proteins. 
SDS -PAGE and subsequent immunoblotting of IPs showed an immunoreactive band of 
-132 K molecular weight corresponding to the STREX -HA BK channel cc- subunits in 
extracts prepared from cells stably expressing STREX -HA variant BK channel cc- 
subunits. No comparable immunoreactive band was found when using protein G- 
sepharose (PGS, beads) alone (figure 4.4), and no reaction was seen in blots of the IPs 
where the primary antibody was omitted (figure 4.4). 
Analogous experiments were carried out to address the association of STREX BK 
channel cc- subunits with PP1 using rabbit anti -PP1 antibody (Upstate) to 
immunoprecipitate PP1 from STREX -HA stable HEK 293 cells. The IPs revealed an 
immunoreactive band of -132 K molecular weight corresponds to the STREX -HA 
variant BK channel cc- subunit and no reaction was found upon omission of the primary 
antibody (figure 4.4). 
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Figure 4.4 
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Figure 4.4: Co- immunoprecipitation of PP2A and PP1 with 
STREX variant BK channel ix- subunits 
HEK 293 cells stably expressing STREX -HA variant BK channel cc.- subunits were 
immunoprecipitated with rabbit anti- PP2A -A antibody and rabbit anti -PP1 antibody (described in 
"Materials and Methods" section 2.4.5.2) or protein -G sepharose (beads, Sigma) alone. A: The 
lysate and IPs were subjected to SDS -PAGE on a 7.5% gel and transblotted (section 2.4.6). The 
blots were incubated with 1/1000 rabbit anti -HA antibody ( "Materials and Methods" table 2.2) and 
a -132 K (arrow) HA- immunoreactive band (plausibly corresponding to the STREX -HA BK 
channel cc- subunit) was found in the IPs of PP2A -A and PP1. The specificity of IPs was shown 
by the absence of HA protein immunoreactivity in precipitations with protein -G sepharose alone. 
B: The specificity of Western blot was determined by incubation of the blots with HRP secondary 
antibody alone. Western blot analysis: Rabbit anti -HA antibody (1/1000), HRP- conjugated anti - 
rabbit antibody (1/3000). Detection was by ECL. 
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4.2.3 Which region of C- terminal of BK channel cc-subunit is required for 
association to PP2A? 
The data reported above revealed that PP2A constitutively associates with STREX and 
ZERO BK channels in HEK 293 cells stably transfected with the respective BK channel 
a- subunits (section 4.22). 
To address which region of the BK channel is required for association to PP2A, HEK 
293 cells were transiently transfected with the following STREX variant BK channels: 
i) Full- length of STREX -HA variant BK channel a- subunits. 
ii) STREX -HA variant BK channel a- subunits truncated at Glycine 1020, (G1020 -HA 
channel: lacks C- terminal 202 amino acid residues and contains domains such as S7- 
S10, RCK domain, calcium bowl and STREX splice insert, refer to figure 1.6). 
iii) STREX -HA variant BK channel a- subunits with no C- terminal, truncated at amino 
acid 322 of C- terminal (1322 -HA channel, lacks C- terminal 900 amino acid residues after 
the transmembrane S6 helix, refer to figure 1.6). 
Full- length STREX -HA BK channel a- subunits and G1020 -HA channels were 
immunoprecipitated with sheep antisera (section 2.4.5.1) and 1322 -HA channels with 
rabbit anti -HA antibody (section 2.4.5.3). The expression of HA- tagged channels and 
PP2A -C subunit was assessed by Western blot analysis using rabbit anti -HA antibody 
and mouse anti- PP2A -C antibody. A representative experiment is illustrated in figure 
4.5. HA- tagged channels were detected in the IPs of STREX -HA BK channel a- subunit 
( -132 K), G1020 -HA channel ( -106 K) and 1322 -HA channel ( -35 K). PP2A -C protein 
band ( -36 K) was detected in the IPs of STREX -HA BK channel and G1020 -HA 
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Figure 4.5 
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Figure 4.5: Co -IP of PP2A -C subunit requires C- terminal of BK 
channel ix- subunit 
HEK 293 cells were transiently transfected with expression plasmids for 1)STREX -HA BK 
channel cc- subunits 2)G1020 -HA channel, STREX -HA BK channel oc- subunits truncated at 
Glycine 1020 of C- terminal 3) 1322 -HA channel, STREX -HA BK channel cc- subunits truncated 
at isoleucine 322 of C- terminal 4) pcDNA3 vector (as control cells) ( section 2.3.1). The 
transfected cells were lysed in 1% Triton X -100 lysis buffer (section 2.4.1). STREX -HA channel, 
G1020 -HA channel and pcDNA3 vector cell lysates were immunoprecipitated with sheep 
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antisera anti -BK channel cc- subunits (section 2.4.5.1). 1322 -HA channels were 
immunoprecipitated with rabbit anti -HA antibody (section 2.4.5.3). The IPs were run on 12.5% 
SDS -PAGE gel, transferred to FL -PVDF membrane and detected by LI -COR (section 2.4.6). A: 
The HA- reactive protein bands, indicated by black arrows, were detected at 1) a -106 K in 
G1020 -HA HEK 293 cells 2) a -132 K in STREX -HA HEK 293 cells and 3) a -35 K in 1322 -HA 
HEK 293 cells, using rabbit anti -HA antibody ( "Materials and Methods" table 2.2). B: a -36 K 
band corresponding to PP2A -C was revealed in the IPs of STREX -HA channel and G1020 -HA 
channel, indicated by black arrows, using 1/500 mouse anti- PP2A -C antibody ( "Materials and 
Methods" table 2.2). Two protein bands with molecular weights of 50 kDa and 25 kDa (red 
arrows) can be visualized, which correspond to the heavy and light chains, respectively, of IgG. 
Western blot analysis: First antibodies were detected by IrDye800- labelled anti -rabbit antibody 
(1/3000), Alexa680- conjugated anti -mouse antibody (1/3000), LI -COR detection. 
121 
Figure 4.6 
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Figure 4.6: Reciprocal Co- immunoprecipitation of PP2A -A with 
STREX -HA BK channel a- subunit 
HEK cells STREX 
channel, 1322 -HA channel constructs (in pcDNA3) and pcDNA3 alone as control (described in 
section 2.3.1). The transfected cells were lysed in 1% Triton X -100 lysis buffer (described in 
section 2.4.1). The cell extracts were immunoprecipitated with anti- PP2A -A antibody (described 
in section 2.4.5.2). The IPs were subjected to 7.5% SDS -PAGE gel, following transferred to 
PVDF membrane and detected using ECL (section 2.4.6). A -132 K HA- reactive band (top 
arrow) corresponding to STREX -HA variant channel detected in the IPs from HEK 293 cells 
transiently transfected with STREX -HA BK channel cc-subunits. Also a -106 K HA- 
immunoreactive protein band corresponding to G1020 -HA variant channel (bottom arrow) was 
detected in the IPs from HEK 293 cells transiently transfected with G1020 -HA variant channel. In 
contrast, no HA band was found in the IPs from HEK 293 cells transiently transfected with 1322 - 
HA variant channel or pcDNA3 alone. Western blot analysis: Rabbit anti -HA antibody (1/1000). 
HRP- conjugated anti -rabbit antibody (1/3000); Detection was by ECL. 
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channel. However, no co- immunoprecipitation of PP2A -C with 1322 -HA was found 
(figure 4.5). 
Subsequent reciprocal immunoprecipitations were performed using rabbit anti- PP2A -A 
antibody (section 2.4.5.2). IPs were subjected to SDS -PAGE and Western blot analysis 
using rabbit anti -HA antibody (Zymed). The data showed co- immunoprecipitation of 
PP2A -A with STREX variant BK channel cc- subunit and G1020 -HA, but not with 1322 - 
HA subunits (figure 4.6): 
Taken together, the results suggest that the association of PP2A with STREX variant 
BK channel cc- subunit is between residues 1322 and G1020. 
4.2.4 Subcellular localisation of C- terminal truncated STREX variant BK channel CI- 
subunit 
To verify which segment of STREX variant BK channel is involved in the targeting of the 
channel to the plasma membrane, HEK 293 cells were transiently transfected with: i) 
Full- length STREX variant BK channel cc- subunits ii) G1020 -HA channels iii) 1322 -HA 
channels. Cells fixed on glass cover slips were processed for indirect 
immunofluorescence using rabbit anti -HA as the primary antibody. The bulk of full - 
length STREX -HA channel cc- subunits was localised at or very near the plasma 
membrane (figure 4.7). G1020 -HA channels showed similar targeting to the plasma 
membrane (figure 4.7). In contrast, STREX -HA channel cc- subunits truncated at 1322 
were diffusely distributed throughout the cell, plausibly reflecting retention in the 
endoplasmic reticulum (ER) (figure 4.7). 
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Figure 4.7 
Immunocytochemical localisation of C- terminal STREX variant 
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Figure 4.7: Immunocytochemical localisation of C- terminal 
STREX variant BK channel x- subunits 
HEK 293 cells were transiently transfected with STREX -HA variant BK channel cc-subunits, 
G1020 -HA channel and 1322 -HA channel. Immunocytochemistry was performed using rabbit 
anti -HA antibody (Zymed) for 3 h at room temperature and 30 min with Alexa Fluor® 488 anti - 
rabbit antibody (described in "Materials and Methods" section 2.4.9). The sections were viewed 
under a Zeiss LSM 510 confocal microscope. The bar denotes 10 micrometers. A: Fluorescence 
image of HEK 293 cells transiently transfected with STREX -HA variant BK channel oz-subunits 
was prominently localised at the plasma membrane. B: The G1020 -HA channel that lacking C- 
terminal 202 amino acid residues of oc- subunit was also observed at the plasma membrane C: A 
shorter STREX -HA channel cc- subunit (1322 -HA channel, lacking almost the entire C- terminal 
tail) was largely retained in the endoplasmic reticulum (ER). 
124 
Thus, these data demonstrated that STREX -HA BK channel cc- subunits are localised at 
the plasma membrane and that in addition to the association with PP2A the C- terminal 
domain of the STREX -HA channel cc- subunit between 1322 and G1020 is critically 
involved in trafficking of the channel to the plasma membrane. 
In summary, the results indicate that STREX BK channel a- subunits localised to the 
plasma membrane associate with PP2A, whereas the variant that showed retention in 
the cytoplasm does not' interact with PP2A. 
4.2.5 No effect of dexamethasone on the amount of immunoreactive PP2A 
associated with STREX BK channels 
To address whether glucocorticoids modify the association of PP2A with the BK 
channel, STREX -HA and ZERO -HA stable HEK 293 cells were pretreated with 100 nM 
dexamethasone or vehicle (0.001% DMSO) for 120 min under the same conditions 
used for previous electrophysiological studies that showed dexamethasone induced 
blockade of PKA- mediated inhibition of STREX variant BK channels through PP2A 
(Tian et al., 2001b). STREX -HA and ZERO -HA variant BK channel cc- subunits were 
immunoprecipitated with the sheep antisera (described in section 2.4.5.1). The 
presence of the PP2A -C subunit in the IPs was probed with mouse anti- PP2A -C 
antibody. 
The PP2A -C and HA bands (corresponding to BK channel cc- subunits) in each blot were 
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Figure 4.8: Effect of dexamethasone on expression of PP2A -C 
associated with STREX variant BK channel cc- subunits 
HEK 293 cells stably expressing STREX -HA variant BK channel or- subunits were pretreated with 
100 nM dexamethasone or vehicle (0.001% DMSO) for 120 min. The cells were lysed in 1% 
Triton X -100 lysis buffer (section 2.4.1) and cell extracts were immunoprecipitated using sheep 
antisera anti -BK channel z.- subunits (anti -STREX + anti -S869) (section 2.4.5.1). IPs were run on 
12.5% SDS -PAGE gel and transferred to FL -PVDF membrane (section 2.4.6). The blots were 
probed for HA- tagged channel (A) and PP2A -C subunit (B) by Western blotting. HA- tagged 
channels ( -132 K, black arrow) and PP2A -C ( -36 K, black arrow) were detected in IPs of 
STREX -HA stable HEK 293 cells pretreated with vehicle or dexamethasone. C: The ratio of O.D 
of PP2A -C to STREX -HA channel at vehicle group was calculated and the corresponding ratio 
for dexamethasone 120 min was expressed as percentage of this value. Data showed no 
change between vehicle and dexamethasone 120 min. Data are Means ± S.E.M, (p <0.05, t test, 
n =3 /group). Two protein bands of IgG (50 kDa and 25 kDa) are showed with red arrows. 
Western blot analysis: Rabbit anti -HA antibody (1/1000), Mouse anti- PP2A -C antibody (1/500), 
IrDye 800 -labelled anti- rabbit antibody (1/3000), Alexa680- conjugated anti -Mouse antibody 
(1/3000), LI -COR detection. 
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Figure 4.9 
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Figure 4.9: Effect of dexamethasone on expression of PP2A -C 
associated with ZERO variant BK channel cc- subunits 
HEK 293 cells stably expressing ZERO -HA variant BK channel cc- subunits were pretreated with 
100 nM dexamethasone or vehicle (0.001% DMSO) for 120 min. The treated cells were lysed in 
1% Triton X -100 lysis buffer (section 2.4.1) and cell extracts were immunoprecipitated by sheep 
antisera (section 2.4.5.1). IPs were run on 12.5% SDS -PAGE gel and transferred to FL -PVDF 
membrane (section 2.4.6). The blots were probed for HA- tagged channels (A) and PP2A -C 
subunits (B) by Western blotting. HA- tagged channels (a -125 K corresponding to ZERO -HA 
variant BK channel cc- subunits, black arrow) and a -36 K corresponding to PP2A -C (black arrow) 
were detected in IPs. C: The ratio of O.D of PP2A -C to ZERO -HA channel at vehicle was 
calculated and the corresponding ratio for dexamethasone 120 min was expressed as 
percentage of this value. Data showed no change between vehicle and dexamethasone 120 min. 
Data are Means ± S.E.M, (p <0.05, ttest, n =3 /group). Two protein bands of IgG (50 kDa and 25 
kDa) are showed with red arrows. Western blot analysis: Rabbit anti -HA antibody (1/1000), 
Mouse anti- PP2A -C antibody (1/500), IrDye 800 -labelled anti -rabbit antibody (1/3000), Alexa 
680- conjugated anti -Mouse antibody (1/3000), LI -COR detection. 
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The data showed that 100 nM dexamethasone for 120 min had no effect on BK channel 
cc- subunit protein expression in STREX -HA stable HEK 293 cells or ZERO -HA stable 
HEK 293 cells (equal protein loading was verified by Coomassie blue staining). To 
determine the effect of dexamethasone on the level of PP2A -C subunit associated with 
BK channels, the ratio of optical densities the PP2A -C and the HA bands were 
compared for the different treatment groups. The data indicated that dexamethasone 
treatment for 120 min did not change the amount of PP2A -C subunit associated with 
STREX -HA BK channel cc- subunits (figure 4.8) or ZERO -HA BK channel cc- subunits 
(figure 4.9). 
4.2.6 Evidence for the association of PP2A -C subunits with native STREX variant 
BK channels in mouse corticotroph tumour (AtT20) cells 
As in transfected HEK 293 cells the level of expression of the transfected protein can be 
over 20 -times the physiological levels (Antoni et al., 1998), it was important to assess 
the association of endogenously expressed BK channels with endogenous PPase. 
Mouse AtT20 corticotroph cells express predominantly STREX variant BK channel 
mRNA and endogenous BK channels in these cells display characteristics similar to the 
STREX variant expressed in HEK 293 cells including the same regulation by PKA and 
PP2A (Tian et al., 2001 b). Mouse AtT20 corticotroph cells were pretreated with 100 nM 
dexamethasone or vehicle (0.001% DMSO) for 120 min. The native BK channels were 
immunoprecipitated using sheep antisera against the BK channel cc- subunits (anti - 
STREX + anti -S869) (described in section 2.4.5.1). Control, STREX -HA stable HEK 293 
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Figure 4.10 
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Figure 4.10: Endogenous co -IP of BK channel with PP2A -C 
subunit in AtT20 cells 
AtT20 cells were pretreated with 0.001% DMSO (Vehicle) or 100 nM dexamethasone for 120 
min. Native BK channels were immunoprecipitated with sheep antisera anti -BK channel cc- 
subunits (anti -STREX + anti -S869) (section 2.4.5.1). STREX -HA stable HEK 293 cell lysates 
were used parallel as control. The specificity of IP antisera in AtT20 cells was checked using IP 
with sheep non -immune serum. The lysates and IPs were separated by electrophoresis (12.5% 
SDS -PAGE gel) and analysed by Western blotting (section 2.4.6). A: BK channel cc-subunits 
(black arrow) were detected using rabbit anti -BK channel C- terminal antibody (Chemicon) 
( "Materials and Methods" table 2.2). No band was detected in IPs of non -immune serum in 
AtT20 cells. B: The association of PP2A -C subunit with BK channel cc-subunits were detected by 
mouse anti- PP2A -C antibody ( "Materials and Methods" table 2.2) as shown using black arrow. 
Two protein bands of IgG (50 kDa and 25 kDa) are showed with red arrows. Western blot 
analysis: Rabbit anti -BK channels C- terminal antibody (1/300), mouse anti- PP2A -C antibody 
(1/500), HRP- conjugated anti -rabbit antibody (1/1000) and HRP- conjugated anti -Mouse antibody 
(1/3000), Detection was by ECL. 
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cells were used as positive controls. The BK channel cc-subunits were detected with an 
antibody against the C- terminus (CHEMICON) (Ling et al., 2003; Friis et al., 2003). The 
immunoreactive bands found were similar to those observed in STREX -HA stable HEK 
293 cells. Furthermore, no immunoreactive band was found in the IPs with preimmune 
sera in AtT20 cells (Figure 4.10). The IPs contained a -36 K band reactive with anti - 
PP2A-C subunit (figure 4.10). Once more, dexamethasone had no effect on the 
apparent amount of PP2A -C co- immunoprecipitating with the cc- subunit (figure 4.10) at 
any of the time -points examined. 
In summary, Single- channel analysis from AtT20 cells (Tian et aL, 2001 b) and rat 
cerebellar Purkinje neurons (Widmer et aL, 2003) demonstrated that the activity of 
BK channels is regulated by multiple endogenous protein kinases and protein 
phosphatases in the membrane patch. These channels were regulated by PKA 
associated with the patch and the extent of PKA activation was limited by an 
opposing endogenous PP2A. Furthermore, it has been shown that in 
hippocampal CA1 neurons and AtT20 cells (Joels & de Kloet., 1989; Shipston et 
a/., 1996; Tian et al., 1998), the activity of BK channels is modulated by 
glucocorticoid- induced signalling pathways. Single- channel recording in HEK 293 
cells also revealed the same glucocorticoid- induced signalling pathway (Tian et 
al., 2001b). However, the underlying mechanism(s) are poorly understood. Our 
results showed that PP2A is constitutively associated with STREX variant as well 
as ZERO variant BK channel cc-subunit in transfected HEK 293 cells. Similar data 
were also obtained in AtT20 cells, where the levels of STREX variant are in the 
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physiological range. Dexamethasone, which has marked PPase- dependent 
effects on the electrophysiological properties of the STREX variant BK channel 
failed to change the apparent amount of immunoreactive PP2A co- 
immunoprecipitated with the channel cc-subunit. Thus, it is reasonable to 
hypothesize that dexamethasone may alter the enzymatic activity rather than the 
amount of the PP2A associated with the STREX BK channel. 
4.3 Discussion 
In an attempt to examine the association of PP2A with BK channels in HEK 293 cells, 
we demonstrated that i) Endogenous serine /threonine PP2A is constitutively associated 
with both STREX and ZERO variant BK channel a- subunit. ii) PP2A association 
requires amino acids 322 -1020 from the cytoplasmic C- terminal domain of the STREX 
BK channel a- subunit. iii) The same segment of the STREX BK channel a- subunit is 
involved in trafficking of the channel protein to the plasma membrane. iv) Glucocorticoid 
action does not appear to involve the recruitment of the PP2A complex to the BK 
channel; rather it could entail stimulation of constitutively associated PPase activity. 
4.3.1 Endogenous serine /threonine PP2A is constitutively associated with BK 
channel a- subunit 
Electrophysiological studies have indicated that BK channels are regulated by PP2A 
and /or PP1 activity closely associated with the BK channel complex (Shipston., 2001; 
Tian et al., 2001 b; Schubert and Nelson., 2001; Hall and Armstrong., 2000; Levitan., 
1999; Wang et al., 1999). Although BK channels have been demonstrated to be 
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regulated by endogenous protein kinases and protein phosphatases in a number of 
systems (Tian et aL, 2001b; Ling et al., 2000; Wang et aL, 1999; White et al., 1991), 
biochemical demonstration of the association of BK channel with protein 
phosphatase(s) has not been previously reported. 
In order to address this issue immunoprecipitations were carried out which is an 
established method for the analysis of protein /protein interactions. We 
immunoprecipitated the BK channel using antisera directed against the BK ix- subunit 
and probed for the presence of co- immunoprecipitating PP2A protein subunits. 
Our biochemical analysis revealed that PP2A is constitutively associated with both 
STREX and ZERO variant BK channels, as immunoblotting of cell lysates and IPs of 
STREX and ZERO variant BK channel cc- subunits from HEK 293 cells stably expressing 
the STREX and ZERO variant BK channel rc- subunits resulted in specific co- 
immunoprecipitation with PP2A -A and PP2A -C subunits. Furthermore, IPs of PP2A also 
confirmed the association of PP2A with STREX variant BK channel x- subunits. 
The specificity of the co -IP was verified extensively. 
1) Specificity of IPs of BK channel cc- subunits were confirmed by no immunoreactive 
band in the i) IPs with preimmune sera from respective sheep ii) IPs with the same 
antisera from wild -type HEK 293 cells or HEK 293 cells transfected with pcDNA3. iii) IPs 
of beads (PGS) alone. 
2) The specificity of Western blotting was also verified. 
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4.3.2 PP2A association requires the cytoplasmic C- terminal segment of the BK 
channel cc- subunit 
Which region of C- terminal of STREX variant channel is involved in association of with 
PP2A? To address this, we used truncated STREX variant BK channel cc- subunits. We 
found STREX variant BK channel cc- subunits truncated at Glycine 1020 (G1020 variant 
channel) have ability to interact with PP2A. Thus, the terminal 202 residues are not 
required for the association of the channel with PP2A. 
In contrast, STREX variant BK channel cc- subunit truncated at isoleucine 322 with no C- 
terminal tail (1322 variant channel) does not have the ability to interact with PP2A. Thus, 
the C- terminal tail of the STREX variant BK channel x- subunit is necessary for the 
interaction with PP2A. 
Taken together the co- immunoprecipitation experiments with G1020 and 1322 
truncations suggest that residues 322 -1020 of the cytoplasmic domain of the STREX 
BK channel o.- subunit are necessary and adequate for the association of PP2A with the 
BK channel. 
Finally, so far the results showed the interaction of A and C subunits of PP2A with BK 
channel c- subunit, therefore to check the association of 13 subunits of PP2A with BK 
channel, further biochemical study in HEK 293 cells using co- immunoprecipitation of ß 
subunit of PP2A with BK channel cc- subunit is required. 
4.3.3 Cytoplasmic tail of STREX variant BK channel cc- subunit is necessary for its 
cell surface expression 
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In polarized epithelial cells of the cortical collecting duct of the kidney, BK channels are 
located in the apical cell membrane (Wang et al., 2003; Woda et al., 2001). Moreover, in 
COS -7 cells (Kwon and Guggino., 2004) and Madin -Darby canine kidney cells (Bravo - 
Zehnder et al., 2000), it has been shown that the cytoplasmic C- terminal of the BK 
channel cc- subunit is involved in BK channel expression to the cell surface. 
To address which region of C- terminal of BK channel cc- subunit is involved for 
trafficking of the channel to the plasma membrane, we focused on the residues 322- 
1020 in the C- terminal of the STREX BK channel cc- subunit which were required for 
association with PP2A (section 4.3.2). Thus we immunostained STREX -HA variant BK 
channel cc- subunits and STREX -HA variant BK channel cc.-subunits truncated at the C- 
terminus (G1020 variant and 1322 variant channels). 
The results demonstrated that i) STREX BK channel rx- subunit expresses in the plasma 
membrane ii) G1020 variant channel expresses in the plasma membrane as well. Thus, 
the missing 202 residues of C- terminal in G1020 variant channel are not required for 
plasma membrane targeting. iii) STREX BK channel 07- subunit truncated at 1322, 
lacking almost the entire C- terminal tail, was largely retained in the endoplasmic 
reticulum and largely failed to reach the plasma membrane. 
Taken together, the localisation studies revealed that the residues 322 -1020 of 
cytoplasmic tail of STREX BK channel cc- subunit is required for trafficking of the STREX 
BK channel to the plasma membrane. 
It has been reported that the C- terminal of BK channel x,-subunit after residue 1117 is 
essential for plasma membrane targeting in COS -7 cells (Kwon and Guggino., 2004). 
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This is in contrast with our study that shows that 202 residues of C- terminal after 
residue glycine 1020 are not critical for the targeting of STREX BK íx- subunits to the 
plasma membrane. Many reasons may be involved for this different trafficking of C- 
terminal truncated BK channel in these two studies. i) Different trafficking may be 
mediated by different sensitivity of antibody used in two immunostainings (rabbit anti -HA 
antibody in present study and rabbit anti -myc antibody in Kwon and Guggino's results). 
ii) Different cells used in these two studies also may be involved in different trafficking. 
To address this, further immunocytochemistry study in COS -7 cells transfected with 
G1020 -HA variant BK channel could resolve this issue. 
4.3.4 Glucocorticoid action does not appear to involve the recruitment of PP2A 
complex to the BK channel 
This study demonstrates that; i) PP2A and PP1 are constitutively associated with BK 
channel. ii) Glucocorticoid does not involve the recruitment of PP2A to the BK channel 
complex in HEK 293 cells or in native BK channel cells, AtT20 cells. 
It has been reported that the blockade of PKA- mediated inhibition of STREX BK 
channel activity by dexamethasone is mediated by PP2A -like activity intimately 
associated with the channels (Tian et al., 2001 b). Analysis of IPs for PP1 in the present 
study suggested much lower abundance when compared with PP2A. Thus, taken 
together suggest that PP2A is main protein phosphatase for regulation of BK channels. 
Therefore, we have analyzed IPs of BK channel a- subunits pretreated with 
dexamethasone for PP2A immunoreactivity. 
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Our results with HEK 293 cells and AtT20 cells show that PP2A is constitutively 
associated with the STREX variant BK channel cc-subunits and dexamethasone fails to 
change the apparent amount of immunoreactive PP2A associated with the channel. 
single -channel recording in AtT20 cells (Tian et al., 1998) and HEK 293 cells (Tian et 
al., 2001 b) revealed that the STREX BK channel splice variant is potently inhibited by 
PKA activity intimately associated with the channel complex and the extent of PKA 
inhibition is limited by PP2A. Intriguingly the action of the PP2A is only evident in 
dexamethasone treated cells. Thus the results of electrophysiological work (Tian et al., 
2001 b; Tian et al., 1998) and our biochemical studies in AtT20 cells and HEK 293 cells 
suggest that the regulation of BK channels by glucocorticoid is likely to be due to 
changes in the enzymatic activity of the associated PP2A rather than the recruitment of 
more PP2A to BK channel. 
In order to confirm this, we propose to analyse protein phosphatase activity (by using a 
malachite green phosphatase assay) of IPs of BK channels treated with 
dexamethasone for different times in HEK 293 cells (transfected with BK channels) and 
in AtT20 cells (as a native source of BK channels). 
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Chapter Five 




General discussion & future work 
Steroid hormones are fundamentally important for body homeostasis by regulating the 
expression of a large number of genes. Glucocorticoid hormones, a class of steroid 
produced in the adrenal cortex, are pivotal for adaptation to environmental challenge in 
a wide range of tissues, but the understanding of the mode of action of these steroids is 
incomplete. 
Identification of the BK channel complex as a target for glucocorticoid action should 
allow us to characterize glucocorticoid- induced proteins involved in the control of ion 
channel activity and provide further insights into the mechanisms of the regulation of 
cellular excitability by glucocorticoids. 
Thus, the aim of the present project was to investigate the expression of glucocorticoid- 
induced proteins and the regulation of BK channels by glucocorticoid hormones using 
molecular and biochemical approaches in HEK 293. 
HEK 293 cells 
The characteristic of glucocorticoid modulation of the cAMP- dependent control of BK 
channels in HEK 293 cells were identical to those observed in AtT20 cells (Shipston et 
al., 1996; Tian et al., 2001a). Moreover, the same protein phosphatase dependent 
signaling cascades on BK channels are induced by glucocorticoids in AtT20 cells (Tian 
et al., 1998) and HEK 293 cells (Tian et al., 2001 b). 
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As the level of endogenous BK channel in AtT20 cells are relatively low, an important 
advance for the biochemical analysis of glucocorticoid signalling to BK channels would 
be the reconstruction of glucocorticoid regulation in a model system that expresses high 
levels of transfected protein. Therefore, HEK 293 cells (which do not endogenously 
express BK channel subunits) are a suitable model for the analysis of glucocorticoid 
regulation of BK channels, and possibly other, ion channels. 
In contrast, there are some disadvantages of using HEK 293 cells. i) HEK 293 cells 
express the glucocorticoid receptor (type lI) and mineralocorticoid receptor, MR (Tian et 
al., 2001 b; Kolla and Litwack., 2000). Glucocorticoids cortisol and corticosterone have 
affinity for binding to the MR (Myles and Funder., 1994) and MR binds specifically to 
GREs (Lombes et al., 1993). Thus, binding of glucocorticoids to MR and following 
binding of MR to GREs may alter the response of glucocorticoid receptors to 
glucocorticoids in HEK 293 cells. ii) High level of BK channels in transfected HEK 293 
cells may lead to non specific protein -protein interaction and therefore, regulation of BK 
channels. 
Therefore, to solve this issue, we checked the results of HEK 293 cells with AtT20 cells 
as native BK channels cells. 
The main findings in this project were as follows: 
i) In HEK 293 cells, dexamethasone exerts its actions via endogenous glucocorticoid 
receptors in a concentration- and time -dependent manner. 
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ii) High levels of Dexrasl mRNA are expressed by HEK 293 cells and exposure of the 
cells to dexamethasone has no effect on the levels of Dexrasl mRNA. 
iii) In HEK 293 cells, SGK -1 mRNA levels are increased by dexamethasone in a time- 
and concentration -dependent manner. 
iv) The amount of SGK -1 protein in a Triton X -100 insoluble fraction was increased by 
dexamethasone. 
v) Endogenous SGK -1 is not associated with STREX BK channel cc- subunits and 
dexamethasone does not lead to association of SGK -1 protein with the channel. 
vi) Endogenous serine /threonine PP2A is constitutively associated with STREX and 
ZERO BK channel cc- subunits in HEK 293 cells as well as AtT20 cells. 
vii) PP2A association with STREX BK channel cc- subunits requires the cytoplasmic C- 
terminal domain of the cc- subunit (residues 322 -1020). These residues are also involved 
in the trafficking of the cc- subunit to the plasma membrane. 
viii) In HEK 203 cells, treatment with dexamethasone did not alter the amount of PP2A- 
A or C subunits associated with the cc- subunit of the BK channel. 
There is consonant evidence from hippocampal CA1 neurons (Joëls and De Kloet., 
1989) and neuroendocrine tumour (AtT20) cells (Shipston et al., 1996) which shows that 
glucocorticoid action is mediated by type ll glucocorticoid receptors, occurs within 2 h 
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and requires de novo synthesis of mRNA as well as protein. In this study, the MMTV- 
LTR luciferase reporter plasmid data showed that HEK 293 cells contain endogenous 
glucocorticoid receptors and are maximally activated by 100 nM dexamethasone within 
2 h. Therefore, 100 nM dexamethasone (up to 2 h exposure) was used in this study to 
investigate the expression of glucocorticoid- induced proteins and the regulation of BK 
channels by dexamethasone in HEK 293 cells. 
The levels of various mRNAs such as SGK -1 (Webster et al., 1993a) and Dexrasl 
(Kemppainen and Behrend., 1998) are reportedly increased by glucocorticoids (within 2 
h) but there is currently no published information whether or not the SGK -1 or Dexrasl 
are glucocorticoid- induced proteins in HEK 293 cells. 
Dexrasl 
Dexrasl, a newly identified member of the Ras superfamily of proteins, was discovered 
in AtT -20 corticotroph cells in 1998 as a gene rapidly induced by dexamethasone 
(Kemppainen and Behrend., 1998). Several nucleotide sequences predicting proteins 
with high degrees of homology to mouse Dexrasl have been reported, including human 
Dexrasl (GenBank Accession No. AF069506) and rat Dexrasl (GenBank Accession 
No. AF239157), which share 98% homology with mouse Dexrasl (Cismowski et al., 
1999). Dexrasl is expressed in several tissues including heart, liver, skeletal muscle, 
kidney, pancreas cells (Tu and Wu., 1999) and the pituitary gland (Kemppainen et al., 
2000). Recently, a glucocorticoid response element has been identified in the 3'- flanking 
region of the human Dexrasl gene (Kemppainen et al., 2003). 
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The fact that the Dexrasl gene is rapidly and positively responsive to glucocorticoids 
suggests that this molecule may serve a role mediating effects of these steroids. As the 
aim of this thesis project was to investigate the mechanisms by which glucocorticoid 
hormones regulate the activity of BK channels in HEK 293 cells, we addressed whether 
or not Dexrasl is a glucocorticoid- inducible protein in these cells. For this aim, Dexrasl 
mRNA was examined by RT -PCR and Northern blot analysis in HEK 293 cells. 
Although full -length Dexrasl mRNA could not be detected by RT -PCR in HEK 293 cells, 
experiments with overlapping primer pairs clearly indicated the presence of full -length 
Dexrasl mRNA. The Northern mRNA analysis also confirmed the presence of full - 
length Dexrasl mRNA in HEK 293 cells. Several different factors might have caused 
the failure to amplify the full length mRNA in RT -PCR, for example; insufficient template, 
insufficient primer, poor primer design and contamination that inhibits the DNA 
polymerase. 
Northern mRNA in AtT -20 corticotroph cells showed that dexamethasone increases the 
level of Dexrasl mRNA (40 -fold) within 30 min, with levels declining sharply after 2 h of 
treatment (Kemppainen and Behrend., 1998), but Northern mRNA analysis in the 
present project revealed no change in the level of Dexrasl mRNA in response to 100 
nM dexamethasone in HEK 293 cells. It is reasonable to suggest that the lack of a 
change of Dexrasl mRNA in response to dexamethasone may be due to the high basal 
level of Dexrasl mRNA expressed in these cells. Varying of the conditions of the 
experiment to achieve low basal Dexrasl mRNA level may lead to a system where 
Dexrasl is induced. 
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No induction of Dexrasl mRNA strongly suggests that under the same conditions in 
which dexamethasone regulates BK channel in HEK 293 cells, Dexrasl does not play a 
major role. However, experiments with Dexrasl gene knock -down technology should be 
used to address a possible involvement of Dexrasl in glucocorticoid action in HEK 293 
cells. 
SGK -1 
Previous studies havé reported the rapid induction of SGK -1 in response to 
dexamethasone in various cell types (Chen et al., 1999b; Webster et al., 1993a); 
however there was no evidence available for HEK 293 cells. In the present study, 
Northern mRNA and Western immunoblots of SGK -1 revealed that SGK -1 is a potential 
mediator of glucocorticoid action in HEK 293 cells. Because of constraints of time the 
issue as to whether SGK -1 is a genuine early gene- induction by dexamethasone or 
involves another mRNA and protein was not probed with blockers of protein synthesis. 
However, the significant rise of SGK -1 mRNA within the first 15 min of dexamethasone 
exposure strongly suggests that this is indeed a primary gene induction. 
The potential functional role of SGK -1 as a mediator of glucocorticoid action in HEK 293 
cells should be explored. As there are no specific pharmacological blockers of SGK -1 
activity, a genetic knock -down approach such as anti -sense RNA or double stranded 
RNA interference would be required. Provided these manipulations bring about the 
desired reduction of SGK -1 protein levels, the effects of these manipulations on 
glucocorticoid induced changes in the characteristics of the BK channel could be 
analysed. A major challenge in this context would be to prove that it is indeed the 
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glucocorticoid regulated pool of Triton X100 insoluble SGK -1 protein that is contributing 
to the glucocorticoid effect. Virtually nothing is known about the intracellular targeting of 
this kinase to intracellular compartments. It is of note, that SGK -1 activity is controlled 
via the PI3- kinase signaling pathway (Gamper et al., 2002b; Park et al., 1999; 
Kobayashi et al., 1999), which is known to influence the membrane association of 
various signaling proteins. Thus, inhibition of PI -3 kinase activity by drugs such as 
wortmannin or LY294002 and monitoring of SGK -1 levels in the Triton X -100 insoluble 
fraction may shed light on this question. A further issue would be to prove that it is 
indeed the protein kinase activity of SGK -1 that is involved. For this purpose, dominant 
negative mutants lacking kinase activity (Park et al., 1999) could be transfected and the 
impact on dexamethasone mediated modulation of BK- channel activity analysed. 
Should a role for SGK -1 in dexamethasone action on BK channels emerge from the 
experiments outlined above, it would be important to determine the target(s) of SGK -1 
phosphorylation. The present project demonstrated no association of STREX BK 
channel ix-subunit with SGK -1 protein in HEK 293 cells. Furthermore, the STREX BK 
channel oc- subunit, which is sufficient for dexamethasone mediated regulation of BK 
channel activity, contains no consensus sites for phosphorylation by SGK -1. Thus, any 
involvement of SGK -1 in the regulation of the BK channel is likely to be indirect, i.e. 
through the phosphorylation of molecules distinct from channel subunits. Mass 
spectrometric identification of the proteins co- immunoprecipitating with BK channels 
may help to uncover the nature of proteins that contribute to the BK channel signaling 
complex and whether or not these might be substrates of SGK -1. 
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Interaction of PP2A with BK channel c.- subunit 
Reversible protein phosphorylation represents a fundamental cellular regulatory 
mechanism to control the activity and function of plasma membrane ion channels 
(Levitan., 1999). The co- ordination, specificity, and compartmentalization of ion channel 
regulation by reversible protein phosphorylation is facilitated by assembly with signaling 
complexes comprising cognate protein kinases and protein phosphatases. BK channels 
have been widely exploited as models of ion channel regulation by reversible protein 
phosphorylation through the action of multiple protein kinases and phosphatases that 
are associated with the channel complex (Widmer et al., 2003; Shipston., 2001; Tian et 
al., 2001 a; Hall and Armstrong., 2000; Levitan., 1999; Wang et al., 1999; Reinhart and 
Levitan., 1995; Bielefeldt and Jackson., 1994; White et aL, 1991) For example, single - 
channel analysis from inside -out patches isolated from the soma of dissociated rat 
cerebellar Purkinje neurons demonstrated that the activity of BK channels is regulated 
by PKA and PP2A in the membrane patch (Widmer et al., 2003). 
In mammalian pituitary tumour cells, somatostatin (an agonist of Gi- coupled receptor) 
increases the activity of BK channels through dephosphorylation of a cAMP- dependent 
phosphorylation site in the BK channel protein or a closely associated regulatory 
molecule by one or more protein phosphatases (White et al., 1991). 
In AtT20 cells (Tian et al., 1998) and HEK 293 cells (Tian et al., 2001 b), the STREX BK 
channel cc-subunit is potently regulated by PKA and protein phosphatase activity 
intimately associated with the channel complex. 
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Although BK channels are potently regulated by dephosphorylation by multiple protein 
phosphatases (Widmer et al., 2003; Tian et al., 2001 b; Tian et al., 1998; White et al., 
1991), the molecular identity of protein phosphatase(s) assembled with the BK channel 
complex is unknown. 
The dynamic interactions of protein phosphatases with the BK channel complex provide 
an important mechanism to tune BK channel function and behaviour. Thus, in order to 
address the association of BK channel with protein phosphatase(s), 
immunoprecipitations, which is an established method for the analysis of protein /protein 
interactions, with antisera directed against the BK channel cc- subunits were carried out 
in HEK 293 cells as the model system for glucocorticoid- action. 
In the present study, the ability of both STREX and ZERO BK channel splice variants cc- 
subunits to co- immunoprecipitate endogenous catalytic and regulatory subunits of PP2A 
demonstrated that endogenous PP2A is in constitutive association with both types of BK 
channel x.- subunits tested. This result supports previous electrophysiological and 
pharmacological data showing that BK channel function is regulated via endogenous 
PP2A -like phosphatase activity associated with the channel (Tian et al., 2001 b). In this 
context two issues are of importance, firstly the mode of association of PP2A with the 
channel and secondly the regulation of PP2A activity associated with the channel. 
BK channels show considerable diversity in their modulation by distinct 
kinase /phosphatase signaling pathways (Shipston., 2001; Levitan., 1999). For example, 
Serine -942 (S942) of the drosophila BK channel was identified as a putative site of 
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direct phosphorylation by PKA following the inhibition of the PKA- mediated response 
(Nara et al., 1998; Esguerra et al., 1994). 
The alternative splicing at site of splicing C2 in the mouse BK channel C terminus 
generates five distinct splice variants: ZERO, e20, e21(STREX), e22, and e23. These 
splice variants are differentially sensitive to phosphorylation by endogenous cAMP- 
dependent protein kinase; ZERO, e20, and e22 variants are all activated, whereas e21 
(STREX) is the only variant that is inhibited (Chen et al., 2005). The distinct response of 
the STREX and ZERO channel o :subunits to PKA is the result of the differential 
phosphorylation of specific PKA consensus sites (S4sTREx and S869) within the splice 
variants (Tian et al., 2001 b). The activation of ZERO BK channel by cAMP- dependent 
protein kinase is dependent upon a conserved C- terminal PKA consensus motif (S869), 
whereas inhibition of STREX BK channels by cAMP- dependent protein kinase is 
dependent to a PKA consensus site in the STREX insert (S4sTREx) of the C- terminus 
(Tian et al., 2001 a). 
Throughout this study, the data demonstrated that the cytoplasmic C- terminal segment 
(residues 322 -1020) of the STREX variant BK channel cx- subunits, which contain 
S4STREX and S869, was necessary for the association of the channel with PP2A. Thus, 
in order to address whether the PKA consensus sites (S4sTREx and S869) are or are not 
target for interaction of PP2A with STREX and ZERO BK channel o. subunits, further 
co- immunoprecipitations of PP2A with STREX and ZERO variants BK channel cc- 
subunits in which the S4STREX and S869 sites have been mutated to alanine (S869A and 
S4sTRExA) could be performed to clarify this issue. 
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Recently a structural motif, the leucine zipper (LZ) in the C- terminus of BK channels, 
originally described in classes of DNA -binding proteins (Landschulz et al., 1988), has 
been reported to play an important role in coordinating both the assembly of ion 
channels as well as their interaction with protein kinase and protein phosphatase 
signaling complexes (Tian et al., 2003; Marx et al., 2002; Hulme et al., 2002; Marx et al., 
2001; Simmerman et al., 1996). It has been demonstrated that Leucine zipper 1 (LZ1, 
residues 513 -543) is required for the association and regulation of the channels by PKA, 
and other putative leucine zippers in the BK channel protein may provide anchoring for 
further regulatory enzyme complexes (Tian et al., 2003). Thus, the use of LZ may be 
found to be a common mechanism of regulating and mediating protein -protein 
associations with profound implications, especially to the elucidation of the functioning 
and component identification of dynamic signaling complexes. 
In this study, the data demonstrated that PP2A constitutively associated with the 
cytoplasmic C- terminal domain of STREX variant BK channel cc- subunits, which 
contains LZ1 and LZ2 (Tian et al., 2003). Thus, to address whether LZ1 or LZ2 is 
required for interaction of PP2A with BK channels, Western immunoblots of co- 
immunoprecipitations of PP2A with BK channels from LZ1 or LZ2 mutant BK channel oc- 
subunits could be carried out. 
Protein kinases and protein phosphatases may associate with ion channels directly 
(Levitan., 1999; Wang et al., 1999) or through adaptor proteins, for example A kinase 
anchoring proteins (AKAPs) (Hulme et al., 2002; Marx et al., 2001; Fraser and Scott., 
1999). In order to elucidate whether PP2A binds directly or through an intermediary 
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protein to BK channels, a blot -overlay assay using recombinantly expressed and 
purified STREX variant BK channel C- terminal or- subunit proteins could be devised to 
identify proteins that bind directly to the a-subunit, rather than through an intermediary 
protein. 
Cytoplasmic tail of the STREX variant BK channel .- subunit is necessary for its 
cell surface expression 
It has been demonstrated that the C- terminal of BK channel is necessary for the 
targeting of the channel to the plasma membrane (Chen et al., 2005; Kwon and 
Guggino., 2004; Bravo -Zehnder et al., 2000). However, the structural determinants that 
are involved in the trafficking of the channel to the plasma membrane are largely 
unknown. 
Immmunocytochemical studies of HEK 293 cells transiently expressing ZERO, STREX 
splice variants showed that ZERO and STREX splice variants of BK channel c- subunit 
are expressed at the cell surface (Chen et al., 2005). In addition, immunocytochemistry 
study of two isoforms of BK channel cc- subunit (rbslol and rbslo2) from rabbit renal cells 
showed that rbslol (NCB' accession number AF201702), which is highly homologous to 
BK channels from other species such as mslol and hslol , expresses in plasma 
membrane. Whereas the rbslo2, which was truncated at position Gly781, was localised in 
the endoplasmic reticulum and Golgi region (Wang et ai, 2003). 
In Madin -Darby canine kidney cells (Bravo -Zehnder et al., 2000), it has been shown that 
the BK channel cc- subunit truncated immediately after the S6 transmembrane region 
149 
(after residue 323) loses the capability for transport to the cell surface and is retained in 
the endoplasmic reticulum. Our results also demonstrated that STREX BK channel C-- 
subunit truncated at 1322, lacking almost the entire C- terminal tail, is largely retained in 
the endoplasmic reticulum and failed to reach the plasma membrane. 
Furthermore, our results revealed that STREX BK channel cc- subunit and STREX BK 
channel or- subunit truncated at glycine (G1020) is expressed in the plasma membrane. 
Therefore, the residues 322 -1020 of cytoplasmic tail of STREX BK channel cc- subunit, 
which is required for PP2A association with STREX BK channel cc- subunit, are also 
required for trafficking of the STREX BK channel to the plasma membrane. The lack of 
association of 1322 variant channel with PP2A may be due to not targeting of the 
channel to plasma membrane. 
Scanning mutations could be carried out to investigate whether or not the PPase 
association and plasma membrane targeting could be dissociated. In order to address 
this, further immunocytochemical and co- immunoprecipitations studies with BK channel 
cc- subunits mutated at C- terminal could resolve this issue. 
Regulation of PP2A by glucocorticoid hormones 
Our data showed that PP2A and PP1 are constitutively associated with the BK channel, 
the intensity of the reaction indicated that PP2A is much more abundant than PP1. 
Furthermore electrophysiological findings also pointed towards PP2A as the 
phosphatase involved in the action of glucocorticoid hormones on the BK channel. 
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Therefore, we have analyzed the IPs of BK channel cc- subunits pretreated with 
dexamethasone for PP2A immunoreactivity. 
Throughout this study, our data demonstrated that dexamethasone, which has marked 
PPase- dependent effects on the electrophysiological properties of the STREX variant 
BK channel (Tian et al., 2001 b; Shipston et al., 1996) does not enhance the recruitment 
of the PP2A complex to the BK channel cc.-subunits in HEK 293 cells and in native BK 
channel expressing cells, AtT20 cells. Consequently, the regulation of BK channels by 
glucocorticoid is likely to be due to changes in the enzymatic activity of the associated 
PP2A rather than the recruitment of more PP2A catalytic subunits to BK channels. 
Therefore direct monitoring of the PPase activity associated with BK channel cc- subunits 
pretreated is desirable to clarify the role of PP2A and /or PP1 in the action of 
glucocorticoids on the function of the STREX -BK channel. 
Final thoughts 
The data obtained indicate the association of PP2A with the BK channel. As the exact 
regulatory properties of PP2A depend on its subunit composition, it will be of importance 
to determine which additional components are present in the BK channel complex with 
the A and C subunits identified in the present study. This could be particularly relevant 
for the action of adrenal steroids on BK channel function. It would appear that the best 
plausible approach would be immunoaffinity isolation of the BK channel cc-subunit and 
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No effect of dexamethasone on Dexrasl mRNA Human Embryonic Kidney 
(HEK 293) cells 
Ghassem Attarzadeh Yazdi, Michael J Shipston and Ferenc Antoni, 
Department of Neuroscience, University of Edinburgh, EH8 9JZ, Membrane Biology 
Group, University of Edinburgh Medical School, Hugh Robson Building, Edinburgh, EH8 
9XD. Scotland, United Kingdom 
Previous work has indicated that Dexrasl is a glucocorticoid- induced protein that could 
mediate the effects of adrenal corticosteroids on the secretion of adrenocorticotrophic 
hormone. In the present study the effect of the synthetic glucocorticoid dexamethasone 
on Dexrasl expression was examined in HEK293 cells. A GR- reporter construct in 
which the expression of luciferase is under the control of the mammary tumor virus long- 
term repeat segment was transiently transfected into HEK 293 cells. The cells were 
exposed to dexamethasone 48h later. Analysis of dexamethasone action revealed dose - 
and time -dependent induction of luciferase activity. Analysis of the expression of 
endogenous mRNAs revealed expression of a -5kb Dexrasl and a -2.6kb 
glucocorticoid- induced protein kinase (SGK -1) mRNA species in HEK 293 cells. 
Dexamethasone had no significant effect on Dexrasl mRNA following varying times of 
treatment (0 to120 min) but significantly increased SGK -1 mRNA with maximum effect at 
30 min. The results suggest that in HEK 293 cells; 1) dexamethasone acts via 
endogenously expressed GR; 2) Dexrasl is not a glucocorticoid- induced gene in this 
system, while SGK -1 mRNA is induced. 
0468 
Ser/Thr protein phosphatases constitutively associated with large- conductance 
calcium- activated potassium (BK) channels 
Ghassem Attarzadeh Yazdi, Michael J Shipston, Ferenc Antoni 
Division of Neuroscience, University of Edinburgh, EH8 9JZ, Membrane Biology Group, 
University of Edinburgh Medical School, Hugh Robson Building, Edinburgh, EH8 9XD. 
Scotland, United Kingdom - 
Variants of BK- channels that arise through alternative exon splicing have distinct 
regulatory properties. Variants lacking splice inserts (ZERO) are activated by cAMP- 
dependent protein kinase (PKA) while those expressing STREX -1 at splice site 2 
(STREX) are inhibited. Glucocorticoid hormones block PKA- mediated inhibition of 
STREX through a protein phosphatase (PP) but have no effect on ZERO. As under 
control conditions PP does not regulate STREX, we hypothesized that glucocorticoids 
could recruit PP to STREX. Therefore, we have analyzed immunoprecipitates (IPs) of 
BK- channel a- subunits for PP subunit immunoreactivity. The A and C subunits of PP2A 
were detected in IPs from transfected human embryonic kidney 293 cells (HEK 293) 
expressing STREX and similar results were obtained in cells expressing ZERO. IPs 
prepared with an antibody against the A subunit of PP2A contained STREX -BK channel. 
Analysis of IPs for PP1 C subunit indicated much lower abundance when compared with 
PP2A. Subunits of PP2A also coimmunoprecipitated with BK- channels in extracts of 
mouse corticotroph tumour cells that predominantly express STREX. Treatment with 
dexamethasone did not produce a change in the amount of PP2A subunits associated 
with STREX or ZERO. In summary, PP2A is constitutively associated with STREX and 
ZERO BK- channels and this is not altered by glucocorticoid treatment. 
